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Abstract  
Growth hormone (GH) modulates adipocyte function to promote lipolysis via a cell surface 
GH receptor (GHR) which activates multiple signalling cascades including STAT5 and 
p42/44 MAP kinase (MAPK) pathways. The growth promoting effects of GH are mediated 
primarily by STAT5 activation but little is known about pathways mediating the effects of GH 
on adipocyte function. We therefore studied the effect of GH on STAT5 and MAPK (ERK) 
activation in the 3T3-L1 mouse pre-adipocyte cell line during adipogenesis. Cells were 
plated, allowed to reach confluence and cultured in adipogenic medium containing the 
PPAR agonist, pioglitazone. GH induced activation (10 minutes exposure) of STAT5 and 
MAPK was analysed on days 0, 2, 5 and 8 during adipogenesis by phospho-specific western 
blotting and densitometry.  
 
During adipogenesis, GH progressively loses the ability to activate p42/44 MAPK despite 
elevated GHR and unaltered total ERK levels. In contrast, GH-stimulated STAT5 activation 
increases as 3T3-L1 differentiation proceeds. Subsequently we investigated possible 
explanations for the altered GHR signalling. The adapter protein p66Shc is thought to be 
necessary to link GHR activation to the ERK pathway. However levels of this protein, 
measured by western blotting and densitometry, did not decrease as 3T3-L1 cells underwent 
adipocyte differentiation. GHR levels increase with adipogenic differentiation of 3T3-L1 cells 
leading us to hypothesize that this may lead to preferential association with JAK2-STAT5. 
This was tested by overexpressing the GHR in 3T3-L1; similar GH-stimulated ERK pathway 
activation was obtained in cells transfected with the GHR vector and in those transfected 
with the empty vector. Finally, we have investigated whether changes in GHR signalling also 
occur during adipogenesis of primary pre-adipocytes from mice and various human depots. 
There was minimal GH-induced phosphorylation of ERK at all time points before and during 
differentiation (required up to 15 days in primary cells) and no depot, either murine or 
human, demonstrated a reduction in pERK, suggesting that this feature is unique to 3T3-L1. 
Furthermore, ERK phosphorylation may be the stimulus for mitotic clonal expansion which 
occurs in the cell line but not in human primaries. GH-stimulated STAT5 activation increases 
as human and mouse primary pre-adipocytes differentiation progresses, as in the 3T3-L1 
cell-line, and may be the result of increased GHR transcript levels as differentiation 
proceeds. Future studies could investigate the mechanisms responsible for these similarities 
and differences. 
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General Introduction 
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1. Chapter one (General Introduction)  
 
 
1.1 Endocrine system 
The nervous system works together with the endocrine system to maintain homeostasis and 
long-term control of the organism using chemical signals known as hormones that regulate 
body processes. The principal glands that make up the human endocrine system include the 
hypothalamus and pituitary which together form the hypothalamic-pituitary axis, which is the 
basis of the link between the nervous system and the endocrine system. The hypothalamus 
secretes hormones into the blood which travel through the hypophyseal portal vessel to the 
secondary capillary plexus in the pituitary gland. The hypothalamic releasing hormones 
stimulate pituitary cells to release their hormones into the secondary plexus. The pituitary 
gland consists of two lobes known as the anterior pituitary or ‘adenohypophysis’ and the 
posterior pituitary or ‘neurohypophysis’. The posterior pituitary is not a separate organ, but 
instead is a physical extension of the hypothalamus that is primarily composed of the axons 
of hypothalamic neurons which extend downward forming a large bundle behind the anterior 
pituitary. The posterior pituitary releases the hormones vasopressin and oxytocin. The 
anterior pituitary is a gland composed chiefly of cells that secrete a variety of endorphins 
along with six different types of secretory cells. The anterior pituitary releases a number of 
hormones including growth hormone (GH) which plays a role in stimulating growth (Lloyd, 
2004). 
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“This image has been removed by the author for copyright reasons”. 
 
 
 
 
Figure 1.1 Hypothalamic-pituitary axis.  To view image see http://kcampbell.bio.umb.edu 
 
1.2 Growth hormone 
1.2.1 Historical background 
The first indication that the pituitary gland was involved in growth control came in 1886 when 
Pierre Marie observed that this gland was enlarged in one of his acromegalic patients 
(Marie, 1886; Brunori et al., 1995). Later, in the first half of the 20th century, Evan and Long 
(1922), demonstrated the complexity of the pituitary gland’s role in a study of the effects of a 
saline extract of bovine anterior pituitary gland on the growth of animals. Additional studies 
revealed that hypophysectomization (surgical removal of the pituitary gland) significantly 
altered the growth process. Hypophysectomy of young animals such as rats, frogs and dogs 
inhibited their growth. In older animals the procedure caused visceral atrophy and weight 
loss (Cole, 1938; Chawla et al., 1983).  
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In 1927, Smith et al. demonstrated that hypophysectomized rats treated with pituitary extract 
regained their normal growth pattern. The extract contained substances from the anterior 
pituitary gland of mammals and it was thought to be responsible for promoting body growth. 
This work with hypophysectomized animals helped to clarify the role of the pituitary gland in 
development. By 1945, other research had successfully isolated specific growth hormone 
(GH) from anterior pituitary glands (Li et al., 1945; Kopchick and Andry, 2000). Later, around 
1950, human GH was isolated from the pituitary and was used to treat short stature patients 
suffering from dwarfism (Raben, 1958). This condition is the result of pituitary growth 
hormone deficiency (GHD). 
 
1.2.2 Structure and secretion of GH 
GH is a member of the cytokine superfamily that also includes the hormones prolactin (PRL) 
and chorionic somatomammotropin, which share some structural homology with GH (Barsh 
et al., 1983; Forsyth, 1986; Corbacho et al., 2002; Jeay et al., 2002; Anderson et al., 2004; 
Le Tissier et al., 2012). The human GH gene is part of a cluster of 5 related genes on 
chromosome 17q23 which contains the GH1 and GH2 genes, two chorionic 
somatomammotropin genes and a pseudogene (CSHPI) (Barsh et al., 1983; Ohta, 1993; 
Procter et al., 1998) and is believed to have arisen following gene duplication events. The 
genes differ in their 3' flanking regions, but are essentially homologous through their 5' 
flanking regions (Barsh et al., 1983; Chen et al., 1989; Procter et al., 1998). 
The term "growth hormone" refers to the hormone produced and released from 
somatotrophic cells in the anterior pituitary gland (Anderson et al., 2004); it is also known as 
somatotrophin (Cole, 1938). GH affects the growth and differentiation of cartilage, bone and 
adipose cells through cell surface GH receptors (GHRs), which influence the metabolism of 
carbohydrates, proteins and lipids (Maharajan and Maharajan, 1993; Le Roith et al., 2001; 
Liao and Zhu 2004; Wei et al., 2009; Fuentes et al., 2012). GH primarily promotes growth 
indirectly; it binds to GHR on liver cells and promotes the release of insulin-like growth 
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factor-1 (IGF-1). IGF-1 then travels via the circulation to act directly on muscle, long bones 
and fat cells via IGF-1 receptors (Berneis and Keller, 1996; Wei et al., 2009) Figure 1.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Regulation of the GH secretion 
The hypothalamus regulates GH secretion through two hypothalamic peptides, a stimulating hormone 
called ‘‘growth hormone releasing hormone’’ (GHRH) and the inhibiting hormone ‘‘somatostatin’’ (SS). 
Regulation is via two pathways with the feed forward pathway affecting the liver/cells that secrete 
IGF-1. This hormone affects the hypothalamus and pituitary to inhibit further secretion GHRH and GH. 
GH then stimulates the hypothalamus to secrete SS which in turn prevents further secretion of GH. 
(Adapted from www.elp.manchester.ac.uk). 
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The GH gene, is localized on the 17q22-24 region of the long arm of chromosome 17 is 
about 3 kb long and is composed of 5 exons and 4 introns, which encode a 217-amino-acid 
protein. Cleavage of the signal peptide forms a mature single-chain polypeptide of 191-
amino-acid residues with a molecular weight of 22,124 Daltons (Da) (Niall et al., 1971; 
Chawla et al., 1983; Kopchick et al., 2002). 
 
 
 
 
“This image has been removed by the author for copyright reasons”. 
 
 
 
 
 
 
Figure 1.3 Three-dimensional structure of GH 
The structure of GH was elucidated after being crystallized in complex with its receptor.GH consists of 
four anti-parallel-helical bundles symbolized here as helix rods (shown as cylinders) arranged in an 
up-up-down-down topology. To view image see Abdel-Meguid et al., (1987) Proc. Natl. Acad. Sci. 
84:6434–6437. 
 
 
 
X-ray crystallography reveals the three dimensional structure of hGH as comprising two 
disulphide bridges linked to one large and one small peptide loop at residues 110 and 6 
respectively. Antiparallel secondary and tertiary structures with four -helices are arranged 
with an unusual configuration comprising a left handed bundle with an up-up-down-down 
topology (Abdel-Meguid et al., 1987; Watahiki et al., 1989; de Vos et al., 1992; Kopchick, et 
al., 2000). Three shorter helices, that could cause conformational changes of hGH when 
binding to its receptor, reside in the loop connecting the major helices (Kopchick et al., 2002) 
(Figure 1.3). 
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The level of GH secretion is controlled by a complex regulatory system (Figure 1.2). Many 
physiological factors influence GH secretion including age, gender, nutrition and hormones 
(Roemmich and Rogol, 1997; Trobec et al., 2011). The primary control of this system is 
exerted by two hypothalamic neuroendocrine hormones: growth hormone releasing hormone 
(GHRH) that stimulates secretion of GH and somatostatin (SS) which inhibits its secretion 
(Muller, 1987; Butler and Le Roith, 2001; Anderson et al., 2004). GH acts directly on the 
hypothalamus by a short loop mechanism to inhibit GHRH and stimulate production of SS to 
reduce secretion of GH. IGF-1 exerts indirect negative feedback via a long loop mechanism 
that inhibits secretion of GHRH (Colonna et al., 1989). Additionally, other hypothalamic 
neuropeptides contribute both directly and indirectly in the regulation of GH secretion. The 
complexities surrounding the regulation of each of these neuropeptides are determined at 
both the physiological and molecular levels (Butler and Le Roith, 2001).  
 
Additionally, free fatty acids act on the pituitary gland to inhibit GH production by forming a 
feedback loop while GH stimulates the mobilization of lipid (Butler and Le Roith, 2001). The 
action of leptin on rodents has been observed to stimulate the secretion of GH by acting on 
the hypothalamus to regulate GHRH and SS activity. Leptin stimulates GH release via its 
inhibition of the GH inhibitory peptide, neuropeptide Y. GH secretion is also regulated by 
other factors such as gonadotropin releasing hormone (GnRH), ghrelin, pituitary adenylate 
activating polypeptide (PACAP) and thyrotrophic releasing hormone (TRH) (Anderson et al., 
2004). Excess secretion of GH in young people causes gigantism and acromegaly in adults 
and deficiency of GH causes dwarfism (Zhou et al., 1997; Stewart, 2000).  
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1.2.3 Growth hormone receptor and distribution 
For understanding the regulation of growth and role of the GH in adipogenic differentiation, it 
is important to study the principles of GH action. At the molecular level the biological effect 
GH is initiated in the cell by binding on the cell surface growth hormone receptor (GHR). The 
GHR is a member of the Class I superfamily of transmembrane cytokine receptors, also 
known as the hematopoietic cytokine receptor family that comprises receptors for 
interleukins, interferon, colony-stimulating factors and tumour necrosis factors. These 
receptors share similar mechanisms of signal generation and transmission (Moutoussamy et 
al., 1998; Kopchick et al., 2002; Liongue and Ward, 2007). 
 
The Class I cytokine receptor family is the main group of cytokine receptors comprising 
structurally homologous cell surface receptors which do not posses intrinsic tyrosine kinase 
activity (Gent et al., 2002; Perret-Vivancos et al., 2006; Waters et al., 2006; Liongue and 
Ward, 2007; Deng et al., 2007). The Class I cytokine superfamily receptor has several 
characteristics which include a single membrane-spanning domain, an extracellular domain 
of about 210 amino acids with significant sequence homology (14-44%), along with 
preserved pairs of cysteine residues present in the extracellular domain (seven cysteine 
residues, six are paired and one unpaired) and a preserved tryptophan residue next to the 
second cysteine in the N-terminal fibronectin domain. The intracellular region immediately 
proximal to the membrane spanning region contains an 8 amino acid proline-rich box 1 
region and a box 2 region of approximately 15 hydrophobic amino acid residues and one or 
two positively charged amino acids which are located approximately 30 amino acids toward 
the c-terminal from box 1 in the GHR (Kopchick and Andry, 2000; Zhu et al., 2001; Gent et 
al., 2002). GHR lacks intrinsic tyrosine kinase activity therefore the activation of one or more 
members of the Janus kinase (JAK) family is required for the initiation of GH signal 
transduction upon ligand to the receptor. 
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Figure 1.4 Schematic representation of the GHR. 
A schematic digram of the GHRin which N represents extracellular domain N-linked glycosylation site, 
C represents cysteine residues and Y the tyrosine residues. (Adapted from Kopchick and Andry, 
2000, Mol Genet Metab. 71: 293–314). 
 
 
The interaction of the box 1/box 2 regions and the N-terminal region of JAKs leads to 
alignment of the JAK causing dimerization and reconfiguration of the receptor resulting in 
phosphorylation of both the JAKs and the receptor following GH binding, (Figure 1.4) 
(Murakami et al., 1991; Carter-Su et al., 1996; Kopchick and Andry, 2000; Zhu et al., 2001; 
Deng et al., 2007). Both box 1 and box 2 deletions and mutations abrogate signalling in 
members of the cytokine receptors superfamily (Ihle et al., 1995). In addition, mutation of the 
box 1 GHR region abrogates JAK2-STAT5 signalling in vivo, but preserves other signalling 
pathways (Barclay et al., 2010).  
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The GHR can exist in one of two distinct forms: the membrane-bound full length receptor or 
a soluble form of GHR also known as GH binding protein (GHBP) which comprises the 
extracellular domain of the GHR. In humans the GHR cDNA encodes a 638-amino acid 
polypeptide that consists of both a mature full-length receptor of 620-amino acids and an 18-
amino acid signal peptide. The mature GHR consists of an extracellular GH-binding domain 
of 246 amino acid residues, a transmembrane domain of 24 amino acid residues and a 
cytoplasmic domain of 350 amino acid residues (Postel-Vinay and Kelly, 1996; Edens and 
Talamanles, 1998; Moffat et al., 1999; Kopchick et al., 2002). The extracellular domain of the 
GHR includes two β sandwich subdomains (N-terminal 1-123 amino acids and C-terminal 
128-238 amino acids) which include seven β strands in both subdomains. The two 
subdomains 1 and 2 are bound together with seven strands via six loops organized into two 
antiparalle β sheets, while two highly preserved disulphide bridges maintain the stability of 
subdomain 1 (Postel-Vinay and Kelly, 1996; Behncken and Waters, 1999; Frank, 2002). The 
predicted molecular weight of the GHR is 70 kDa, but the apparent molecular weight 109 
kDa in human IM-9 lymphocyte and 124 kDa in human liver are due to post-translational 
modification, such as N-glycosylation (Kopchick and Andry, 2000). 
 
Low levels of GHR mRNA are present at birth, but increase in the postnatal period in organs 
such as the liver, adipose tissue, kidney, heart and muscle. GH regulates GHR gene 
expression (Moffat et al., 1999).  
 
The hGHR gene is located on the short arm of chromosome 5 spanning about 87 kbp in the 
5p13-p12 region. The hGHR gene encodes nine exons (exon 2-exon 10), exon 2 codes the 
signal peptide, exons 3-7 encode the extracellular domain, the transmembrane domain is 
encoded by exon 8, exons 9 and 10 encode the cytoplasmic domain (Amselem et al., 1996; 
Moffat et al., 1999; Blum et al., 2006).  
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GH binding protein (GHBP) corresponds to the extracellular ligand binding domain of the 
GHR (Moffat et al., 1999; Talamantes and Ortiz, 2002). In some species such as human 
and chickens, GHBP arises from the proteolytic cleavage of a membrane-spanning 
receptor, but in rats and mice the GHBP arises from an alternately spliced mRNA in which 
exons encoding the transmembrane and cytosolic domains of GHR are replaced with an 
exon that encodes a hydrophilic peptide (Frick et al., 1998; Moffat et al., 1999; Kopchick et 
al., 2002).  
 
The GHR is distributed in many tissues, including adipose tissue, hepatic tissue and 
immune tissue; it is also present in the eye, brain, heart, muscle, bone and kidney. GHR 
expression in adipose tissue is depot specific. For example, in the rat a high level of 
expression of the GHR is observed in the epididymal fat pad, while the retroperitoneal fat 
pad in contrast expresses a low level of GHR (Nam and Lobie 2000; Kopchick et al., 2002).  
 
1.2.4 GHR signalling  
GH has two GHR-binding domains and thus initiates signalling by binding to the 
extracellular domain of two receptors (Zhu et al., 2001). The GHR lack intrinsic tyrosine 
kinase activity and was the first cytokine receptor identified that induces signal transduction 
through receptor dimerization. Using X-ray crystallographic analysis of the molecular 
structure it was found that GH binds to two receptor molecules (Sundstrom et al., 1996). A 
model was designed showing how hGH has two receptor-binding sites with distinctive 
binding faces on either side of the molecule. These interactions are responsible for the 
structure and stabilization of the GH/GHR complex (Behncken and Waters, 1999; Zhu et al., 
2001; Waters et al., 2006). 
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Current models of receptor activation suggest that GH induces rotation of the receptor 
monomers within a pre-existing receptor dimer (see Figure 1.5), resulting in activation of 
Janus kinase 2 (JAK2), a cytoplasmic tyrosine kinase that is associated with box 1 domain of 
GHR. Upon ligand binding, JAK2 autophosphorylate and phosphorylate seven different 
tyrosine residues in the cytoplasmic domain of the hGHR. Adapter proteins contain multiple 
SH2 and/or PTB domains and can bind to other phosphotyrosine (PY) containing signalling 
proteins thus binding them to the cytoplasmic domain of the GHR and forming a multip 
rotation signalling complex (Zhu et al., 1998). The GHR cytoplasmic domain phosphtyrosine 
residues then act as docking points for SH2 and PTB domain-containing proteins resulting in 
the formation of a multiprotein signalling complex centred around the focal adhesion kinase 
associated protein p130Cas and the adaptor protein Crkll (Zhu et al., 1998).  
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Figure 1.5 Mechanism of GH binding to GHR 
GH binds first via its site 1 to receptor 1. Then binding to GH site 2 realigns the receptors such that 
receptor 1 is raised and rotated relative to receptor 2 because of the asymmetric placement of the 
receptor binding sites on the hormone. This relocation is transmitted through the transmemberane domain 
(TMD), aligning JAK2 kinases bound to box1 of the receptor, which facilitates their activation by 
transphosphorylation, so initiating the GH signaling cascades. (Adapted from Lichanska and Waters, 
2008, Horm Res. 69: 138-145). 
 
 
The complex comprises at least 15 different proteins including adaptor/scaffold proteins, 
cytoskeletal proteins and components of ERK and PI-3 kinase pathways and Src, thereby 
linking GHR activation to multiple downstream cell signalling pathways. The complex may be 
associated with the caveolae and lipid raft plasma membrane fraction and it is suggested 
that this localisation is necessary for coupling of the GHR to ERK pathway activation (Yang 
et al., 2004). The pathways leading from the GHR to ERK and PI3-kinase activation are 
complex and much remains to be determined. GH activates the ERK pathway both in a 
JAK2-dependent manner via the well characterised SHC-Grb2-SOS-Ras-Raf-MEK route 
(Vanderkurr et al., 1997) possibly involving Gab1 (Kim et al., 2002) and in a JAK2 
independent manner via Src (Zhu et al., 2002). Negative regulators of cell signalling are also 
associated with the GHR and possibly form part of the signalling complex. The protein 
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tyrosine phosphatase, SHP2, binds to the GHR where it may serve to down regulate GHR-
associated signalling and possibly to act as an adapter protein (Rowland et al., 2005). The 
suppressor of cytokine signalling proteins (SOCS2, SOCS3 and CIS) bind GHR 
phosphotyrosine residues (Du et al., 2003) and are believed to inhibit GH-induced 
transcription by competing with STAT5 (Figure 1.6). 
 
 
Figure 1.6 Tyrosine phosphorylation of the GHR cytoplasmic domain 
GH binding results in multiple tyrosine phosphorylation of the GHR which then act as docking points for 
signalling proteins resulting in activation of multiple signalling pathways. (Adapted from Lichanska and 
Waters, 2008, Horm Res. 69: 138-145). 
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1.2.5 Activation of multiple signalling pathways 
STAT5 
The signal transducer and activator of transcription (STAT) pathway is important in 
mediating the effects of GH. STATs are a family of latent transcription factors, including 
STAT1, 3, 5a and 5b, which are located in the cytoplasm of cells and are central regulators 
of the biological effects of GHR. Following GHR activation JAK2 phosphorylates the receptor 
cytoplasmic domain generating docking sites for specific signalling proteins, including STAT 
proteins (Ward et al., 2000; Waxman and O’Connor, 2006). STATs then become tyrosine 
phosphorylated by JAK2. Phosphorylated STAT5 forms a homodimer through its phospho-
tyrosine residues and is then translocated to the nucleus where it acts as a transcription 
factor resulting in the increased expression of specific target genes. Activation of the JAK2-
STAT5 pathway appears to be necessary for normal growth by regulating the expression of 
the target gene, IGF1 (Floyed et al., 2007; Moller and Jorgensen, 2009) (Figure 1.7).  
 
ERK  
Mitogen-activated protein kinases (MAPKs) are a family of signal transduction protein 
kinases which are activated by extracellular factors and produce downstream control of a 
variety of cellular actions. The MAPKs super-family is composed of three major sets of 
kinases: the extracellular signal regulated kinases (ERK 1-5) and two types of MAPK-related 
kinases; (c-Jun N-terminal kinases/stress-activated protein kinases (JNK1-3) and the p38 
MAP Kinases (p38 alpha, p38 beta2, p38 gamma and p38 delta). The MAPKs are a group of 
serine/threonine protein kinases. The extracellular signal-regulated kinase pathway, also 
known as p42/44 MAPK cascade consists of the MAPKKKs A-Raf, B-Raf and Raf-1, the 
MAPKKs MEK1 and MEK2 and the MAPKs ERK1 and ERK2. ERK1 and ERK2 are 
expressed in all tissues and cells with ERK2 levels generally higher than ERK1 (Roux and 
Blenis, 2004). The ERK 1/2 cascade is activated by a variety of stimuli such as growth 
factors, GH, insulin and cytokines, and controls proliferation, differentiation, cell cycle 
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progression, survival and many other cellular processes (Chuderland and Seger, 2005, 
Matsushita et al., 2009). The Ras/ERK pathway is activated by GH when JAK2 stimulates 
tyrosine phosphorylation of the Src homology-collagen adapter protein shc. This leads to 
activation of guanosine triphosphate (GTP)-binding proteins and Ras by inducing the 
exchange of GDP with GTP. This converts Ras into its active form (Horbinski and Chu, 
2005, Vantaggiato et al., 2006) enabling it to interact with a number of downstream effectors 
(Kolch, 2000). Activated Ras binds to Raf kinases at the cell membrane, which in turn 
activates MEK1 which then phosphorylate and activates ERK1 and ERK2 (Matsushita et al., 
2009). Activation of ERKs 1 and 2 by GH in 3T3-F442A pre-adipocytes leads to 
phosphorylation of the nuclear transcription factor CEBPβ and differentiation into adipocytes 
(Lanning and Carter-Su, 2006) (Figure 1.7).  
 
PI3 kinase 
Phosphatidylinositol 3-kinase (PI3 kinase) plays an important role in regulating many cellular 
processes including cellular metabolism, glucose uptake, lipid deposition, adiponectin 
secretion from adipocytes, cell proliferation and survival. GH stimulates actin cytoskeletal 
reorganization and lipogenesis via activation of PI3 kinase (Zhu et al., 2001, Del Rincon et 
al., 2007). GH activation of PI3 kinase follows activation of the insulin receptor substrate 
(IRS) proteins that associate with p85 protein, leading to activation of the protein kinase Akt 
(Wang et al., 2008; Moller and Jorgensen, 2009). Akt contributes to GH induction of ERK, 
p70 S6 kinase and phosphodiesterase activation, as well as engaging in antiapoptosis and 
proliferation (Wang et al., 2008). Akt plays a role in cell survival via inhibition of the 
proapoptotic caspase-3 protein (Lanning and Carter-Su, 2006) (Figure 1.7).  
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Figure 1.7 GH/GHR signalling pathways 
Diagram shows the various GH/GHR signalling pathways. To view image see Xu and  Messina, 
(2009) Vita & Horm 80: 125–153. 
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1.2.6 Effects of GH 
GH is involved in the control of several complex physiological processes, including growth 
and aspects of metabolism (Le Roith et al., 2001; Kopchick et al., 2002; Wei et al., 2009). It 
plays an important role in regulation of many processes including differentiation of 
adipocytes, supports maintenance and development of the immune system, neurological 
and cardiac function (Kopchick et al., 2002). An important concept in understanding GH 
activity is that it has two distinct types of effects: direct and indirect (Nam and Lobie, 
2000).The direct effects of GH are via the GHR on target cells such as chondrocytes and 
osteoblasts. GH also affects adipocytes leading to stimulation of triglyceride breakdown and 
suppression of their ability to take up and accumulate circulating lipids (Davidson, 1987, 
Richelsen et al., 1994; Moller and Jorgensen 2009).The principal function of GH in 
promoting body growth is an indirect effect caused by stimulating the liver and various other 
tissues to secrete IGF-I. IGF-I then acts on its target cells, for example by stimulating 
proliferation of chondrocytes, resulting in bone growth. IGF-1 also plays an important role in 
the regulation of 3T3-L1 adipocyte differentiation and lipid accumulation (Kloting et al., 2008, 
Wei et al., 2009). Stimulation of IGF1 synthesis by GH in peripheral tissue regulates many 
other processes such as insulin sensitivity (Clemmons, 2007). GH has important effects on 
protein and carbohydrate metabolism, both directly and indirectly via IGF-1. These functions 
vary from protein synthesis, leading to increased muscle mass to calcium retention and 
mineralization of bones, as well as stimulating the immune system to maintain functions 
such as homeostasis (Morikawa et al., 1984). 
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1.3 Adipocytes 
The balance between both lipogenesis and lipolysis is modulated by hormonal signals from 
the bloodstream, which provide an indication of the body’s metabolic condition (Large et al., 
2004; Kim and Ntambi 1999). In addition, adipose tissue can be regarded as the largest 
endocrine organ in mammals acting as a secretory and endocrine organ that mediates 
physiological and pathological processes (Gregoire, 2001; Galic et al., 2009; Li et al., 2009). 
The adipocyte plays an essential role in energy balance and storage in the form of 
triglycerides (Gregoire et al., 1998; Leonardsson et al., 2004; Li et al., 2009) which can be 
broken down into free fatty acids when energy is required. Adipose tissue growth involves an 
increase in adipocyte size and the development of new adipocytes from precursor cells 
(Gregoire et al., 1998; Louveau and Gondret 2004). Hormones and proteins secreted by 
adipocytes include more than 50 types of adipokines (Goralski and Sinal 2007) and include 
leptin, adiponectin, resistin and tumor necrosis factor α (TNFα) (Maeda et al., 2002; Fain and 
Gerald, 2006; Scherer, 2006). 
 
 
The adipocyte develops from an embryonic stem cell precursor with the capacity to 
differentiate into the mesodermal cell types of adipocytes, chondrocytes, osteoblasts, and 
myocytes (Gregoire et al., 1998). Several transcription factors regulate the differentiation of 
preadipocytes into mature adipocytes (Figure 1.8). Following growth arrest, at the G1/S 
phase, preadiopcytes receiving appropriate mitogenic and adipogenic signals differentiate 
into mature adipocytes. Mitotic clonal expansion may be required for progression through 
subsequent steps in the differentiation program. Upregulation of the transcriptional 
regulators C/EBPα and PPAR is essential for activation of adipocyte specific genes 
following addition of an adipogenic cocktail comprising insulin or IGF-1, a glucocorticoid and 
a mediator to enhance levels of cAMP (Figure 1.8) (Altiok et al., 1997; Otto and Lane, 2005).  
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Two types of adipose tissue exist: white and brown (Tiraby and Langin, 2003). White 
adipose tissue (WAT) stores energy when food intake exceeds energy expenditure. WAT 
development takes place quickly after birth as a consequence of enlarged adipocyte cell size 
and an increase in adipocyte cell number (Kozak et al., 1988). Brown adipose tissue (BAT) 
stores less lipid and has more mitochondria than WAT (Kozak et al., 1988; Klaus, 2004). The 
inner mitochondrial membrane of BAT cells expresses the uncoupling protein 1 (UCP-1) 
which renders the inner mitochondrial membrane leaky. Thus energy utilization is uncoupled 
from ATP generation, instead producing heat in a process called adaptive thermogenesis 
(Klaus, 2004). 
 
A variety of cell culture models, including preadipocyte cell lines and primary cultures, have 
been used to understand the molecular and cellular activities that take place during the 
adipocyte differentiation process (Gregoire et al., 1998). The most commonly utilized cells for 
the study of adipocyte differentiation are the 3T3-L1 and 3T3-F442A preadipocyte cell lines 
(Watt, 1991; Salazar-Olive et al., 1995).   
 
These were clonally isolated from Swiss 3T3 fibroblast cells derived from disaggregated 17-
19-day old mouse embryos (Green and Kehinde; 1974; Green and Meuth, 1974; Green and 
Kehinde, 1975). Adipocyte differentiation of 3T3-L1 and 3T3-F442A cells occurs 
spontaneously after growth arrest in confluent cultures and cells develop characteristics of 
mature adipocytes. The phenotype changes to a rounded cell shape characteristic of 
adipocytes with accumulating lipid droplets.  
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Figure 1.8 The adipocyte differentiation pathway 
Pluripotent stem cell precursors give rise to a mesenchymal precursor cell with the potential to 
differentiate into myoblast, chondroblast, osteoblast and adipoblast. Adipoblast conversion into 
mature adipocytes occurs at the terminal differentiation stage. To view image see Gregoire et al., 
1998 Physiol Rev 78:783-809. 
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1.3.1 Adipogenesis 
Obesity is a major health problem, especially in the developed world. It is a risk factor for a 
number of pathological disorders such as cardiovascular disease, hypertension, insulin 
resistance, Type 2 diabetes, certain cancers, and atherosclerosis (Caprio, et al., 1995; 
Ntambi and Young-Cheul, 2000; Hossain et al., 2007; Knai et al., 2007). Obesity is a result 
of increased food intake and low energy expenditure leading to increased tissue mass. 
Adipose tissue increases its’ mass by increasing the size of adipocytes; known as 
hypertrophy, increase in cell number (hyperplasia) involves differentiation of preadipocytes 
(Otto and Lane, 2005). 
Understanding adipogenesis is an important goal towards understanding the way to control 
obesity (Ntambi and Young-Cheul, 2000). Under growth arrest conditions, several cell lines 
such as 3T3-L1 can convert to adipocytes in response to hormones and growth factors 
(Smith et al., 1988; Shang and Waters, 2003). In cell culture, the adipogenic process can be 
initiated by adipogenic hormonal cocktails, which can include insulin, glucocorticoids and 
fetal calf serum (FCS), dexamethasone (Dex), methylisobutylxanthine (IBMX) and 
triiodothyronine (T3) (Smith et al., 1988; Salazar-Olive et al., 1995 Farmer, 2006). 
Differentiated cells then display adipocyte morphology with increased accumulation of 
triglycerides and high expression of lipogenic enzymes (Smith et al., 1988). Insulin also 
affects adipogenesis in the early stages by acting through the insulin-like growth factor 1 
(IGF-1) receptor. IGF-1 promotes proliferation in preadipocyte and enhances cell 
differentiation in cell lines and primary cultures (Kamai et al., 1996; Gerfault et al., 1999). 
Dex is a synthetic glucocorticoid agonist that stimulates the glucocorticoid receptor pathway 
(Wang et al., 2012). IBMX is a cAMP-phosphodiesterase inhibitor that stimulates the cAMP-
dependent protein kinase pathway. Glucocorticoids may also lead to an increase in cAMP 
(Green and Kehinde, 1974; Green and Kehinde 1975; Green and Meuth, 1974; Morrison 
and Farmer, 1999; Ntambi and Young-CheulKim, 2000; Morrison and Farmer, 2000).  
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Glucocorticoids and cAMP signalling are required during adipogenesis to induce the 
transcription of CEBPα and CEBPβ (Cao et al., 1991; Zhang et al., 2004). T3 appears to 
function as a positive modulator of PPAR activity (Obregon, 2008). Pref-1 is expressed in 
pre-adipocytes and down regulation is required for cells to progess along the adipogenic 
pathway. Pref-1 is present in 3T3-L1 preadipocytes, but absent in mature adipocytes and 
plays an important role in inhibiting of adipocyte differentiation (Sul et al., 2000). 
 
1.3.2 Transcriptional regulation of adipogenesis 
PPAR 
PPAR is a member of the nuclear hormone receptor family (Adams et al., 1997; Fajas et al., 
2001; Viswakarma et al., 2010; Shen et al., 2012) which plays an important role in control of 
various biological processes (Koeffler, 2003; Shen et al., 2012). The three major types that 
have been identified are: PPARα, PPARβ and PPAR. PPAR is expressed in two isoforms, 
PPAR1 and PPAR2. PPAR2 is mainly expressed in adipocyte cells while PPAR1 is also 
expressed in liver and breast. PPAR is a master key for regulation and stimulation of 
adipogenesis (Tontonoz et al., 1994; Viswakarma et al., 2010; Cipolletta et al., 2012). 
C/EBPα interacts with PPAR gene (Fajas et al., 2001; Rosen et al., 2002; Miard and Fajas, 
2005) regulating numerous genes leading to adipogenesis (Kletzien et al., 1992; Sandouk et 
al., 1993; Tontonoz et al., 1994; Lehmann et al., 1995; Chen et al., 1998; Saladin et al., 
1999; Grimaldi, 2001; Fajas et al., 2001; Viswakarma et al., 2010). 
 
The expression of PPAR is both essential and sufficient for adipocyte differentiation in vitro 
and in vivo (Tamori et al., 2002; Shang and Waters, 2003; He et al., 2003; Matsuaue et al., 
2004; Imai et al., 2004, Kim and Chen, 2004; Jones et al., 2005). PPARs are activated by 
specific ligands which act to stimulate expression of specific target genes (Marx, 2002). 
PPAR is activated by a number of endogenous activators including the eicosanoids 9 and 
 23 
 
13-hydroxyoctadecadienoic acids (Willson et al., 2000), prostaglandin D2 derivative 15-
deoxy-Δ 12, 14-prostaglandin J2 (15d-PGJ2) forms of oxidized linoleic acids (Touyz & 
Schifrin, 2006) and conjugated linoleic acid (CLA) (Moya-Camarena et al., 1999). PPAR 
activation lead to heterodimers with the retinoid X receptor (RXR) causing the 
heterodimerization and binding of PPAR response elements (PPREs) within the promoter 
target genes enhancing gene expression (Figure 1.9). Many factors such as protein kinase A 
(PKA) and PKC, ERK, 5’ adenosine monophosphate-activated protein kinase (AMPK), 
medium and long-chain fatty acids and eicosanoids enhance the expression of PPARs 
(Escher and Wahli, 2000; Touyz and Schifrin, 2006). Growth factors such as platelet derived 
growth factor (PDGF) phosphorylate PPARs through the ERK signalling pathways and 
decrease transcriptional activity of PPAR (Paoletti et al., 2004). Once PPAR is ligand-
activated the co-repressor complex begins to dissociate while a co-activator complex, 
containing histone acetylase activity is recruited by the PPAR/RXR heterodimer. These 
PPARs have been demonstrated to regulate gene expression by a number of transcriptional 
activities. First, PPARs bind to response elements thus the initiating of transcription; 
secondly, PPARs can negatively regulate the expression of gene in a ligand dependent 
manner (Ricote and Glass, 2007). 
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Figure 1.9 PPARs/RXR heterodimers 
PPARs form heterodimers with RXR. The heterodimers bind to PPAR response elements (PPREs) 
stimulating gene expression. To view image see Marx (2002). Curr Hypertens Rep 4:71-77. 
 
C/EBP 
CCAAT/enhancer binding protein α (C/EBPα) is a member of the C/EBP family and was the 
first transcription factors recognized to play a major role in adipocyte differentiation (Freytag 
et al., 1994). In the early stage of adipocyte differentiation treatment of the pre-adipocyte 
with factors and hormonal inducers of adipogenesis leads to increased expression of 
C/EBPβ and C/EBP followed by an increase of expression of C/EBPα (Darlington, et al., 
1998; Rosen et al., 2000; Tong et al., 2005; Khanna-Gupta, 2008; Moller and Jorgensen, 
2009; Rahman et al., 2012). The main role of C/EBPα is to conserve PPAR expression 
during adipogenesis and insulin sensitivity (Lazar, 2002; Lefterova et al., 2008). Evidence 
from C/EBPα knockout mice supports the physiological function of C/EBPα in adipose tissue 
development, since C/EBPα null mice do not develop either WAT or BAT (Chen et al., 
2000). C/EBPβ and C/EBP are essential factors for terminal differentiation of WAT and BAT 
adipocytes, but do not induce spontaneous differentiation without hormonal inducers 
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(Tanaka et al., 1997; Darlington et al., 1998). Knockout of C/EBPβ and C/EBP genes in 
mice do not produce any effect on the levels of PPAR or C/EBPα. In addition, they do not 
induce adipogenesis (Tanaka et al., 1997). C/EBPα is involved in the regulation of 3T3-L1 
adipocyte differentiation (Breed et al., 1997, Tong et al., 2005). C/EBPα binds and 
transactivates the promoters of several adipocyte genes that include aP2, stearoyl-CoA 
desaturase (SCD1), glucose transporter type 4 (GLUT-4), phosphoenolpyruvate 
carboxykinase (PEPCK), leptin and the insulin receptor (Darlington et al., 1998).  
 
KLFs 
Some kruppel-like zinc figure transcription factors (KLFs) act as promoters, but others act as 
transcriptional repressors. (Li et al., 2005; Brey et al., 2009). KLF2-7, KLF11 and KLF15 are 
key factors for controlling adipocyte differentiation (Brey et al., 2009). Overexpression of 
KLF15 leads to increased PPAR expression and adipogenesis (Mori et al., 2005). However 
inhibition of KLF15 does not affect the expression of C/EBPβ (Mori et al., 2005). Reduction 
of KLF4 blocks differentiation and represses C/EBPβ expression (Birsoy et al., 2008). KLF5 
regulators the transcription factor network that governs and promotes adipocyte 
differentiation at an early stage. Inhibition of KLF5 and KLF6 exhibit a decrease in 
differentiation (Oishi et al., 2005; Li et al., 2005; Brey et al., 2009). KLF2 is present in pre-
adipocytes and overexpression inhibits PPAR and C/EBPα expression, but does not effect 
C/EBPβ and C/EBP (Banerjee et al., 2003; Brey et al., 2009). Overexpression of KLF7 in 
pre-adipocyte represses differentiation (Kanazawa et al., 2005; Brey et al., 2009). 
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Other transcription factors 
Several molecules are expressed at different levels over the course of adipocyte 
differentiation. Overexpression of the zinc finger-containing transcription factor Krox20 
promotes the early stage of differentiation through the transactivation of C/EBPβ (Chen et 
al., 2005; Birsoy et al., 2008). Adipocyte determination and differentiation factor 1/sterol 
regulatory element-binding protein (ADD1/SREBP) is a member of helix-loop-helix leucine 
zipper (HLH-LZ) family takes part in the differentiation by repressing differentiation (Kim et 
al., 1998). ADD1/SREBP1c may stimulate pre-adipocyte differentiation through induction of 
the endogenous ligand of PPAR (Kim and Spiegelman, 1996; Kim et al., 1998). In addition, 
ADD1/SREBP1c mediates insulin stimulation of the fatty acid synthase (FAS) and leptin 
genes through transactivation promoters (Kim et al., 1998). ADD1/SREBP1c knockout mice 
exhibit normal WAT development, but reduced fatty acid synthesis in the liver (Shimano et 
al., 1997). However, a mouse model with adipose tissue specific overexpression of SREBP-
1c driven by adipocyte-specific aP2 enhancer/promoter shows retarded WAT differentiation, 
fatty liver, insulin resistance and diabetes (Shimomura et al., 1998).  
 
Liver X receptors (LXRs) are nuclear hormone receptors. In liver and macrophages LXRs 
regulate cholesterol, fatty acid and glucose homeostasis. LXR enhances lipogenesis and 
binds to the promoters of PPARγ and ADD1/SREBP1c to increase gene expression and 
enhance differentiation (Seo et al., 2004). LXRβ is crucial for adipocyte size enlargement. In 
LXRβ deficient mice reduced lipid accumulation in adipose tissue and impaired glucose 
sensitivity leads to reduced insulin secretion (Gerin et al., 2005). 
 
 
 
 
 27 
 
1.3.3 Effect of GH on adipocyte biology 
The differentiation of pre-adipocytes into adipocytes takes place following a specific 
sequence of events (Gregorie, 2001). GHR expression is present in both immature and 
mature adipocytes, but GHR numbers increase with differentiation (Zou et al., 1997, Yu, 
2000). GH plays an important role in the stimulation of the differentiation of pre-adipocytes to 
adipocytes both directly (Berneis and Keller, 1996; Zou et al., 1997; Iida et al., 2003; Flint et 
al., 2006) and indirectly via IGF-1 (Daughaday and Rotwein, 1989; Zou et al., 1997; Flint et 
al., 2006). A stimulatory effect of GH on adipogenesis is seen in GHD patients who have an 
enlarged mean adipocyte volume with decreased numbers of adipocytes and regain normal 
levels of adipocytes following GH treatment (Bengtsson et al., 1992; Rosenbaum et al., 
1989). GH has two opposite actions on adipose tissues: to induce an insulin-like effect that 
stimulates adipogenesis and an anti-insulin-like effect to induce lipolysis (Moller et al., 1999). 
The regulation of adipocyte differentiation and function by GH mediated signalling involves 
PPAR and C/EBPα (Richter et al., 2003; Floyed et al 2007). In young rodents the lack of 
STAT5 or GHR causes weight loss from the epididymal fat pads, while in the mature subject 
this affects accumulation of subcutaneous fat (Aubert et al., 1999; Lichanska and Waters, 
2008). In COS cells STAT5 plays a role in inhibition of PPARα transcriptional activity 
stimulated by GH. Both STAT5 and PPAR signalling cascade stimulation by GHR in 
preadipocytes induces differentiation into adipocytes (Aubert et al., 1999). 
 
The process of triglyceride breakdown into free fatty acids and glycerol along with the 
release of energy inside the adipocyte is known as lipolysis (Figure 1.10)(Langin, 2006). GH 
is an important stimulator of lipolysis (Sakharova et al., 2008, Dietz and Schwartz, 1991) 
causing the breakdown of fat, thus reducing the mass of adipose tissue by the activation of 
hormone-sensitive lipase (HSL) (Dietz and Schwartz, 1991; Asada et al., 2000). 
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GH acts together with adrenergic catecholamines (Kamel et al., 2000) released from the 
hypothalamus to cause the phosphorylation of HSL, an effect mediated by cAMP-protein 
kinase A. Phosphorylated HSL is then translocated to the surface of lipid droplets which are 
then hydrolysed into FFAs and glycerol leading to increased fatty acid release to the blood 
(Vernon et al., 1993; Yang et al., 2004; Miyoshi et al., 2008). Other factors play a critical role 
in regulating lipolysis, such as leptin, which is secreted by adipocytes and functions as an 
inhibitor of lipogenesis (Fruhbeck et al., 1997; Ramsay, 2003) and adipokines, such as 
resistin, adiponectin and visfatin (Bouloumie et al., 2005) that have the ability to regulate fat 
metabolism, energy balance and insulin sensitivity (Trayhurn et al., 2006). 
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Figure 1.10 Lipogenesis/lipolysis. 
The balance between lipogenesis and lipolysis. To view image see Kahn and Flier, 2000, J Clin 
Invest. 106: 473–481 
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1.4 Objectives 
The primary objective of this study was to increase the understanding of those 
mechanisms which allow GH to regulate the function of adipocytes. Secondary objectives 
were to provide a unifying framework and to validate objective through experimentation. 
Therefore, the first part of this study was to determine if 3T3-L1 cells are a suitable model 
for this study of pre-adipocyte differentiation under this protocol. The second part of the 
study was to determine the level of GHR during differentiation and observe GH-activated 
cell signalling pathways at various time points as the 3T3-L1 cell line progresses along the 
differentiation pathway. Results from Chapter 3 show that ERK activation declined as 3T3-
L1 cells underwent differentiation. Therefore, the third part of this study was to find possible 
explanations as to why ERK declined. As the effect of the GH on adipocyte function is 
poorly understood, the study was broadened to observe the GH signalling pathways on 
primary mouse and human cell as they undergo differentiation.  
 
 
 
 
  
 
Chapter Two
The 3T3-L1 cell line as a model for the
study of adipocyte differentiation
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2. Chapter Two 
2.1 Introduction 
2.1.1 The 3T3-L1 cell line 
Although cell lines had been originally developed by the zoologist Harrison earlier in 1907 
(Walker and Rapley, 2008), those cell lines in use during the 1960s were not evolved 
according to any protocol that would ensure defined properties (Todaro and Green, 1963). 
Therefore, in 1963 Todaro and Green decided to develop a new approach that would allow 
any researcher to control both the inoculation density and frequency of transfer, thereby 
allowing the cell density to be regulated. With their strict protocol they succeeded in deriving 
stable cell lines which include the now ubiquitous 3T3-L1 cell line. Green then went on to 
develop the 3T3-L1 cell line as a model for adipose differentiation (Green and Kehinde, 
1975). 
3T3-L1 cells exhibit a fibroblast-like morphology that under appropriate incubation conditions 
are able to differentiate into adipocyte-like phenotypes. Once confluent the medium is 
replaced with a cocktail comprised of hormones and growth factors. When the cell 
morphology begins to change an increase in enzyme activity related to the metabolism of fat 
can be observed (Grimaldi et al., 1978). A critical regulator of the transcriptional cascade 
that leads to adipogenesis is PPAR (Grimaldi, 2001). PPAR is the main target for the class 
of drugs known as thiazolidinediones (TZD) that are used to treat Type 2 diabetes. In 
addition to their use in adipogenesis and increasing insulin sensitivity they increase glucose 
uptake to mediate glucose homeostasis. By including a PPAR agonist such as pioglitazone 
in the medium, adipocyte differentiation can be improved which allows for an increase in the 
synthesis and accumulation of triglycerides. Also, PPAR expression can be used as the 
marker of the differentiation of pre-adipocytes cells into adipocytes. 
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The 3T3-L1 pre-adipocyte cell line can be used as an in vitro model of adipogenesis through 
the inducement of differentiation. In turn, the encouragement of differentiation reveals 
morphological changes that are characteristic of adipogenesis such as the appearance of 
vacuoles occupied with lipid (Rose et al., 2002; Stephens and Pekala, 1992). A combination 
of phase contrast microscopy, cell staining and quantitative real time polymerase chain 
reaction (QPCR) were valid procedures for investigating the effect that physiological 
mediators had upon pre-adipocyte differentiation using the 3T3-L1 cell line. 
 
2.1.2 The polymerase chain reaction 
The polymerase chain reaction (PCR) was invented in 1983 by Kerry Mullis and is one of the 
most widespread methods of analysing DNA (Bartlett and Stirling, 2003). The sole purpose 
of PCR is to amplify specific regions of a section of DNA. PCR produces several million 
copies of a gene which allows a template for sequencing. The first of three steps in a PCR is 
denaturation where the double stranded the DNA split to form two single strands of DNA 
molecules. Next is annealing of the primers which takes place. Finally, the extension is an 
ideal working temperature for the polymerase. This technique was further refined by Higuchi 
et al., (Higuchi, 1993) to allow the real-time analysis of PCR product accumulation. This 
technique is also known as quantitative PCR (QPCR). The main advantage of QPCR over 
conventional PCR is that QPCR allows for the determination of the starting template copy 
number with a high level of accuracy and sensitivity across a broad dynamic range. QPCR is 
based on the relationship between the amount of the initial template and the threshold cycle 
(CT) value obtained during amplification. Also, as the QPCR reactions are run and evaluated 
within a closed-tube system the possibility for contamination is significantly reduced. Finally, 
this method is fast, easily automated and allows for the use of SYBR green. Also, samples 
can be analysed with any pair of primers for the detection of any product without the need to 
specify specific probes. QPCR allows the DNA to be measured after each cycle through the 
use of one of several fluorescent markers. 
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Of the various QPCR techniques, the simplest uses the fluorescent dye, SYBR Green 
(Rasumussen et al., 1998). When the dye binds to the double stranded (ds) DNA the 
fluorescent signal increases proportionally to the quantity of dsDNA present. The starting 
quantity of the amplified target DNA molecule is inversely proportional to the Ct which is the 
cycle at which the fluorescent signal of the sample has increased above background 
fluorescence level. Ct is measured during the exponential phase of PCR when the amount of 
amplicon doubles each cycle. In QPCR samples with a higher initial concentration of 
template take less time to accumulate a threshold concentration and have a lower Ct value 
than a template with a lower starting concentration. 
 
Absolute and relative quantification are the two methods used to present quantitative gene 
expression. Absolute quantification calculates the copy number of the gene usually by 
relating the PCR signal to a standard curve; whereas relative gene expression presents the 
data of the gene relative to some calibration or internal control gene. The selection and 
optimization of the reference housekeeping gene is an extremely important step in the 
development of QPCR assay. For many genes, expression levels alter significantly from 
gene to gene or cell to cell. An internal control gene are the transcription of such genes 
should not affected by experimental conditions. The housekeeping gene used as an internal 
standard and the transcription of such genes is used for the normalization of gene 
expression data. QPCR is used to look at expression levels of adipocyte differentiation 
markers in 3T3-L1 cells undergoing differentiation. The cytosolic enzyme glycerol-3-
phosphate dehydrogenase (GPDH) catalyse the conversion of dihydroxyacetone phosphate 
(DHAP) to glycerol 3-phosphate as part of the process of triglyceride synthesis in adipose 
tissue. The level of this enzyme has been shown to increase in cells during the later stages 
of adipocyte differentiation (Wise and Green, 1979; Sottile and Seuwen, 2001) and as such 
is a useful late stage differentiation marker. Additionally, PPAR expression is up-regulated 
in cells undergoing adipocyte differentiation (section 1.3.2) and can also be used as a 
differentiation marker.  
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2.1.3 Oil Red O staining 
Lipids within tissues are difficult to stain as they are un-reactive and possess only a limited 
number of sites where molecules from a stain can bind. Also, as lipids are leached out 
during routine procedures by those solvents for staining, their presence is inferred by the 
absence from tissue. Furthermore, most lipid stains do not form covalent, ionic or hydrogen 
bonds with lipid components, therefore stains such as Oil Red O depend upon the 
preferential solubility of some chemicals. However, the advantages of Oil Red O are that it is 
inexpensive, simple and useful stain for revealing the presence of fat in 3T3-L1 cells during 
differentiation. Oil Red O is a fat-soluble diazo dye used to stain neutral triglycerides and 
lipids that allows the differentiation changes to become visible under microscopic 
observation based on the identification of cytoplasmic lipid. Differentiation was evaluated by 
measuring the lipid content by Oil Red O staining and expression of adipocyte differentiation 
markers. Special stains for neutral fats are often helpful in establishing the lipid content of 
cytoplasmic vacuoles as well as a diagnostic tool for the differentiation of 3T3-L1. 
2.1.4 Aims  
The principle aim was to validate a differentiation method that would maximize the 
differentiation of the 3T3-L1 pre-adipocyte cell line into adipocytes using a combination of 
QPCR, phase contrast microscopy and cell staining. In addition, I wished to study the effect 
that the GH/GHR complex had upon cell signalling during 3T3-L1 cell differentiation while 
becoming familiar with these methods. 
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2.2 Materials and Methods 
2.2.1 Cell culture 
Culture procedures were carried out within an aseptic environment maintained in a laminar 
flow hood. All culture media and components were obtained from Lonza (Lonza Group, 
Basle, Switzerland) and tissue culture plates from Nunc (Fisher Scientific UK Ltd., 
Loughborough, UK). 
2.2.1.1 3T3-L1 cell culture medium 
3T3-L1 cells were obtained from American Type Culture Collection (ATCC). The medium 
was Dulbeco’s Modified Eagle Medium (DMEM) with 4.5 g/l glucose, L-glutamine without 
sodium pyruvate, supplemented with 10% calf serum and antibiotics with a final 
concentration of 100 µg/ml penicillin, 100 µg/ml streptomycin and 2.5 µg/ml fungizone. The 
cultures grew as a monolayer and were maintained in an incubator at 37˚C in a humidified 
atmosphere of 5% CO2 in air. 
2.2.1.2 Trypsinization of cell cultures 
3T3-L1 cultures were trypsinized at 70-80% confluence, to avoid spontaneous differentiation. 
Culture medium was aspirated and the monolayers washed twice with 5 ml Hank’s Balanced 
Salt Solution (HBSS) with phenol red without Ca2+ or Mg2+. Trypsin (0.05% w/v in HBSS), 5 
ml per 75 cm2 flask culture cell was added until they detached from the plate aided by 
manual agitation. Trypsin was removed and the flask washed with 5 ml complete medium 
(section 2.2.1.1) then added to 5 ml trypsin to remove the cells. The cell suspension was 
centrifuged at 1000 rpm (Sanyo, MSE, Fisons, UK) for 5 minutes at room temperature. The 
supernatant was removed and the cell pellet re-suspended in 5 ml of culture medium 
(section 2.2.1.1) pre-warmed to 37˚C. Cells were counted using a haemocytometer (Weber 
Scientific International Ltd, Teddington, Middlesex, UK) and maintained by trypsinzing and 
plating at 1:5 dilution two times per week. 
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2.2.1.3 Freezing and thawing of cells 
3T3-L1 cultures were trypsinized (section 2.2.1.2) then centrifuged for 5 minutes at 1000 
rpm at room temperature. The supernatant was aspirated and the pellet was re-suspended 
at 1x106 cells/ml in chilled 10% Dimethylsulfoxide (DMSO) in FCS then aliquot into 1 ml 
sterile cryo vials. Cells were cooled at a controlled rate to -85˚C using a Nalgene Cryo 1 C 
container. The following day cells were transferred into liquid nitrogen until required. Cells 
were quickly thawed under warm tap water and transferred to 10 ml culture medium, 
centrifuged at 1000 rpm for 5 minutes supernatant removed. Pellet was re-suspended in 5 
ml of culture medium and cell suspension transferred to a 25 cm2 tissue culture flask. After 
24 hours of incubation, the medium was removed by aspiration and replaced with 5 ml 
fresh culture medium. These cells were then trypsinized until 70-80% confluent. 
 
2.2.1.4 Differentiation of 3T3-L1 
In order to induce adipocyte differentiation the pre-adipocyte 3T3-L1 cells were changed to 
differentiation medium (Table 2.1) (Zhang et al., 2006) when the cells became confluent. The 
differentiation medium comprised a 1:1 mix of DMEM and Ham’s F12 supplemented with 5% 
FCS and a cocktail of supplements (Table 2.1). 
 
Table 2.1: Components of the differentiation medium 
 
Components Final concentration 
Biotin 33 µM 
Pantothenic acid 17 µM 
T3 1 nM 
Hydrocortisone 1 µM 
Pioglitazone 1 µM 
Insulin 500 nM 
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2.2.1.5 Oil Red O staining 
The degree of adipocyte differentiation was calculated by staining the cells with Oil Red O 
(Sigma-Aldrich, Saint Louis, MO, USA). Prior to use, 3 ml Oil Red O solution was mixed with 
2 ml distilled water and left at room temperature for 5-10 minutes, the solution was then 
filtered with Whatman filter paper (Whatman Ltd, Maidstone, Kent, UK) and used within one 
hour. The volumes stated below are for cells in a 12 well plate. Cells were carefully washed 
twice in 1 ml phosphate buffered saline (PBS) before fixing in 1 ml 60% isopropanol for 10 
minutes, the cells were washed once with 1 ml PBS and 1 ml Oil Red O solution was added 
to the cells for 15 minutes, after which the background was cleared by rinsing in 1 ml 60% 
isopropanol and then 1 ml of water. A microscope was used to observe the lipid droplets 
which displayed a red colour. 
 
2.2.2 QPCR analysis of gene expression 
2.2.2.1 Extraction RNA of 3T3-L1 cells 
Quality RNA is necessary for QPCR analysis as RNA is susceptible to degradation by 
RNAses. RNA was extracted using the Absolutely RNA RT-PCR Miniprep kit (Stratagene, La 
Jolla, CA, USA) according to the manufacture’s instructions which included a DNAse 
treatment step to eliminate genomic DNA contamination. RNA was quantified by 
spectrophotometric measurement (Gene Quant pro RNA/DNA calculator Biochrom Ltd, 
Cambridge, UK) at 260 and 280 nm. The quality of the RNA was assessed by the ratio of 
optical density 260/280 nm. Pure RNA solutions have 260/280 ratio of 2.0 whereas ratios 
less than this indicates contamination by protein or phenol. Electrophoresis in 1% agarose 
gel (Melford Laboratories Ltd., Ipswich, UK) in 1x TAE shows the spectrum of RNA sizes 
(Figure 2.1) including 28s and 18s ribosomal RNA, and illustrates the integrity of the RNA. 
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2.2.2.2 Reverse transcription 
RNA was reverse transcribed to cDNA to provide a QPCR template. Prior to reverse 
transcription the RNA 1 µg/µl then 1 µl was added to 6.5 µl water and denatured by heating 
at 65˚C for 10 minutes. RT requires primers for cDNA synthesis which binds to the poly A tail 
at the 3’ terminus of mRNA forming the necessary double strand to initiate synthesis. 5 µl 
oligo deoxythymidine primer (ODT) 100 µg/ml (Promega, Madison, WI, USA), 1 µl RNAse 
inhibitor 8 µg/µl (Promega), 5 µl deoxyribonucleotide triphosphate dNTP 10 mM (Promega), 
2 µl Moloney Murine Leukemia Virus Reverse Transcriptase MMLV RT (Promega); 6 µl 5 x 
reverse transcriptase buffer (Promega) and 3.5 µl distilled water were added sequentially to 
the tube. To maintain a final reaction volume of 30 µl the ratio of RNA to water was inversely 
proportional, incubated at 37˚C for 1 hour then heat treated to stop the reaction at 95˚C for 
10 minutes. The cDNA was stored at -20˚C prior to QPCR analysis. 
Figure 2.1: 1% Agarose gel 
electrophoresis  
Agarose gel electrophoresis (1%) in 1 x TAE 
which shows the separation of the RNA 
sizes. Lane M: DNA 1Kb ladder, Lanes 1 
through 4: which contains the RNA products, 
shows 28S and 18S RNA.   
28S 
18S 
M 1 2 
 
3 4 
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2.2.2.3 QPCR reaction 
QPCR reaction was performed using Mx3000P™ (Stratagene Corp, La Jolla, CA, USA). The 
QPCR primers were designed using primer 3 software (http://frodo.wi.mit.edu/primer3/). 
Primers of 20 bases were chosen to ideally give a QPCR product in the 70-150bp range. 
The specificity of the resulting primers was checked against known DNA sequences using 
the Basic Local Alignment Search Tool (BLAST) (http://blast.ncbi.n/m.nih.gov/Blast.cgi). The 
primers were obtained from Invitrogen and used at a final concentration of 500 nM. The 
primers for the PPAR, GPDH and acidic ribosomal phosphoprotein (ARP) (Zhang et al., 
2009) QPCR assays are detailed (Table 2.2). 
 
Table 2.2: QPCR primers 
QPCR primers PPAR, GPDH and ARP along with amplicon size. 
 
PPAR   
Forward Reverse Amplicon size 
TTTTCAAGGGTGCCAGTTTC 
Exon 6 
AATCCTTGGCCCTCTGAGAT 
Exon 6 
220bp 
ARP   
Forward Reverse Amplicon size 
GAGGAATCAGATGAGGATATGGGA 
Exon 7 
AAGCAGGCTGACTTGGTTGC 
Exon 7 72bp 
GPDH   
Forward Reverse Amplicon size 
ATGCTCGCCACAGAATCCACAC 
Exon 8 
AATCCTTGGCCCTCTGAGAT 
Exon 8 
124bp 
 
 
QPCR master mix for each reaction was a mixture of 9 µl H2O, 12.5 µl of master mix 
(Invitrogen Platinum SYBR Green QPCR super mix-UDG), 1.25 µl of forward and 1.25 µl of 
reverse primers that were combined in the order described above. The first well on the plate 
was filled only with distilled water which will act as a negative control, the second well on the 
plate was filled with 24 µl master mix along with 1 µl distilled water as no template control 
(NTC), while remaining wells were filled with 24 µl of master mix and target gene 1 µl cDNA. 
QPCR assay was heated to between 94-95˚C 2 minutes to allow the cDNA to completely 
denature and then reduced temperature to allow the primers anneal to the template. Next a 
40 cycle amplification phase at 95˚C for 15 seconds then 60˚C for 30 seconds and extension 
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primer at 72˚C. The fluorescent signal was measured for each well at the end of each cycle 
followed by the melt curve analysis. Temperature was held at 95˚C for one minute then 55˚C 
for 30 seconds to allow PCR product to anneal. As the temperature increased toward 95˚C 
the fluorescent signal was measured to determine at what point the PCR product melted. 
ARP was the housekeeping gene (Zhang et al., 2009). PPAR and GPDH gene expression 
levels were analysed by comparison with ARP gene expression using the MxPro software 
Mx3000 (Stratagene) and expressed relative to the appropriate control sample, usually day 
0. 
2.2.2.3.1 Agarose gel electrophoresis analysis of QPCR product 
QPCR products were analysed in a 2% agarose gel containing 400 ng/ml ethidium bromide 
(Promega) was prepared in 1x TAE buffer, (50x TAE, 242 g Tris, 100 ml EDTA [50 mM, pH 
8] and 57.1 ml glacial acetic acid, 1 M); the same concentration of ethidium bromide was 
maintained in TAE. The product containing 5 µl PCR and 2 µl loading buffer (Promega) 
loaded into each well while 5 µl DNA ladder (Promega) and 2 µl buffer were loaded into the 
first well. Each PCR product was compared against a 100bp DNA ladder to confirm the size 
of the amplicon. 
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2.2.2.4 DNA Sequencing  
The QPCR product was sequenced to confirm the identity. 
2.2.2.4.1 DNA purification 
QPCR purity was achieved using Wizard SV gel and PCR clean-up system (Promega). 
QPCR products were purified using equal volumes of membrane binding solution to the 
reaction. Samples were transferred to SV Minicolumn placed on fresh 2 ml collection tube 
and incubated for 1 minute at room temperature. Tubes were centrifuged at 14,000 rpm for 1 
minute and liquid discarded. SV Minicolumn was washed with 700 µl ethanol centrifuged at 
14,000 rpm for 1 minute. Column was washed a second time with 500 µl then transferred to 
a new 1.5 ml tube. DNA was eluted in 20 µl of Nuclease-free water then stored at 4C. 
2.2.2.4.2 Agarose gel electrophoresis analysis of purified QPCR product 
QPCR purity was verified by agarose gel as described earlier (section 2.2.3 1). 
2.2.2.4.3 Sequencing 
Each sequence reaction contained 2 µl Big Dye Terminator Cycle Sequencing Ready 
Reaction mix (Life Technologies, Grand Island, NY, USA), 1 µl forward and reverse primers 
PPAR, GPDH (10 pmol/µl) (Table 2.2), approximately 25 ng (typically 5 µ)l of purified 
QPCR product as quantified by comparison with 100bp DNA ladder on an agarose gel then 
made up to 10 µl with H2O. Sequencing reactions were run on a Genius (Bibby Scientific 
Limited, Staffordshire, UK) PCR machine (Table 2.3). 
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Table 2.3: Program used for Sequencing 
The number of cycles, temperature and times used in the program for PPAR and GPDH. 
 
Number of cycles Temperature °C Time 
1 96 2 min 
30 96 30 sec 
 60 4 min 
 
2.2.2.4.4 Sodium acetate precipitation  
Prior to sequencing, the QPCR product was precipitated. 1 µl of 3 M sodium acetate (pH 
5.2) and 30 µl of absolute ethanol was added to each 10 µl sample to be sequenced then 
vortexed and incubated at room temperature for 10 minutes. Samples were centrifuged for 
30 minutes at 13,000 rpm, the supernatant was discarded and the pellet washed with 500 µl 
of 70% ethanol. The supernatant was discarded and samples were air dried before re-
suspension and analysis on an ABI 3100 Genetic Analyser. 
2.2.3 Statistical analysis 
Data was expressed as the mean ± SE. The ANOVA Statistical programme was used to 
examine differences between control and treated groups with post hoc analysis using the 
Student-Newman-Keuls test to examine differences among various groups. 
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2.3 Results 
2.3.1 Morphology of 3T3-L1 during differentiation 
During incubation in differentiation medium 3T3-L1 cells underwent morphological changes 
that are characteristic of conversion from a fibroblast to an adipocyte. Undifferentiated 3T3-
L1 cells have the appearance of fibroblasts with an elongated shape (Figure 2.2 A+B). 
Whereas the cells cultured in differentiation medium (section 2.2.5) appear to have a 
morphology more typical of mature adipocyte cells at day 8 where they appear as very 
rounded and with extensive lipid droplet accumulation in approximately 80% of the 3T3-L1 
cells (Figure 2.2 C+D). 
2.3.2 Oil Red O of 3T3-L1 during differentiation 
3T3-L1 cells which underwent adipogenic differentiation were stained with Oil Red O to allow 
the visualization of the lipid droplets (see Figure 2.2). No Oil Red O staining was detected 
during day 0 (see Figure 2.2 B), however after 8 days in differentiation medium 
approximately 70-80% of the cells  were observed to contain Oil Red O stained lipid droplets 
(Figure 2.2 D).  
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Figure 2.2: Phase contrast photomicrograph stages of adipocyte differentiation 
(A) Undifferentiated cells day 0 (C) after 8 days in differentiation medium. (B) Undifferentiated Oil Red 
O stained cells day 0 (D) after 8 days in differentiation medium. After 8 days lipid droplet accumulation 
in differentiated cells is clearly visible in 70-80% of the cells. Magnification 100x. 
 
 
2.3.3 Validation of QPCR assays 
In order to confirm that the QPCR assay performed correctly the experimental data was 
validated by confirming that: (a) gel electrophoresis was a single product of the appropriate 
size, (b) there was a single peak for the melt curve, (c) the reaction efficiency through the 
analyse of serial 10 fold dilutions which contained pooled cDNA sample and (d) the identity 
of the DNA sequencing product.  
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2.3.3.1 Validation of the ARP assay 
Agarose gel electrophoresis and melt curve analysis (Figures 2.3 and 2.4B) confirmed that 
the ARP assay produced a single PCR product of 71bp. Analysis of serial 10 fold dilutions of 
pooled cDNA (Figure 2.4A) determined the efficiency of the assay. This was calculated from 
the Ct slope plotted against the initial cDNA concentration where the undiluted pool was 
defined using the MxPro software (Stratagene). This technique determined the ARP 
efficiency to be 97.9%. As ARP was intended to be use as the housekeeping gene it must be 
expressed at relatively high levels and be unaltered through experimental procedures. ARP 
when amplified with Ct value in the range of cycle 15-16 thereby was unaltered by the state 
of the differentiation (Figure 2.5), which confirmed that ARP was a suitable hosusekeeping 
gene for studies which look at differentiation of 3T3-L1. The intra assay coefficient of 
variation for the APP QPCR assay was 3.2%. This was typical for all QPCR assays, none 
having an intra assay CV of greater than 5%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: ARP QPCR product 
Agarose gel (2%) electrophoresis 
in 1x TAE shows the ARP product. 
Lane M: DNA 100bp ladder, lane 
1: no template control and lanes 2 
through 6: These contain the ARP 
QPCR products. The size of 
amplicon was 71bp. 
 
 
71bp 
M 1 2 3 4 5 6 
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Figure 2.4: QPCR analysis of ARP 
QPCR analysis of ARP which shows (A) amplification plots along with (B) the melt curve analysis 
which plots serial dilutions of pooled 3T3-L1 cDNA from 1:1 to 1:100,000 that were used to calculate a 
plot of Ct vs. initial starting dilution (C), the slope which gives the efficiency of the ARP QPCR assay 
of 97.9%. 
 
Figure 2.3.2 
Contained over (A & B) 
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Figure 2.5: ARP amplification plot 
Amplification plots show that ARP expression was unchanged during 3T3-L1 differentiation. Cells by 
length of time in differentiation medium (Table 2.4). 
 
 
 
 
 
 
Table 2.4: ARP Ct values 
Ct values for the ARP QPCR assays during 3T3-L1 adipogenic differentiation for days 0 to 8 show 
unaltered of Ct values. 
 
 
 
 Ct value 
 0 days 2 days 5 days 8 days 
ARP 16.7 16.61 16.25 16.80 
 
 
■Day 0 
 
▀Day 2 
 
◄Day 5 
 
♦Day 8 
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2.3.3.2 Validation of the PPAR assay 
Agarose gel electrophoresis (Figure 2.6) along with melt curve analysis (Figure 2.7B) 
confirmed that the PPAR assay produced a single PCR product of the correct size 220bp. 
Analysis of serial 10 fold dilutions of pooled cDNA (Figure 2.7A) was used to determine the 
efficiency of the assay. This can be calculated from the slope of the line of Ct value plotted 
against initial cDNA concentration where the undiluted pool was defined as one using the 
MxPro software (Stratagene, La Jolla, CA, USA). This technique was used to determine the 
value of the PPAR assay to be 97.9% efficiency. PPAR was intended to be used as a 
maker gene of 3T3-L1 differentiation as results confirmed that the QPCR assay was 
appropriate to be used as detector of PPAR expression. 
 
M 1 2 3 4 5  
Figure 2.6: PPAR QPCR product 
Agarose gel electrophoresis (2%) in 1x 
TAE which shows confirmation of the 
sizes of the PPAR QPCR product 
220bp. Lane M: DNA 100bp ladder, 
lane 1: no template control and lanes: 2 
through 5 which contain the amplified 
PCR products.  
 
220bp 
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Figure 2.7: PPAR QPCR analysis 
Mention the results (A) cDNA from 1:1 to 1:10000 (B) which result in the melt peak curve analysis of 
the products and (C) the standard curve.  
■ 1:1 
 
▼1:10 
 
■1:100 
 
▰1:1000 
 
♦1:10000 
 
●1:100000 
B 
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2.3.3.3 Validation of the GPDH assay 
Agarose gel electrophoresis (Figure 2.8) along with melt curve analysis (Figure 2.9B) 
confirmed that the GPDH assay produced a single PCR product of the correct size 124bp. 
Analysis of serial 10 fold dilutions of pooled cDNA (see Figure 9A) was used to determine 
the efficiency of the assay which was found to be 105%. These results confirmed that the 
GPDH QPCR assay was an appropriate detector of GPDH expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
M 1 2 3 4 5  
Figure 2.8: GPDH QPCR product 
 
Agarose gel (2%) electrophoresis in 
1x TAE which shows confirmation of 
the size of the GPDH QPCR 
product, 124bp. Llane M: DNA 
100bp ladder, lane 1: no template 
control and lanes 2 through 5: 
contain the amplified PCR products.  
124bp 
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Figure 2.9: GPDH QPCR analysis 
The results (A) cDNA from 1:1 to 1:10000 (B) which result in the melt peak curve analysis of the 
products and (C) the standard curve. QPCR products sequenced were matched. 
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2.3.3.4 PPAR expression during 3T3-L1 cell differentiation 
QPCR was used to determine PPAR gene expression at 0, 2, 5 and 8 days after start of 
differentiation. PPAR expression increased (Figure 2.10 and Table 2.5) with higher 
expression of PPAR observed in differentiated cells at day 5 (mean ± SE, 7.68 ± 1.346 P 
0.05) and day 8 (mean ± SE, 11.73 ± 3.11 P 0.01) compared to day 0, (mean ± SE, n=4 
separate experiments). Analysis was way ANOVA post hoc test with Student-Newman-Keuls 
test (Figure 2.11). 
 
Figure 2.10: PPAR amplification curve  
PPAR amplification curves at day 0, 2, 5 and 8 after the addition of differentiation medium. PPAR 
expression increased during the 3T3-L1 differentiation. 
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Figure 2.11: PPAR expression during 3T3-L1 differentiation 
QPCR analysis of PPAR expression during 3T3-L1 differentiation shows increase of PPAR at day 5 
and day 8 with differentiation medium compared to control cultures day 0. * P<0.05, **P<0.01 vs. 
control, n=4 separate experiments, ANOVA, post hoc analysis with Student-Newman-Keuls test. 
 
Table 2.5: PPAR Ct values 
Ct values for PPAR  and ARP QPCR assays during 3T3-L1 adipogenic differentiation for days 0 to 8 
shows increased the level of PPAR expression, reduced the Ct value, minimum effect on ARP. 
 
 
 Ct value 
 0 days 2 days 5 days 8 days 
ARP 14.82 15.03 15.81 15.95 
PPAR 21.74 21.76 20.23 19.99 
 
 
2.3.3.5 Expression GPDH during 3T3-L1 differentiation 
QPCR was used to determine GPDH gene expression at day 0, 2, 5 and 8 days after 
initiation of differentiation. GPDH expression was increased during the differentiation 
process (Figure 2.12 and Table 2.6) with significantly higher expression observed in 
differentiated cells at day 8, n=4 separate experiments. 
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Figure 2.12: GPDH amplification curve 
GPDH amplification curve shows at day 0, 2, 5 and 8. GPDH expression was increased during 3T3-
L1 differentiation. 
 
Table 2.6: GPDH Ct values 
Ct values for the GPDH and ARP QPCR assays during 3T3-L1 adipogenic differentiation for days 0 to 
8 shows differentiation increased level of GPDH which reduced Ct value, no effect on ARP. 
 
 
 Ct value 
 0 days 2 days 5 days 8 days 
ARP 14.82 15.03 15.81 15.95 
GPDH 29.92 30.84 24.52 21.41 
 
 
 
Figure 2.13: GPDH expression during 3T3-L1 differentiation 
QPCR analysis of GPDH during 3T3-L1 differentiation shows significant increase of GPDH at day 8 
compared to control day 0. ** P<0.01 vs. control cultures, n=4 separate experiments, ANOVA, post 
hoc analysis with Student-Newman-Keuls test. 
 
2.3.3.6 Sequence of cDNA  
The QPCR products sequenced were matched. 
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2.4 Discussion 
Analysis of my results clearly demonstrates that I was able to validate a protocol that would 
maximize the differentiation of the 3T3-L1 pre-adipocyte cell line into adipocytes. This 
method was accomplished through a combination of phase contrast microscopy, cell staining 
and QPCR. 
 
Since Todaro and Green’s pioneering research in 1963 the 3T3-L1 cell line has played a 
central role in identifying specific transcriptional factors as well as numerous signal cascades 
that are responsible for the regulation of adipogenesis. Although the results from this chapter 
have built upon their work by demonstrating that the murine pre-adipocyte 3T3-L1 cell line 
can be induced to differentiate and is convenient for those studies, this is dependent upon 
the conditions of the cell culture. In addition, when the cell culture conditions are altered, the 
3T3-L1 cell line can differentiate from fibroblast into an adipocyte which then acquires the 
ability to accumulate lipids (section 2.3.2).  
 
Oil Red O was selected as this dye is generally fast and easy to use. However, this dye does 
require tissue fixation and more time to process (Listenberger and Brown 2007). Never the 
less, results clearly showed that after 8 days this dye was successfully absorbed by 
approximately 70-80% of the 3T3-L1 cells which allowed for the qualitative observation of 
lipid cells with a phase contrast microscope (section 2.3.2 and Figure 2.2D). The 
characteristic sign of Oil Red O staining and morphological changes of round cells with the 
manifestation of lipid droplets were detected during 3T3-L1 differentiation. Alternately, Nile 
Red dye could have been used. However, Nile Red dye ability to offer more quantitative 
results in difficult samples, its use where interaction with cellular membranes must be 
minimized or multiple labelling is required (Bonilla and Prelle, 1987). 
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Analysis of the QPCR confirmed that expression levels of adipocyte differentiation markers 
(Figure 2.4), PPAR (Figure 2.10) and GPDH (Figure 2.12) increased when the cells were 
incubated in a differentiation medium. Also, GPDH as a marker of terminal differentiation 
appeared later than PPAR with higher levels observed in differentiated cells only at day 8 
while PPAR showed significantly higher levels from day 5 (Figure 2.11). The combination of 
gel electrophoresis and analysis of melt curves when used together validated the QPCR 
assay (section 2.3.3.1.2). However, running a standard curve via serial-fold dilution of 
template DNA with SYBR Green fluorescent dye helped to verify the robustness of the 
QPCR assay. 
 
Alternative markers to monitor adipocyte differentiation could include pref-1 for pre-
adipocytes, LPL (Smas et al., 1997; Smas et al., 1998; Kim et al., 2007), GLUT4 
(Fernyhough et al., 2007) and ALBP/aP2 (Marr et al., 2006). Also, C/EBP α and β also play 
early catalytic roles in the differentiation pathway and can be used as markers of the early 
phase of differentiation (Herrera et al., 1989). Another alternative approach to measure 
adiponectin in culture medium using a commercial ELISA.   
 
QPCR was used with SYBR green reporter to reveal the expression of differentiation 
markers and is identical in principle to PCR except that a fluorescent SYBR reporter 
molecule include in the reaction. Following the first use of SYBR Green for PCR in 1997, 
very little consideration has been given to the advancement of alternate dyes. The limitations 
of SYBR Green known such as limited dye stability, dye-dependent PCR inhibition and 
selective detection of amplicons. On the other hand, a distinct disadvantage of SYBR 
chemistry is its inherent non-specificity. SYBR dye will bind to all dsDNA molecules that is 
mean the fluorescent signal amplified non specific contaminating genomic DNA and primer 
dimmers. Alternately, EvaGreen dye is a green fluorescent nucleic acid dye with features 
that make the dye useful for QPCR. The DNA-bound dye has excitation and emission 
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spectra very close to those of SYBR Green, making the dye readily compatible with 
instruments equipped with the 488 nm argon laser or any visible light excitation with 
wavelength in the region. EvaGreen dye is extremely stable both thermally and 
hydrolytically, providing convenience during routine handling. EvaGreen dye is non-
mutagenic and non-cytotoxic by being completely impermeable to cell membranes (Ohta et 
al., 2001). 
 
Absolute quantification expresses results as an absolute copy number where as relative 
quantification expresses results as a fold change relative to a reference point such as 
untreated cells with the advantage there is no need for a standard curve. However, the 
problem is that absolute quantification gives the concentration of transcript in terms of copy 
number by relating the QPCR signal to a standard curve, whereas the standard curve often 
uses a plasmid containing the sequence of the gene of interest.  Therefore, sequence in 
cDNA and plasmid is not the same, while the proportion of a plasmid which contains the 
sequence of interest can increase the risk of contamination.  
 
An optimized QPCR can be recognized as conforming to a linear standard curve, a high 
amplification efficiency and consistency across replicate reactions. To test whether or not the 
QPCR assay’s were optimized serial dilutions of a template were run (section 2.3.3.1) and 
the results used to create a standard curve (Figure 2.4) that was plotted against the Ct value 
obtained during the amplification phase of each dilution. These graphs show an evenly 
spaced amplification curve with each amplification cycle almost doubling. In addition, the 
spacing of the fluorescence curves also show a linear progression. However, the simplicity 
of the QPCR method is that it is relatively easy to produce a result, effective quality control is 
necessary in order to create results which are dependable and meaningful. The principal 
variables regarding a QPCR reaction are contamination, amplification bias, poor efficiency 
and sensitivity. 
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An alternative technique for the analysis of protein marker expression would have been 
western blotting as this technique can identify specific proteins from a mixture or synthesized 
in vitro and can detect the size along with the expression of a protein. However, western blot 
is dependent on the quality of antibody that use to probe for protein of interest, and how 
specific it is for this protein. Western blotting is able to detect existence of a specific protein 
hiding amongst others, the state phosphorylation as well as measuring the PPARγ activation 
as a result of differentiation by using a high-quality antibody directed against the PPARγ 
protein (Zhang et al., 2009). However, with respect to this study western blotting is slow in 
comparison to QPCR while the results are only semi quantitative. However, in this study 
agarose gel electrophoresis was used (section 2.3.3.1.3) which allowed the measurement 
amplicon size of PPAR and GPDH as a result of differentiation (Figures 2.3, 2.6 and 2.8).  
From these results it is clear that the murine pre-adipocyte 3T3-L1 cell line can be induced to 
differentiate and that induced differentiation is an appropriate model with which to study 
those changes in GHR signalling that are related to lineage specific differentiation. 
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3. Chapter Three 
3.1 Introduction 
3.1.1 GH signalling 
GH has a variety of functions, including an important role in the regulation of adipose 
tissue biology (Nam and Lobie, 2000; Flint el at., 2003; Ray et al., 2012). The major 
isoform of human growth hormone is a peptide secreted from the pituitary gland of 
191 amino acids with a molecular weight of 22kDa (Li et al, 1969). The effects of GH 
on the tissues of the body are mediated via the cell surface growth hormone receptor 
(GHR). 
Like GH, GHR is also a member of the cytokine receptor superfamily which as 
previously described (section 1.2.3) comprises an extracellular ligand–binding 
domain, a single transmembrane region and a cytosolic domain  lacking intrinsic 
tyrosine kinase activity (Figure 3.1) (Uyttendaele et al., 2007; Ma et al., 2011). Each 
GH molecule has two receptor binding sites with the latest evidence suggesting that 
GH binding to the receptor induces a conformational change in a pre-existing 
receptor dimer (Lichanska and Waters, 2008). This causes the tyrosine kinase JAK2 
that is associated with the each GHR cytoplasmic domain to come into close 
proximity to each other resulting in their trans-activation, leading to the 
phosphorylation of multiple tyrosine residues of the receptor cytoplasmic domain 
(Argetsinger et al, 1993; Brown et al., 2005). The resulting cytoplasmic domain 
phospho-tyrosines then act as docking points for proteins containing SH2 or PTB 
domains such as STAT5, Grb2, Sos and IRS-1 leading to the activation of multiple 
signalling pathways including p42/44 MAPK, also known as ERK and JAK2-STAT5 
(Figure 3.2) and described in a review by Waters et al. (2006). These pathways 
regulate a variety of functions that result in the ability of GH to control growth and 
other metabolic processes. 
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Figure 3.1: GHR-associated JAK2 
This diagram shows the mechanism of GH. GH activates the GHR-associated JAK2 by 
phosphorylation (JAK2-P). This result in auto-phosphorylation and phosphorylation of the 
intracellular domain stimulating STAT. SCOS is also able to bind the GHR and may, 
therefore, block STAT5 and JAK2. 
 
Of the GHR signalling pathways STAT5 is regarded as the most important mediator 
of the effects of GH. After GHR activation, STAT5 is phosphorylated by JAK2. 
Phosphorylated cytoplasmic STAT5 forms a homodimer via its phospho–tyrosine 
residues and translocates to the nucleus (Benekli et al., 2003; Wang et al., 2009). 
After nuclear translocation the STAT5 dimer binds to specific DNA sequences in the 
promoter region of its target genes where transcription starts. The most important of 
these in the case of longitudinal growth is the IGF-1 gene. STAT5 is implicated in the 
regulation of adipogenesis in other model systems (Richter et al., 2003, Wang et al., 
2009; Stewart et al., 2011). In differentiating 3T3-L1 cells STAT5 protein is directly 
regulated with both PPAR and C/EBPα under a combination of different conditions 
(Stewart et al., 2011). 
 62 
 
 
Figure 3.2: GHR cell signalling 
Schematic drawing of cell Signalling via the GHR. (Adapted from www.biocarta.com). 
 
Activation of ERK via the GHR is regulated by a phosphorylation cascade from the 
cell membrane to the nucleus mediated through specific components such as Ras, 
Raf and MEK leading to ERK phosphorylation. ERK1 (p44) and ERK2 (p42) are 
widely expressed and involved in a range of functions (Johnson and Lapadat, 2002; 
Wang et al., 2009). The role of ERK in the differentiation of adipocytes is complex 
and depends on many parameters (Bost et al., 2005). ERK1 and ERK2 are essential 
for induction of mitotic clonal expansion that is an essential early step for the initiation 
of differentiation which is then followed by expression of genes that produce the 
adipocyte phenotype. Many contemporary studies argue that mitotic clonal expansion 
is not a required step for 3T3-L1 pre-adipocyte differentiation into adipocytes as 
inhibition of ERK1 and ERK2 activation abolishes mitotic clonal expansion, but does 
not prevent adipogenic differentiation (Qiu et al., 2001, Tang et al., 2003). 
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3.1.2 Western blotting 
Western blot, also known as western immunoblotting or immunoblot, originated from 
Stanford University to visualise assay for antigens specific to monoclonal antibodies. 
Proteins exist in phosphorylated or non-phosphorylated states which distinguish 
between active and inactive forms allowing specific pathways to be located (Mandell, 
2003). The proteins are separated depending on size using sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein is then 
transferred from the SDS-gel to a membrane, the blot, which is then incubated. A 
secondary antibody, such as horseradish peroxidase (HRP), is used to visualize the 
protein bands on the blot. 
 
The 3T3-L1 cells were incubated with serum free DMEM medium at 37C for 4 hours 
to ensure down regulation of the signalling pathways. Cells were treated with GH for 
10 minutes as previous research by Lewis et al. determined that 10 minutes is the 
optimum time for GH regulated ERK and STAT5 (Lewis et al., 2004). Additional 
research by Lewis et al., examined the GHR-associated signalling pathways in 
mesenchymal stem cells (MSCs) derived from rat bone marrow stem cells (BMSCs) 
induced to differentiate (Lewis et al., 2006). GH treatment activated STAT5 alone in 
undifferentiated BMSCs, but activated both STAT5 and the ERK pathway in 
adipocyte-differentiated stem cells. The level of GH induced ERK pathway activation 
increased in a time-dependent manner over a 7 day adipocyte differentiation period, 
therefore ERK activation may be particularity important in mediating the effects of GH 
on adipocyte function. Building upon the research by Lewis et al., (2006) this study 
hypothesised that adipocyte differentiation modulates coupling of the GHR to 
activation of the ERK pathway. As Lewis et al. has argued that the profile of signal 
pathway activation differs with adipocyte differentiation this study will develop 
research by using the 3T3-L1 pre-adipocyte cell line. 
 
 64 
 
3.2 Materials and Methods 
3.2.1 GH signalling during 3T3-L1 differentiation 
3T3-L1 cells were cultured as described previously (section 2.2.1.1), in 6 wells plates 
with 150,000 cell per well in 2 ml DMEM containing 10% calf serum. Once confluent, 
medium was changed (section 2.2.1.4) day 0 and cells were incubated for 2, 5 and 8 
days. To study those pathways associated with the GHR at each time point, cells 
were treated with GH and studied using phospho-specific western blotting. The 
medium was removed and all cells were washed twice with 1 ml of PBS and 2 ml 
serum free DMEM was added. Cells were incubated for 2 hours at 37˚C, the medium 
removed and 2 ml of serum free DMEM was added at 37˚C for 2 hours. Recombinant 
human GH (50 nM, Genotropin, Pfizer, UK) was added to one well then incubated for 
10 minutes at 37˚C. The cells were then washed twice with 1 ml of ice cold PBS 
containing 1mM sodium orthovanadate (Sigma-Aldrich, Saint Louis, MO, USA) to 
preserve the phosphorylated proteins that inhibited endogenous phosphatases. Cells 
were lysed with 250 µl loading buffer without pyronin Y (Appendix 1) frozen in liquid 
nitrogen and stored at -20˚C. 
 
3.2.2 SDS–PAGE and western blotting 
The protein sample was heated with 2-mercaptoethanol reducing agent (Sigma-
Aldrich, Sant Louis, Missouri, USA) and denatured with SDS (Fisher Scientific, 
Loughborough, UK). Proteins were separated by gel electrophoresis. The samples 
were loaded onto a polyacrylamide gel where 200v was applied causing smaller 
proteins to migrate more quickly as they were retarded less by the gel. After gel 
electrophoresis the bands were transferred onto a polyvinylidene fluoride membrane 
(PVDF, Hybond-PTM) (GE Healthcare, Little Chalfont, Bucks, UK) for detection using 
specific antibodies and western blotting. The key processes are described below. 
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3.2.2.1 Cellular protein quantitation 
For the detection of differences in protein expression during the period of the cell 
differentiation to be meaningful, an equal amount of protein from each sample must 
be compared. The protein concentration of the cell lysates must be determined. The 
protein assay was performed with loading buffer without pyronin Y (Sigma, St Louis, 
MO, USA). To achieve this, samples were boiled for 5 minutes and centrifuged at 
14,000 rpm for 5 minutes and 20 µl of each cell lysate aliquotted into a 96 well 
microtitre plate. The standard curve of 1-20 µg was prepared from a bovine serum 
albumin stock solution (Sigma) 1 mg/ml in loading buffer (Appendix 1) and the 
volume adjusted to 50 µl with loading buffer. Subsequently 50 µl of 60% 
trichloroacetic acid (Sigma-Aldrich, Saint Louis, MO, USA) was added to all of the 
wells and the plate incubated at room temperature for 30 minutes. This cocktail was 
measured by reading the absorbance at 630 nm in a plate reader (Dynex, 
Technologies Inc, Chantilly, VA, USA) and a standard curve was constructed 
allowing the protein concentrations for each cell sample to be calculated. 
 
3.2.2.2 Gel preparation 
The mini–gel system from Bio Rad was used for all SDS-PAGE and electroblotting 
procedures. The running gel was prepared as described (Table 3.1). The acrylamide 
concentration, typically 8% or 10% was chosen according to the separation range 
required. The percentage of acrylamide to be used in the running gel depended on 
the size of the protein of interest. Gels of 10% were routinely used and have a useful 
separation range of 30-80 kDa. Proteins of greater than 80 kDa should be separated 
on an 8% or lower gel. A low percentage of acrylamide creates large pores that 
allowed for the separation of proteins that have a high molecular weight, whilst a 
higher percentage was used for gel having smaller sized pores suitable for the 
separation of the proteins that have a lower molecular weight. 
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Casting plates were washed with 100% ethanol and assembled on the casting stand. 
A running mixture of 7.0 ml for 1.5 mm gels was prepared (Table 3.1). Polymerization 
was initiated by ammonium persulphate in the presence of N,N,N’,N’,-
tetramethylethylenediamine (TEMED) (Sigma-Aldrich), added to the mixture prior to 
pouring. Gel mix was poured into plates leaving space at the top for the stacking gel 
to be added. 1 ml water-saturated N-butanol was added on top of gel to exclude 
oxygen and allow polymerization of the acrylamide. When set, the N-butanol was 
removed by tipping the plates upside down then washed three times with water. 
Stacked gel mixture (Table 3.1) was added to the top of the running gel. Combs were 
placed, ensuring no air bubbles were under the comb fingers. 
 
Table 3.1: Components of SDS-PAGE 
SDS-PAGE running and stacking gel components. Volumes above are for 10 ml running gel 
and 10 ml stacking gel. * APS is made up fresh and TEMED added immediately prior to use. 
 
 10% running gel 8% running gel Stacking gel 4% 
30% acrylamide 3.3 ml 2.64 ml 1.3 ml 
Water 2.92 ml 3.58 ml 6.1 ml 
1M Tris (pH8.8) 3.75 ml 3,75 ml - 
0.5M Tris (pH 6.8) - - 2.5 ml 
10% SDS 100 µl 100 µl 100 µl 
10% ammonium persulfate (APS)* 100 µl 100 µl 100 µl 
TEMED* 5 µl 5 µl 10 µl 
 
The stacking gel allows the protein bands to concentrate prior to the running gel. 
Once set the combs were removed from the gels. If the samples were not already in 
loading buffer with pyronin Y, this would be added to the sample to final 
concentration of 0.2%. Samples were then boiled in water for 5 minutes then 
centrifuged for 5 minutes at 13,000 rpm. The molecular weight marker 10 µl pre-
stained (7-175 kDa)(New England Biolabs, Ipswich, MA, USA) and samples  which 
contained 20 µg protein were loaded into the wells and run through the gel at 200v 
for 30 minutes using a Tris-glycine running buffer (Appendix 1) until the tracking dye 
band had reached the bottom of the gel. 
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3.2.2.3 Western blot analysis of protein 
Protein transfer was achieved using Bio Rad Mini Transblot. PVDF membrane was 
cut to fit the gel 5 cm x 8 cm and pre-activated by briefly soaking in 100% methanol. 
After two rinses each lasting 5 minute in distilled H2O, the membrane and previously 
run SDS-PAGE gel were equilibrated in blotting buffer (Appendix 1) for 15 minutes by 
gently shaking. For each SDS-PAGE gel blot, two pieces of filter paper (5 cm x 8 cm) 
and two fibre pads were soaked in blotting buffer for 10 minutes to ensure no air was 
trapped in the fibre pad. The transfer sandwich comprised of a fibre pad on the black 
side of the transfer cassette, followed by filter paper, gel, membrane then filter paper. 
The stack was rolled to ensure good contact between gel and membrane and a fibre 
pad placed on top. The cassette was inserted into the tank containing pre-cooled 
blotting buffer and an ice pack to prevent overheating. Transfer was achieved by the 
application of a constant current of 350 mA for one hour while stirring. 
 
3.2.2.4 Detection of specific proteins by immunoblotting 
All washes/incubations used an orbital shaker. After blotting the membrane was 
transferred and washed for 5 minutes in Tris buffered saline–tween (TBS-T). The 
membrane was blocked with 50 ml blocking buffer (Appendix 1) for 1 hour at room 
temperature then placed in a square Petri dish in 8 ml blocking buffer containing 
primary antibody at optimal dilution (Table 3.2). Membranes were incubated for 1 
hour at room temperature or overnight at 4˚C (Table 3.2). After incubation, primary 
antibody was removed and membrane washed three times for 5 minutes with 15 ml 
TBS-T. Secondary antibodies (GE Healthcare, Little Chalfont, Bucks, UK) were used 
at 1:5000 in 10 ml blocking buffer for 1 hour at room temperature. The membranes 
were then subjected to a series of washes with TBS-T these were: two brief 30 
second washes, one 15 minute followed by three 5 minute washes. 
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Table 3.2: Pimary and secondary antibodies 
Antibodies for western blotting include primary anti-phospho-ERK, anti-phospho-STAT5, mix of 
anti-total ERK1/anti-total ERK2 and total anti-STAT5. 
 
Antibodies ( Ab) Species Supplier Dilution Incubation 
Primary anti-
phospho-ERK 
Mouse 
monoclonal 
Cell Signalling 
Technology,  Danvers, 
MA, USA 
1:2000 4˚C overnight 
(O/N) 
Anti-phospho-
STAT5 
Mouse 
monoclonal 
Millipore, Billerica, MA, 
USA 
1:1000 4˚C O/N 
Mix of anti-total 
ERK1 and anti-total 
ERK2 
Rabbit 
polyclonal 
Santa Cruz, CA, USA 1:2000 1 hour at 
room 
temperature 
(RT) 
Anti-STAT5 Rabbit 
polyclonal 
Santa Cruz, CA, USA 1:500 1 RT 
 
3.2.2.6 Detection of antibody–antigen complex 
Immobilised protein labelled with HRP conjugate was detected via 
chemiluminescence (ECL Plus) (GE Healthcare, Little Chalfont, Bucks, UK) by 
exposing PVDF membrane with antigen–antibody to photographic film. After washing 
the membranes were removed from the TBS-T and any excess drained. ECL reagent 
was prepared (40:1 ratio of solution A: solution B) and 3 ml carefully pipetted onto the 
protein side of the membrane and incubated at room temperature for 5 minutes. 
Excess solution was drained before wrapping in Saran wrap (Dow Chemical 
Company) and placed into an autoradiography film cassette with the protein side up 
and developed in the darkroom. A sheet of film (HyperflimTM ECL) (GE Healthcare, 
Little Chalfont, Bucks, UK) was placed on top of the membrane for 30 seconds to 10 
minutes depending on signal strength. Exposed film was placed into the developer 
solution (Kodak D-19) (Kodak, Hemel Hempstead, Herts, UK) for 2 minutes, then 
briefly rinsed in water and placed in fixer (Kodak D-19) (Kodak, Hemel Hempstead, 
Herts, UK) for 5 minutes. Process was repeated with longer/shorter exposure times 
as needed. Developed film was washed with water for 15 minutes then dried. Film 
was aligned with blot and the position of the standards marked. The final films were 
analysed by imaging densitometry (Alpha Innotech Corp, San Leandro, CA, USA). 
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Figure 3.3: Western blotting schematic (Adapted from Rice, 2008). 
 
3.2.2.7 Stripping and reprobing membrane 
Membranes were reprobed by stripping antibodies off the membrane which were 
then probed with a different antibody. If the blot dries out the membrane would be re-
wetted with methanol for 30 seconds and washed three times 5 minutes with TBS-T, 
if still wet this step would be omitted. Blots were then incubated at 60˚C with 50 ml 
pre-warmed stripping buffer for 30 minutes in a hybridization oven (GE Healthcare 
Life Sciences, Amersham Place, Little Chalfont, UK) with gentle mixing. After 
stripping, blots were washed three times for 10 minutes with 50 ml of TBS-T. These 
blots were blocked with blocking buffer for 1 hour at room temperature and were then 
ready for next primary antibody. 
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3.2.3 RNA extraction and QPCR 
GHR expression was analysed using QPCR (section 2.2.6). RNA was extracted 
(section 2.2.6.2). Reverse transcribed mRNA (cDNA) provided the necessary DNA 
template for PCR amplification (section 2.2.6.3). The nuclear protein ARP was used 
as the housekeeping gene. Primers are detailed below (Table 3.2) were used at a 
final concentration of 500 nM. GHR expression was analysed by comparison with 
ARP expression using the MxPro software (Stratagene). 
 
 
Table 3.3: Primers of GHR and ARP 
Primers for QPCR analysis of GHR and ARP expression. 
 
GHR   
Forward Reverse Amplicon size 
CCATTCAAGCCACACAGCTA CCTTGGGCTCTCACTTCTTG 103 bp 
ARP   
Forward Reverse Amplicon size 
GAGGAATCAGATGAGGATATGGGA AAGCAGGCTGACTTGGTTGC 71 bp 
 
3.2.3.1 Agarose gel electrophoresis analysis of QPCR product 
The QPCR product was verified by agarose gel electrophoresis as described earlier 
(section 2.2.6.3 1). 
 
3.2.3.2 Sequencing  
Sequenced DNA was to confirm the identification of the QPCR product as described 
earlier (section 2.2.6.4) and primers which used (Table 3.3).  
 
3.2.4 Statistical analysis 
Statistical analysis was performed as described earlier (section 2.2.3). 
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3.3 Results 
3.3.1 Basal ERK activation during 3T3-L1 differentiation 
3T3-L1 cells were plated in 6 well plates at 150,000 cells/well (Nunc, Fisher 
Scientific, Bishop Meadow Road, Loughborough, UK) and once confluent were 
incubated with differentiation medium of day 0 until day 20. Medium was changed 
every two days. The 3T3-L1 cells were analysed over a time course when the 
medium was removed and cells were then washed twice with 1 ml of PBS. Cells 
were lysed with 250 l loading buffer and were rapidly frozen in liquid nitrogen before 
being stored at -20˚C. Basal ERK phosphorylation (activation) was detected by 
western blotting. The bands representing phospho-ERK1 (p44) and ERK2 (p42) are 
shown below (Figure 3.2). Basal ERK activation was influenced by the length of time 
in differentiation medium which observed high activation at day 0 and after that the 
level of activation of ERK declines rapidly with increased adipogenic differentiation to 
a level that is barely detectable by day 2. The appearance of the cells altered over 
the course of experiment changing from an elongated fibroblast shape into more 
rounded cells which can be seen from day 5. This is accompanied by an increase in 
lipid droplet accumulation, being seen in approximately 90% of the 3T3-L1 cells by 
day 8. 
 
 
 
 
Figure 3.4: Basal ERK activation  
Basal ERK activation during 3T3-L1 adipocyte differentiation. 
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3.3.2 GH stimulated ERK and STAT5 activation during 3T3-L1 
differentiation 
3T3-L1 cells were plated and cultured (section 3.2.1). Those cells undergoing 
adipocyte differentiation from day 0 to day 8 were exposed to GH for 10 minutes at 
50 nM then placed in loading buffer. ERK / STAT5 activation was detected by 
western blot with antibodies for phospho-ERK and STAT5 (Figure 3.3). GH-induced 
ERK activation in 3T3-L1 was high in undifferentiated cells, with high activation of 
ERK2 (p42) at day 0 after which the level of activation of ERK declines rapidly. In 
contrast, levels of total ERK1 (p44) and ERK2 (p42) show no change with increased 
adipogenic differentiation. In addition, GH-induced STAT5 activation increased during 
3T3-L1 differentiation and total STAT5 increased with the time of differentiation. 
Densitometric analysis of the blots (Figure 3.4) confirmed that ERK activation by GH 
was maximal during the early days of differentiation, but was undetectable by day 8. 
Analysis of data revealed a significant reduction of GH-induced ERK activation at day 
8 compared with day 0 of 4.5%  1.7% (p<0.01, n=4) and that total ERK was 
unchanged. In contrast, GH-stimulated STAT5 phosphorylation was significant 
increased in differentiated cells at day 8 compared with day 0 (734%  52%, p<0.01, 
n=4), as was total STAT5 4784%  1090%, p<0.01, n=4). 
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Figure 3.5: Phosohorylation of ERK and STAT5 
A western blot which shows phosohorylation of ERK and STAT5 following GH stimulation (+) 
over a time course of 8 days in adipocyte differentiation medium. The level of GH-stimulated 
ERK phosphorylation declines with increasing time in differentiation medium. The total ERK 
blot has two bands upper is p44 and lower p42. Only p42 was visible for P-ERK. In contrast 
the level of total STAT5 and GH stimulated STAT5 phosphorylation increased with 3T3-L1 
differentiation. 
P44 
P42
  
P44 
P42
 P42 
 
P95
55 
P95 
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Figure 3.6: Densitometric analysis of ERK and STAT5 
Densitometric analysis of western blots (Fig 3.3) expressed as % day 0 show increased total 
STAT5 and GH-stimulated STAT5 activation following differentiation, but reduced ERK 
activation despite same total ERK, * p<0.05, **p<0.01 vs. control cultures (day 0). n=4 
separate experiments. 
 
3.3.3 Maximal ERK phosphorylation during 3T3-L1 differentiation 
In order to determine whether adipogenesis causes a non-specific reduction of ERK 
with the potential to be phosphorylated, 3T3-L1 cells undergoing differentiation were 
treated with phorbol 12-myristate 13-acetate (PMA, 1μM, Sigma, UK) for 10 minutes 
and the level of ERK phosporylation analysed by western blotting. PMA was used as 
a positive control for ERK pathway activation as it directly activates protein kinase C 
thus causing non-receptor-mediated ERK activation and equivalent experiments 
were performed (section 3.2.1). PMA-induced ERK phosphorylation was unchanged 
by adipogenic differentiation which confirmed that the reduction in GH-induced ERK 
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phosphorylation seen in differentiated cells was specific and not due to a global 
reduction in ERK with the potential to be phosphorylated (Figures 3.7 and 3.8). 
 
 
 
 
Figure 3.7: PMA-induced ERK phosphorylation 
A western blot of 3T3-L1 cells treated with PMA shown levels of ERK activation were the 
same in differentiated cells and no significant difference in any of them. 
 
 
 
 
 
 
Figure 3.8: Densitometric analysis of 3T3-L1 cells with PMA 
Densitometric analysis of western blots of 3T3-L1 cells treated with PMA shown highest levels 
of ERK activation in differentiated cells, n=3. 
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3.3.4 Validation of the GHR QPCR assay 
Agarose gel electrophoresis along with melt curve analysis (Figures 3.7 and 3.8B) 
confirmed that the GHR QPCR assay produced a single product of the correct size 
(103 bp). Analysis of serial 10 fold dilutions of pooled cDNA (Figure 3.8A) was used 
to determine the efficiency of the assay. This can be calculated from the slope of the 
line of Ct value plotted against initial cDNA concentration where the undiluted pool is 
defined as one using the MxPro software (Stratagene). This technique allowed 
determination that the GHR assay had an efficiency of 98.8%. ARP amplified with a 
Ct value typically in the range of cycle 15-16 and this was unaltered by the 
differentiation state of the 3T3-L1 cells (section 2.3.3.1.1). ARP was confirmed as a 
suitable housekeeping gene for GHR analysis as it had a similar effecincy of 98.3% 
(determined as described in section 2.3.3.1) and its expression did not alter during 
3T3-L1 cell differentiation (Table 2.4). Sequence analysis of the GHR QPCR product 
confirmed the sequence was that of the GHR using the BLAST sequence search 
tool. (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: GHR QPCR product 
Agarose gel electrophoresis of 2% in 
1 x TAE confirmed the sizes of the 
GHR QPCR product, 103bp. M: DNA 
100bp ladder, lane 1: no template 
control and lanes 2 through 6: 
contain the amplified PCR products. 
103bp 
 
M    1     2     3    4     5     6 
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Figure 3.10: GHR QPCR analyses 
Validation of GHR QPCR assay performed on (A) serial dilutions of cDNA from 1:1 to 
1:100000 and NTC (B) resulting in the melting peak curve analysis of the resulting products 
and (C) the standard curve. The efficiency of the reaction was determined to be 98.8%. 
 78 
 
3.3.5 GHR expression during differentiation 
The level of GHR gene transcription during 3T3-L1 differentiation was analyzed using 
QPCR. GHR expression was increased during the differentiation process (Figure 3.9, 
3.10 and Table 3.3) with significantly higher levels being observed in differentiated 
cells at day 8 (610%  71% * p<0.05, n=4). 
 
 
Figure 3.11: Amplification curve of GHR 
GHR QPCR amplification curve day for 3T3-L1 cells in differentiation medium from day 0 to 
day 8. GHR expression was increased with the 3T3-L1 differentiation. 
 
Figure 3.12: GHR expression during 3T3-L1 differentiation 
QPCR analysis of GHR expression during 3T3-L1 differentiation shown a significant increase 
with cellular differentiation compared to control cultures, * p<0.05 vs day 0 cultures, n=4. 
 
Table 3.4: GHR and ARP QPCR assays 
Ct values for GHR and ARP QPCR assays during differentiation from days 0-8 had no effect 
on ARP. 
 Ct value 
 0 days 2 days 5 days 8 days 
GHR 23.47 22.54 21.91 20.82 
ARP 15.91 14.73 14.85 15.69 
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3.4 Discussion 
GH modulates the function of adipocytes through the promotion of lipolysis by means 
of the GHR which activates multiple signalling cascades that include both STAT5 and 
MAPK (ERK) pathways. However, although the growth effects of GH are mediated 
primarily by STAT5, at present little is known about how GH effects adipocyte 
differentiation of fat cell precursors. Therefore, the effect of GH on STAT5 and ERK 
activation pathways on 3T3-L1 pre-adipocyte cell line during differentiation was 
observed. 
 
The 3T3-L1 pre-adipocyte cell line was used as an in vitro model of adipogenesis as 
they can be induced to differentiate to adipocytes by modulating the culture 
conditions. After approximately 8 days in differentiation medium cells displayed 
morphological changes typical of adipocytes. Cultured samples were analysed for 
GHR expression using QPCR where increased expression of GHR was detected in 
differentiated cells. 
 
Adipogenic differentiation was found to effect GHR-associated signalling pathways in 
two ways. GH-induced STAT5 activation increased in differentiated cells reflecting 
the increased levels of total STAT5 and GHR, while GH-induced ERK activation 
decreased in differentiated cells, total ERK was unaltered and high levels of PMA-
induced ERK activation were observed. This inverse relationship between GH-
induced ERK activation and GH-induced STAT5 activation/PMA-induced ERK 
activation demonstrates a level of ERK with the potential to be activated. There 
seems to be a specific uncoupling of GHR activation from the ERK pathway in 
adipocyte differentiated 3T3-L1 cells. 
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Results from this study are in general agreement with other studies that show the 
level of GHR expression increases during adipocyte differentiation (Zou et al., 1997; 
Ji et al., 2002, Flint et al., 2006). GH binds to its receptor results in activation of 
STAT5 pathway in many cell types including adipocytes (Story and Stephens, 2006). 
Additionally, bind with the ERK pathway in bone marrow stem cell (BMSCs) and 
adipocytes (Winston and Bertics, 1992; Lewis et al., 2006; Wang et al., 2009). 
 
A range of in vitro studies have shown that STAT5 expression and/or activity is 
related with human and murine adipogenesis (Stephens  et al.,1996; Harp et al., 
2001; Nanbu-Wakao et al., 2002; Shang et al., 2003; Stewart et al., 2011). Previous 
research from Lewis et al., (2006) confirmed that GH-induced STAT5 activation 
increased during differentiation of BMSCs into adipocytes (Lewis et al., 2006). This 
study is in agreement, with my finding that 3T3-L1 differentiation results in increased 
GH-induced activation of STAT5 (Figure 3.3). GH-induced adipogenesis is mediated 
at least in part through STAT5 activation mediation via the transcription adipogeic 
factors C/EBPβ, C/EBPδ and PPAR causing increased expression of lipogenic 
enzymes and in triglyceride accumulation in 3T3-F442A and 3T3-L1 cells (Yarwood 
et al., 1999; Nanbu-Wakao et al., 2002; Kawai et al., 2007). The STAT5 pathway acts 
with other intercellular signalling to induce adipocyte differentiation (Aubert et al., 
1999, Stewart et al., 2011).  
 
Stimulation of the GHR in 3T3-F442A leads to ERK pathway activation (Winston and 
Bertics, 1992; Wang et al., 2009). Other results from this study have demonstrated 
that GH-induced ERK activation decreases in differentiated adipocyte cells (Figure 
3.3). This study is first to demonstrate a finding which contrasts those seen by Lewis 
et al., which showed that adipocyte differentiation increased GH activation of ERK in 
BMSCs (Lewis et al., 2004). However, BMSCs are a mixed population and therefore 
it may be possible that the increase in GH-stimulated ERK was due to cells other 
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than those which differentiated along the adipocyte lineage. Interestingly, other 
studies are in agreement with those results presented in this study which show that 
basal ERK activation pathway declines during differentiation of preadipocytes into 
adipocytes (Kim et al., 2001; Sakaue et al., 2002).  
 
Studies in pre-adipocyte cell lines and embryonic stem cells confirm a critical role for 
the ERK pathway in the early phase of adipocyte differentiation (Sale et al., 1995; 
Bost et al., 2002). This plays a key role in mediating the early mitotic clonal 
expansion initiated by adipogenic stimuli, such as insulin that induce adipogenic gene 
expression program (Qiu et al., 2001). Other studies have shown that in the early 
phase of adipogenesis ERK1/2 activation results in phorphorylation of C/EBPα and β 
(Prusty et al., 2002; Lanning and Carter-Su, 2006) and stimulation of PPAR 
expression leading to initiation of differentiation of fibroblasts into adipocytes (Aubert 
et al., 1999; Horie et al., 2004). The 3T3-L1 pre-adipocytes treated with 
dexamethasone (DEX), insulin (INS), isobutylmethylxanthine (IBMX) and fetal bovine 
serum (FBS) stimulate transient induction of the MEK/ERK pathway. This activation 
of the MEK/ERK pathway takes limited time before starting differentiation (Prusty et 
al., 2002). 
 
Pref-1 (also known as Delta-like protein 1, Dlk1) is a member of the 
Notch/Delta/Serrate family and is expressed in the cell membrane of pre-adipocyte 
(Wang et al., 2006; Sul, 2009; Wang and Su, 2009; Armengol et al., 2012). This 
expression declines with pre-adipocyte differentiation and is absent in mature 
adipocytes (Sul et al., 2000; Gregoire, 2001; Kim et al., 2007; Sul, 2009, Armengol et 
al., 2012). Pref-1 is cleaved to release an extracellular 50 kDa active form by Notch 
ligand Delta TACE [TNFα (tumour necrosis factor α)-converting enzyme] (Smas et 
al., 1997; Wang and Sul 2009; Sul, 2009; Armengol et al., 2012). These studies have 
established that pref-1 prevents adipogenesis and therefore believed that this is 
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mediated via the transcription factors Sox9 that suppresses C/EBPδ and C/EBPβ 
expression (Wang and Sul 2009; Sul, 2009). Also, Pref-1 causes the activation of 
ERK which in turn prevents down regulation of Sox9 thus inhibiting adipogenesis 
(Smas et al., 1997; Kim et al., 2007; Sul, 2009; Wang and Sul, 2009). Other studies 
suggest that Pref-1 could act on adipocyte differentiation during modulation of Notch 
pathways (Armengol et al., 2012). Negative regulation of Pref-1 expression appears 
during adipogenesis in the cell treatment with combination of MIX/DEX, which 
promotes adipocyte differentiation (Sul et al., 2000). 
 
The advantages of western blotting are sensitivity to as little millgrams of protein and 
specificity amongst hundreds of thousands of alternate proteins. Enhanced 
chemiluminescence was used to detect immobilised proteins labelled with HRP. The 
advantages of this technique are sensitivity down to the photon level, speed, non 
hazardous reagents and simple procedures. The only disadvantage involves the very 
high sensitivity which requires secondary anti-bodies to be diluted several thousand 
times in order to avoid background noise (Kricka, 1991). 
 
The advantages of reprobing membrane are the conservation of the sample, quick, 
inexpensive and easy to correct mistakes or anomalies in the blots. However, 
disadvantages are that stripping removes antibodies, but alters also the protein 
quantity on the membrane as they are not covalently fixed. Incomplete stripping may 
result in blocked epitopes by still bound antibodies which are disturbed when re-
probed with another polyclonal antibody. 
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There are several possible explanations as to how GH-induced ERK activation 
declines during 3T3-L1 differentiation. The classic study of Love et al., (1998) 
showed that GH is capable of activating the ERK pathway in 3T3-F442A cells, but 
not in IM-9 lymphocyte cells and that the 66 kDa form of the ERK pathway adapter 
protein Shc is only present in 3T3- F442A cells (Love et al., 1998; Yang et al., 2004; 
Wang et al., 2009). Therefore, the possibility exists that the 66 kDa form of Shc is 
necessary to couple the GHR to ERK pathway activation. Determination of Shc levels 
during 3T3-L1 differentiation could explain the decline in GH-stimulated ERK 
activation; experiments will be performed to look at Shc levels in 3T3-L1 during 
differentiation (Chapter 4). Also, it is possible that the elevated GHR expression 
levels seen in differentiated 3T3-L1 may modulate the profile of signalling pathways 
associated with ERK pathway. 
 
 
 
  
Chapter Four
Do the expression levels of p66Shc and the 
GHR modulate GH signalling during 3T3-
L1 differentiation?
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4. Chapter Four 
4.1 Introduction 
Chapter 3 demonstrated that GH-stimulated ERK pathway activation declines as 
3T3-L1 cells progress down the adipocyte differentiation pathway. In this chapter, two 
possible explanations for the decline in GH-stimulated ERK activation were explored. 
 
Love et al. (1998) demonstrated that GH stimulates the tyrosine phosphorylation of 
JAK2, ERK1/2 and STAT5 in 3T3-F442A cells (another murine pre-adipocyte cell 
line), but failed to activate the ERK1/2 pathways in IM-9 (human B lymphoblastic cell 
line). The 66 kDa form of the ERK pathway adapter protein Shc p66Shc is present in 
3T3-F442A, but absent in IM-9 cells. These observations lead Love et al. to suggest 
that p66Shc is necessary for GHR activation to link with the ERK pathway (Love et al., 
1998). Therefore, this study proposes that adipocyte differentiation of 3T3-L1 cells 
results in the decline of p66Shc levels resulting in the selective uncoupling of the GHR 
from the ERK pathway in 3T3-L1 cells. In order to determine whether the difference 
in the amount of basal p66Shc could explain the decline in GH-stimulated ERK 
activation and the selective uncoupling of the GHR from the ERK pathway, western 
blotting was used to analyse expression of p66Shc in 3T3-L1 cells as they undergo 
differentiation. 
 
Findings from this study confirmed that expression of the GHR increases during 3T3-
L1 differentiation from pre-adipocytes into adiopcytes (section 3.4.5). In addition, 
previous studies have shown that GHR is expressed in both pre-adipocytes and 
mature adipocytes, but GHR expression increases with adipocyte differentiation (Zou 
et al., 1997; Yu, 2000; Ji et al., 2002; Flint et al., 2006). An increase in GHR 
expression may possibly modulate the pattern of signalling pathways associated with 
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GHR activation. As such, elevated GHR levels may result in preferential association 
of the GHR with JAK2-STAT5 leading to reduced ERK activation. To test this 
hypothesis a technique was employed to over-express the GHR in undifferentiated 
3T3-L1 cells in an attempt to mimic the effect of adipogenic differentiation on GHR 
numbers and GHR-associated cell signalling. 
 
4.1.1 Src Homology (Shc) protein 
Shc is an adapter protein and one of several proto-oncogene products which do not 
possess any intrinsic catalytic activity. The molecular structure of Shc is made up of 
at least three tyrosine phosphorylation sites each of which are located within the 
central collagen-homology domain along with two PTB domains, one SH2 domain 
located near the carboxyl terminus and another PTB domain located near the amino 
terminus. Based upon this molecular structure, many studies have demonstrated that 
this protein will function as an adaptor molecule that will assist in the mediation of 
phosphotyrosine-dependent signalling events that take place near cell surface 
receptors (Pelicci et al., 1996; Zhang et al., 2002). This is accomplished by binding 
tyrosine phosphorylated proteins via SH2 and PTB domains, thus acting as a bridge 
that links together proteins in a signalling pathway (Pelicci et al., 1995; Song et al., 
2002). 
The Shc protein exists as three isoforms of 46, 52, 66 kDa; p46Shc, p52Shc and p66Shc. 
These isoforms are produced from one gene through the process of alternative 
splicing (Almind et al., 1999; Kisielow et al., 2002; Purdom and Chen, 2003; Landry 
et al., 2003). Receptors possess tyrosine phosphorylation sites that Shc can bind to, 
which is surprising as it was originally thought that Shc acted solely as an ERK 
pathway adapter protein linking receptor activation to ERK via its interaction with 
Grb2 forming a Shc-Grb2-Sos signalling complex (Figure 4.1) (Charlotte et al., 1998; 
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Sasaoka and Kobayashi, 2000; Ravichandran, 2001, Wang et al., 2009). This 
signalling complex then activates Ras, which in turn triggers the first kinase in a 
three-kinase cascade leading to ERK (MAPK) activation (Charlotte et al., 1998). 
However, recent data suggests that the p66Shc is involved in mitochondrial reactive 
oxygen species generation and thus may play a central role in linking high levels of 
glucose with the adverse side effects of diabetes (Francia et al., 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Shc signaling pathway 
Shc mediate Ras activation downstream of receptor RTK. Shc binds to phosphorylated RTKs 
and recruits the Grb2/SOS complex which activates ERK pathway (adapted from Kleiner, 
2005). 
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4.1.2 GHR expression in 3T3-L1 cells 
GHR levels increase with adipogenic differentiation of 3T3-L1 cells (section 3.3.3) 
which lead to the hypothesis that elevated expression of the GHR may be linked to 
the preferential association of the GHR with JAK2-STAT5 resulting in reduced ERK 
activation. This hypothesis was tested by transfecting 3T3-L1 cells with a GHR 
expression vector to induce over expression of the GHR and thus mimic the elevated 
GHR levels in differentiated 3T3-L1 cells. Studies then determined whether this had 
any effect on GHR associated cell signalling compared to cells transfected with the 
empty vector. 
 
4.1.3 Transfection 
Transfection is the transient introduction of RNA or DNA into cultured cells, including 
mammalian, to study gene function, gene expression or protein production. Carrier 
molecules which enable gene delivery into primary cells include plasmid DNA 
(pDNA), messenger RNA (mRNA) and short interfering RNA (siRNA). No single 
method of delivery can be applied to all types of cells as transfection efficiencies 
depend on the reagent, protocol and cell type utilized. There are two types of 
transfection, transient when the introduced plasmid remains autonomous and is 
gradually diluted out at each cell division and stable in which the plasmid DNA 
becomes incorporated into the host genome and is thus transmitted to all daughter 
cells. Production of the cDNA-encoded protein continues only for a limited time in 
transiently transfected cells (plasmids replicate independently of the chromosomal 
DNA), while in stable transfection the exogenous DNA is integrated into the host 
genome allowing cells to continually produce the cDNA-encoded protein as long as 
the culture is maintained.  
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Liposome-mediated and electroporation are two methods of transfection developed 
to facilitate the introduction of DNA into cells. Liposome-mediated transfection is the 
most widely used. In this type of transfection the plasmid is complexed with cationic 
polymer (polyplex), cationic lipid (lipoplex) or a mixture of these called a lipopolyplex 
(Lechardeur et al., 2002). The charged DNA complex is taken from the extracellular 
compartment by endocytosis and transferred into the nucleus. Advantages of using 
liposome-mediated transfection are its relatively high efficiency of gene transfer, the 
ability to transfect certain cell types that are resistant to calcium phosphate or DEAE-
dextran, the successful delivery of DNA of all sizes including oligonucleotides 
(Felgner et al., 1987), the ability to delivery RNA (Malone et al., 1989), the delivery of 
proteins (Debs et al., 1990) and the ability to generate transient and stable 
integration (Felgner et al., 1995). 
 
Electroporation is a mechanical transfection method that utilizes an electronic pulse 
to form momentary pores within cell membranes (Toneguzzo et al., 1988) through 
which substances such as nucleic acids can pass (Chu et al., 1987). Voltage is the 
critical parameter for electroporation as for a given capacitance/buffer there was an 
optimal voltage for transfection (Chu et al., 1987). Electroporation is a simple process 
where both the target cells and specified molecules are suspended within an 
electrically conductive solution. An electric circuit is closed around the solution. This 
allows an electric pulse lasting beyween several microseconds to a millisecond and 
at an optimal voltage to be discharged through the target cells. This disrupts the 
phospholipid bilayer of the cell membrane by allowing temporary pores to appear. 
Concurrently, the electrical potential across the cellular membrane rises to allow the 
specified molecules, which are now charged, to be forced across the membrane 
through these temporary pores (Chu et al., 1987). Cells can then divide to produce 
new cells that contained the introduced plasmids. This process is approximately ten 
times more effective than that of chemical transformation. However, both of these 
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liposome-mediated and electroporation techniques suffer from problems related with 
cellular toxicity, poor reproducibility, inconvenience or inefficiency of DNA delivery. 
Also, transfection efficiencies can vary noticeably depending on the transfection 
method, reagent, protocol or type of cells 
 
4.1.4 Aims  
The aim of this chapter was to explore possible mechanisms to explain why GH-
stimulated ERK activation declines as 3T3-L1 cells undergo adipogenic 
differentiation. This was determined by measuring the amount of basal p66Shc in 
preadipocytes and at several time points during in vitro induced adipogenesis to test 
the hypothesis that limitation of this adaptor protein could explain the decline in GH-
stimulated ERK activation and the selective uncoupling of the GHR from the ERK1/2 
pathway. Western blotting was used to analyse p66Shc in 3T3-L1 cells as they 
undergo differentiation. Also, elevated GHR expression, as found in differentiated 
adipocytes, could explain the reduction in GH-stimulated ERK observed in 
differentiated 3T3-L1 cells. This was tested by transfecting 3T3-L1 cells pre-
adipocyte with a GHR expression vector and observing GH induced activation of the 
ERK pathway. 
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4.2 Material and methods 
4.2.1 Detection of Shc in differentiating 3T3-L1 cells 
Western blotting techniques have been used to determine Shc expression levels 
during 3T3-L1 differentiation (section 3.2.2.4). 3T3-L1 cells (150,000cells/well) were 
plated in 6 well plates in DMEM containing 10% calf serum and once confluent 
designated day 0 were induced to differentiate along the adipogenic lineage by 
changing the culture medium to differentiation medium (section 2.2.4). Samples were 
then collected at day 0, 2, 5 and 8 when cells were washed 2 times in PBS and lysed 
in 250 µl loading buffer. Protein was measured (section 3.2.2.1) and 20 µg samples 
were run on SDS-PAGE using a 10% gel followed by the detection of Shc using 
western blotting. All SDS-PAGE and western blotting procedures were performed as 
described (section 3.2.2). Blots were blocked for 1 hour and then incubated in 
primary anti-total Shc antibody overnight at 4C (Cell Signalling, Technology, 
Danvers, MA, USA) at 1:2000 dilution. Secondary antibody, anti-mouse IgG 
horseradish peroxidase (GE Healthcare, Little Chalfont, Bucks, UK), was used at a 
1:5000 dilution for 1 hour. The blots were then visualised using ECL Plus (GE 
Healthcare, Little Chalfont, Bucks, UK) as described earlier (section 3.2.2.6). 
 
4.2.2 Over expression of the GHR in 3T3-L1 cells 
The aim of this section was to transfect 3T3-L1 cells with a vector (pUB/Bsd) modified to 
contain the hGHR sequence under the control of the CMV promoter so that the cells over 
expressed the GHR. 
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4.2.2.1 GHR expression vector 
The hGHR vector was prepared by Dr David Millar of the Institute of Medical 
Genetics in Cardiff University. The GHR was PCR amplified from human cDNA using 
primers GHRNHE5, GCTAGCCACCATGGATCTCTGGCAGCTGC, and GHRXBA3, 
TCTAGACTAAGGCATGATTTTGTTCAG. The fragment was cut with the restriction 
enzymes NheI and XbaI (sites in bold on primers) and cloned into pRLCMV cut with 
the same enzymes. Clone was sequenced. Second PCR was performed using 
primers GHRBSD5 GTCGACTTTTGCTCACATGGCTCGAC and GHRBSD3 
CTCGAGGCCACCTGGATCCTTATCG which PCR amplifies the CMV promoter, the 
GHR cDNA and the SV40 3'UTR. The fragment was cut with SalI and XhoI (sites in 
brown bold on primers) and cloned into the SalI site of pUBBsd. Again, clone was 
sequenced to confirm identity. 
 
4.2.2.2 Transformation of E. coli with the plasmid vector. 
Transformation is the process by which bacterial cells take up plasmid DNA which 
allows the introduction of a foreign plasmid into bacteria to use the transformed 
bacteria to amplify the plasmid. When a plasmid is inserted into bacterial cells, they 
can be grown in large amounts to produce milligram quantities of the plasmid which 
can be used in subsequent experiments.  
 
In this study Competent Topp10 E. coli were transformed with the GHR plasmid 
expression vector. 1 µl of the plasmid at a concentration 10 ng/µl DNA was placed in 
the bottom of a microfuge tube. A second tube without plasmid containing 1 µl of 
sterile water was used as a negative control. The competent bacteria were thawed 
on ice, and then 25 µl of competent cells added to each tube. Both tubes were then 
kept on ice for 30 minutes. The competent cells were then heat shocked at 42C for 
30 seconds and then placed back on ice. One ml Luria Broth (LB) medium (Sigma, 
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St. Louis, MO, USA) containing 20 mM filter sterilised glucose was added to the cells 
and shaken at 37C, 200rpm (Orbital shaker S 150, Stuart Scientific) for 1 hour. 
Following this incubation 100 µl of cells were spread onto a LB agar plate (Sigma, 
Gillingham, Dorset; UK) (Appendix 1) containing 100 µg/ml ampicillin (Sigma, UK) 
and incubated overnight. The remaining 900 µl was centrifuged and the resulting 
bacteria were resupended in 100 µl LB broth and were plated on another plate. The 
presence of ampicillin resistant bacterial colonies following an overnight culture 
confirmed that the transfection had been successful. 
 
4.2.2.3 Midi-prep of plasmid DNA 
5 ml of LB broth with 100 µg/ml ampicillin were inoculated with a single colony of 
transformed E. coli and incubated overnight at 37C in an orbital shaker at 200 rpm. 
Next day the culture medium was observed to be cloudy, 1 ml transferred to 
Erlenmeyer flask with 95 ml LB ampicillin then incubated via vigorous shaking orbital 
shaker at 37˚C overnight and a further 1 ml used to prepare glycerol stock (Appendix 
1). Next day the LB bacterial suspension was centrifuged for 50 minutes/4C at 3600 
rpm and plasmid extracted using Pure Yield TM Midiprep system (Promega, Madison, 
WI, USA) according to the manufacturer’s instructions. Briefly the pellet was re-
suspended in cell solution and lysed in cell lysis buffer. Plasmid DNA was 
precipitated and purified using a column based procedure according to the 
manufacturer’s instructions. The purified plasmid DNA was eluted from the column 
with elution buffer and DNA concentration determined via spectrophotometer 
analysis at 260 nm then stored at -80C. 
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4.2.2.4 Transfection of 3T3-L1 with the GHR plasmid 
Transfection is the phenomenon of incorporation of exogenous nucleic acids through 
the cell membrane. 3T3-L1 cells were transfected with an expression vector 
containing the hGHR sequence using two different methods, a reagent liposomal 
based method and an electroporation method.  
 
4.2.2.4.1 Reagent-based transfected 
The reagent-based method uses a polycationic polyamine reagent, GeneJammer 
(Stratagene). GeneJammer has several positively charged amino groups, which bind 
to and neutralize the negatively charged DNA allowing the target cell to readily 
assimilate the DNA by endocytosis. For transient transfections, 150,000 3T3-L1 cells 
were plated in 6 well plates then cultured until confluent (section 2.2.1). Initially, cells 
were transfected with a green fluorescent protein plasmid GFP, (2 µg, pmax GFP) 
(Lonza, Basle, Switzerland) to determine transfection efficiency. The transfection 
mixture was prepared in 50 µl serum free medium with 3 µl GeneJammer and 1 µg 
plasmid, the mixture was then incubated for 15 minutes before being added drop 
wise to the cells in complete culture medium. Cells were cultured for 24 hours and 
examined for GFP expression using fluorescence microscopy. Transfection efficiency 
was determined by counting the GFP positive cells and comparing this against the 
total number of cells. 
4.2.2.4.2 Electroporation 
The hGHR expression vector and empty vector were also transfected into 3T3-L1 
cells using a technique known as electroporation using a proprietary kit optimized for 
3T3-L1 pre-adipocytes (Lonza). 3T3-L1 cells were subjected to electroporation with 
either buffer alone (control), empty vector, GHR expression vector (either 1 µg or 10 
µg) and GFP vector (2 µg, pmax GFP) (Lonza). Cells were cultured before 
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electroporation in a 75 cm2 flask culture cells in DMEM containing 10% calf serum. 
Once 80% confluent, the medium was removed and the cells trypsinized before 
being counted (section 2.2.1.2). The cells were centrifuged and the pellet 
resuspended in 100 µl nucleotector solution per 1x106 cells. The 100 µl cell 
suspension containing the plasmid DNA was then transferred to an Amaxa cuvette 
where the electroporation was performed using an Amaxa Nucleofector II 
electroporation apparatus (Lonza). The appropriate nucleofector program T-30 was 
selected and the cuvette inserted into the holder where the electroporation was then 
performed. The cuvette was removed then 500 µl of the pre-warmed culture medium 
added. The contents of the cuvette was transferred into one well of a 6 well plate 
which contain 2 ml complete medium then cultured. After 24 hours of incubation, the 
medium was removed and replaced with 1.5 ml fresh culture medium. Cells were 
grown for between 2 to 3 days until 80% confluent when a signalling experiment was 
carried out (section 3.2.1). Transfection efficiency was assessed by counting GFP 
positive cells against total number of cells after 24 hours had elapsed. 
 
4.2.2.5 Western blotting techniques  
Experiments were carried out as described previously (section 3.2.2.4). 
 4.2.2.6 RNA extraction and QPCR analysis of human GHR expression 
To determine if transfection with the hGHR vector caused elevated GHR expression, 
RNA was extracted for QPCR analysis (sections 2.2.6, 2.2.6.2 and 2.2.6.3). The 
gene ARP was used as the housekeeping gene. Primers are detailed below (Table 
4.1) and were used at a concentration of 500 nM. hGHR expression was compared 
with ARP using MxPro (MX3000PTM, Stratagene). 
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Table 4.1 Primers of the hGHR and ARP  
hGHR and ARP primers for QPCR analysis were used to detect hGHR expression. 
 
hGHR   
Forward Reverse Amplicon size 
GCCACTGGACAGATGAGGTT TCAGGCCATTCTTTCCATTC 229bp 
ARP   
Forward Reverse Amplicon size 
GAGGAATCAGATGAGGATATGGGA AAGCAGGCTGACTTGGTTGC 71bp 
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4.3 Results 
4.3.1 Basal Shc activation during 3T3-L1 differentiation 
The hypothesis proposed that down regulation of p66 Shc may cause the reduction 
in GH-stimulated ERK seen during 3T3-L1 differentiation. To gain an insight into 
whether the p66Shc level declines in 3T3-L1 cells undergoing adipocyte differentiation, 
Shc levels were analysed by western blotting. The bands representing Shc isoforms 
46 kDa, 52 kDa and 66 kDa from two separate experiments are shown below (Figure 
4.2). Western blots from ten separate experiments were analysed by imaging 
densitometry (Figure 4.3) and the mean level of p66Shc over the time course of 
differentiation showed a transient rise at days 2 to (310% ± 120 of the level at day 0) 
and at day 5 (360± 140 of the level at day 0) followed by a decline at day 8 to (270 % 
± 100 of the level at day 0) but to a level greater than at day 0. None of the results 
were significantly different to the basal day 0 level (p=0.337). Shc level also were 
reanalysed and plotted as a scatter plot (Appendix 2). 
 
 
 
 
 
 
 
Figure 4.2 Shc expression in 3T3-L1 cells 
Western blot analysis of Shc expression in 3T3-L1 cells at day 0 and days 2, 5 and 8 in 
differentiation medium. These blots are two independent experiments. 
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Figure 4.3 66 kDa form of Shc levels  
Densitometeric analysis of 66KDa form of Shc from western blot as 3T3-L1 undergoes 
differentiation. The results are expressed as % of day 0. The results demonstrated no 
significant difference of the level of Shc during 3T3-L1 differentiation (p=0.337, n=10). Shc 
level also were reanalysed and plotted as a scatter plot (Appendix 2). 
 
 
4.3.2 Transfection efficiency 
Transfection efficiency was assessed by counting the number of GFP positive cells 
24 hours after transfection and expressing this as a percentage of the total cells in 
that field. Each result is the mean of four separate fields chosen at random in three 
separate experiments. The reagent-based method using GeneJammer had very low 
transfection efficiency (3-4%, Figure 4.4). In contrast, electoroporation resulted in 
much better transfection efficiency (60-70%, Figure 4.5). Therefore, electoroporation 
was used for all subsequent experiments. 
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Figure 4.4 3T3-L1 cells transfected with GFP using GeneJammer 
The 3T3-L1 cells were transfected with GFP using GeneJammer and were analyzed by 
fluorescence microscopy (B) to check transfection efficiency after 24-48 hours. The same field 
of view is shown with phase contrast (A) to show the total number of the cells. Transfection 
efficiency was 3-4%. 
 
 
 
Figure 4.5 3T3-L1 cells transfected with GFP using electroporation 
The 3T3-L1 cells were transfected with GFP using electroporation and were analyzed by 
fluorescence microscopy (B) to check transfection efficiency after 24 hour. The same field of 
view is also shown with phase contrast (A) to show the total number of the cells. Transfection 
efficiency was 60-70%. 
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4.3.3 Validation of the hGHR QPCR assay 
Agarose gel electrophoresis and melt curve analysis (Figures 4.6 and 4.7B) 
confirmed that the hGHR QPCR assay produced a single product of the correct size 
which was 229bp. Analysis of serial dilutions of pooled cDNA (Figure 4.7A) was used 
to determine the efficiency of the assay. This can be calculated from the slope of the 
line of Ct value plotted against initial cDNA concentration where the undiluted pool 
was defined as one using the MxPro software (Stratagene). This technique was to 
determine that the hGHR assay had an efficiency of 100.5%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 hGHR QPCR product  
Agarose gel (2%) in 1xTAE confirmed 
the sizes of the hGHR QPCR product 
was 229bp. Lanes (M) DNA 100bp 
ladder, (1) empty vector transfected 
cells, sample form hGHR transfected 
cells (2-3) and no template control, 
(4). 
 
229bp 
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Figure 4.7 hGHR qPCR analyses 
Validation of hGHR QPCR assay performed on (A) serial dilutions of cDNA from 1:1 to 1:1000 
and NTC (B) which resulted in the melting peak curve analysis products (C) which result the 
standard curve. 
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4.3.4 Effect of GHR expression on GH-induced ERK and STAT5 
activation 
The effect of elevated GHR expression on GH-induced ERK and STAT5 activation 
was analysed by phospho-specific western blotting (section 3.2.2) in cells treated for 
10 minutes with GH (50 nM) and PMA (1 µM) as a positive control for ERK. The level 
of GHR gene transcription in 3T3-L1 transfected with 1 µg and 10 µg of the hGHR 
vector was analyzed using QPCR. QPCR results confirmed high expression of the 
GHR transcript in 3T3-L1 transfected with the hGHR compared with empty vector in 
three separate experiments (Figure 4.8). 
 
 
 
Figure 4.8 QPCR analysis of GHR expression in 3T3-L1 transfected  
QPCR analysis of GHR expression in 3T3-L1 transfected  which show a 350.00 fold increase 
in cells transfected with 1 µg hGHR plasmid and 400.00 fold increase in cells transfected with 
10 µg hGHR plasmid relative to empty vector tranfected cells, in three separate 
experiments, n=3. 
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Signalling experiments were performed in transfected cells for ERK and STAT5 
activation, detected by western blotting with antibodies for phospho-ERK and 
phospho-STAT5 (Figure 4.9). Densitometric analysis of the data from multiple 
experiments (n=5, Figure 4.10) demonstrated no significant difference in the GH-
stimulated ERK activation between 1 µg GHR and empty vector transfected cells 
(15.6%± 6.9 vs. 16.1% ± 4.4 compared to control respectively p=0.29). Total ERK 
levels did not differ between the two groups. In contrast STAT5 activation showed a 
significant increase in 1 µg GHR transfected cells compared with empty vector 
(26058 ± 12338 and 7680 ± 900, n=5 separate experiments *p<0.05). Maximal 
stimulation of ERK using PMA was unaltered in GHR transfected compared to empty 
vector transfected cells (Figure 4.9). 
 
 
 
Figure 4.9 Phosphorylation of ERK and STAT5 following GH and PMA in transfected 
cells 
Western blot reveals phosphorylation of ERK/STAT5 following GH/PMA treatment in cells 
transfected with empty vector (Vector) and GHR expression vector (GHR). Level of GH-
stimulated ERK phosphorylation is unaltered in GHR transfected cells compared empty 
vector transfected cells; in contrast level of GH stimulated STAT5 phosphorylation increased 
in hGHR transfected cells. 
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Figure 4.10 Densitometric analysis of GH on ERK activation in cells transfected with 
hGHR.  
Densitometric analysis of western blots that look at the effect of GH on ERK activation 
following cells transfected with 1 µg hGHR plasmid. The bands at day 0 observed different 
results therefore, the result is expressed as % PMA. The Each value is the % of the PMA 
band for that experiment (mean ± SE, n=5). These results show no significant difference 
between the vector and GHR transfected cells.  
 
 
 
 
 
 
Figure 4.11 Densitometric analysis of GH on STAT5 activation in cells transfected with 
hGHR.  
Densitometric analysis of the western blot shows in Figure 4.9. The results (integrated density 
value, IDV) show GH-stimulated STAT5 activation in transfected cells with hGHR plasmid 
and empty vector. The results display increased STAT5 activation in hGHR transfected cells.  
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The same experiment was performed using cells transfected with 10 µg hGHR to test 
if greater over expression of the GHR modulated ERK activation. The results 
revealed no difference between the levels of activation ERK in cells transfected with 
1 µg or 10 µg hGHR. In conclusion, over expression of the hGHR was shown to have 
no effect on GH stimulated ERK activation, but slightly increased the level of STAT5 
activation. 
 
 
 
Figure 4.12 Effect of hGHR dose on GH activation of ERK and STAT5 
Western blot which shows phosphorylation of ERK following GH treatment in cells transfected 
with 1µg empty vector (Vector) and the GHR expression vector (GHR) and 10µg empty 
vector (Vector) and the GHR expression vector (GHR). The level of GH-stimulated ERK 
phosphorylation is unaltered in GHR transfected cells compared 1µg transfected cells and 
10µg. 
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The level of GHR expression in cells transfected with 1 ug or 10 ug of plasmid was 
much higher than that achieved during adipogenesis (approximately 10 fold, Chapter 
3). Consequently additional experiments were performed using cells transfected with 
different lower doses 1 µg, 0.1 µg and 0.01 µg hGHR to try to mimic the effects of 
adipogenesis more closely (see Figure 4.13-4.15). The results show no difference 
between the levels of activation of ERK in cells transfected with 1 µg, 0.1 µg and 
0.01 µg hGHR. Level ERK activation was detected in 1 µg, 0.1µg, 0.01 µg GHR 
expression vector compared with empty vector treatment 10 minutes GH (mean ± 
SE, n=3, 1 µg p=0.09, 0.1 µg p=0.23 and 0.01 µg  p=0.06). The results show GH-
stimulated STAT5 activation in transfected cells with 1 µg, 0.1 µg and 0.01 µg hGHR 
plasmid and empty vector. The results display increased STAT5 activation in hGHR 
transfected cells. 
 
 
Figure 4.13 Effect of hGHR dose on GH activation of ERK and STAT5 
Western blot shows phosphorylation of ERK/STAT5 after GH treatment/10 minute in cells 
transfected with 1 µg empty vector (Vector) and 1 µg GHR expression vector (GHR), 0.1 µg 
empty vector (Vector) and 0. 1 µg GHR expression vector (GHR) and 0.01 µg empty vector 
(Vector) and 0. 01 µg GHR expression vector (GHR). Level of GH-stimulated ERK 
phosphorylation altered in GHR transfected cells compared empty vector transfected cells (0. 
1 µg GHR expression vector (GHR) and 0.01 µg empty vector (Vector). Level of GH 
stimulated STAT5 phosphorylation increased with 3T3-L1 transfected with hGHR. 
 106 
 
 
 
Figure 4.14 Densitometric analysis of GH on ERK activation following transfection with 
hGHR.  
Densitometric analysis of western blots which look at the effect of GH on ERK activation 
following in cells transfected with 1 µg, 0.1µg and 0.01µg hGHR plasmid. Each value is the % 
of the control for that experiments (mean ± SE, n=3). These results show no significant 
difference between the vector and GHR transfected cells. 
 
 
 
 
Figure 4.15 Densitometric analysis of GH on STAT5 activation following transfection 
hGHR.  
Densitometric analysis of western blots shown in Figure 4.13. Phospho-STAT5 was 
undetectable in empty vector, but easily detectable in transfected cells with 1 µg, 0.1 µg and 
0.01µg hGHR plasmid, however, since there are no bands empty vector results are 
expressed as IDV absolute values, (mean ± SE, n=3), (integrated density value, IDV). The 
results show GH-stimulated STAT5 activation in transfected cells with 1 µg, 0.1 µg and 0.01 
µg hGHR plasmid and empty vector. The results display increased STAT5 activation in hGHR 
transfected cells. 
% 
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4.4 Discussion 
Results from Chapter 3 demonstrated increased expression of GHR in differentiated 
3T3-L1 cells and that adipogenic differentiation had two distinct effects on GHR-
associated cell signalling pathways. GH-induced STAT5 activation increased in 
differentiated cells which reflected the increase in levels of total STAT5 and GHR. In 
contrast, GH-induced ERK activation declined in differentiated cells while total ERK 
was unchanged. Elevated levels of PMA-induced ERK activation were observed in 
differentiated cells. This would appear to be a specific decline in GH-induced ERK 
activation as GH-induced STAT5 activation and PMA-induced ERK activation both 
increased with cell differentiation clearly indicating that ERK has the potential to be 
activated. As such, there seems to be a specific uncoupling of GHR activation from 
the ERK pathway in adipocyte differentiated 3T3-L1 cells. My second investigation 
tried to explain this decline in ERK activation. 
 
As previously discussed Love et al., (1998) demonstrated that the ERK pathway 
adapter protein p66Shc was necessary for coupling GH to ERK. The p46Shc and p52Shc 
isoforms are expressed in all tissues while the p66Shc form was observed to be 
missing in some types of cells (Almind et al., 1999). Activation of the ERK pathway 
by GH appears to be cell type specific involving the p66Shc form of the adapter 
protein. p66Shc is expressed in 3T3-F442A cells where GH was able to activate both 
ERK and STAT5, but was found to be absent in IM-9 lymphocyte cells that lack ERK 
activation following GH treatment (Love et al., 1998). As such, it was proposed that 
p66Shc was necessary to couple GHR activation to the ERK pathway. As such it was 
hypothesized that down regulation of p66Shc may mediate the reduction in GH 
stimulated ERK in 3T3-L1 cells during conversion of pre-adipocytes into adipocytes. 
To test whether p66Shc levels declined in 3T3-L1 cells undergoing adipocyte 
differentiation, Shc levels were analysed using western blotting. Contrary to the 
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original hypothesis p66Shc levels did not decrease as 3T3-L1 cells undergoing 
adipocyte differentiation, but instead were observed to be similar to cells at day 0 and 
day 8 despite a total lack of GH stimulation of ERK at day 8 in differentiation medium. 
Therefore, a reduction in p66Shc cannot explain the loss of GH-stimulated ERK in 
differentiation. This result eliminates the possibility that a decline of p66Shc levels 
prevents the activation of ERK in GH-stimulated differentiated 3T3-L1 cells.  
 
During 3T3-L1 differentiation, expression of GHR was observed to increase (section 
3.4.5) as previously described by Winston and Bertics, 1992; Jin et al., 2002; Flint et 
al., 2006; Story and Stephens, 2006 and Lewis et al., 2006. Therefore, it was 
hypothesized that altered levels of GHR expression may modulate the signalling 
pathways coupled to the receptor. If this resulted in preferential coupling to JAK2-
STAT5, the hypothesis may explain the reduction in GH activated observed during 
differentiated 3T3-L1 cells. Experiments were performed to test the hypothesis using 
GHR over expression in 3T3-L1 pre-adipocyte cells to mimic the differentiated state, 
but failed to cause a decline in GH activation of ERK. The data presented suggests 
that there is no relationship between the over expression of GHR in 3T3-L1 cells and 
the decline in ERK activation observed in adipocyte differentiated cells. Instead the 
level of ERK activation was the same in empty vector and GHR 3T3-L1 transfected 
cells, while GH-induced STAT5 activation was slightly increased in 3T3-L1 cells 
transfected with the hGHR vector compared to the empty vector. 
 
The finding that high expression levels of GHR increases during 3T3-L1 
differentiation into adipocytes (Zou et al., 1997; Ji et al., 2002; Flint et al., 2006) 
supports the view that GH acts on adipose tissue through GHR and modulates 
cellular function (Zou et al., 1997). GH binding to its receptor results in activation of 
the STAT5 pathway in many cell types including adipocytes (Story and Stephens, 
2006). STAT5 levels are increased during adipocyte differentiation and are important 
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mediators of cell development. Expression of STAT5 proteins correlates with lipid 
accumulation and the expression of PPARγ and C/EBPα in BMSCs and adipocytes 
(Winston and Bertics, 1992; Floyd and Stephens, 2003; Lewis et al., 2006). 
 
During physiological processes the ERK pathway plays a critical role in regulating 
signalling pathways which mediate different cellular processes. The upstream 
activators of ERK kinases, phosphorylate and activate the MAPKs on regulatory 
threonine and tyrosine residues, thereby regulating ERK activity (Imajo et al., 2006). 
ERK is essential in the early phase of adipocyte differentiation while the down 
regulation of the pathway appears to be more important for cells to progress to later 
stages of differentiation. Activated ERK is switched off by dephosphorylation by 
specific phosphateses known as MKPs (Clark, 2003; Dickinson and Keyse, 2006; 
Roth et al., 2009). Defective activation leads to unusual ERK activity by upstream 
signalling pathways and/or by defective regulation of the ERK phosphatase 1 (MKP-
1) (Cuevas et al., 2007; Roth et al., 2009). MKP-1 plays an essential physiological 
role in the regulation of MAPK signal transduction pathways by dephosphorylating 
their serine/threonine and tyrosine residues (Tanoue et al., 2001; Clark, 2003). 
 
The MKP-1 inactivates ERK1 and ERK2, p38 and c-Jun N-terminal kinase (JNK). A 
variety of stimuli induce MKP-1 expression such as: cellular stresses, pro-
inflammatory cytokines and agonists with anti-inflammatory effects which include the 
transforming growth factor (TGF) cholera toxin B subunit and cAMP elevating 
mediators (Clark, 2003; Sakaue et al., 2004). Up regulation of MKP-1 in adipocytes 
differentiation could be the mechanism that causes the reduction of ERK activation in 
adipocytes. Further studies are planned to investigate this possibility. 
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Coupling of the GHR to ERK pathway requires the GHR to be localized in the 
caveolae–lipid raft membrane fraction (Yang et al., 2004). Subcellular fractionation of 
pre-adipocytes demonstrated a high level of GHR in the caveolae membrane fraction 
(CM) along with signalling proteins associated with activation of ERK, but no STAT 
signalling molecules (Yang et al., 2004; Lanning and Carter-Su, 2006). Furthermore, 
disruption of the CM resulted in reduced activation of ERK by GH, but unaltered 
activation of STATs (Yang et al., 2004). In differentiated 3T3-L1 cells, the level of GH 
activation of ERK declined, therefore the possibility may exist that differentiation 
caused the GHR to move from the CM to the plasma membrane thus explaining the 
reduced GH-stimulated ERK signalling in adipocyte-differentiated 3T3-L1. Further 
work is required involving separation of the plasma membrane and CM fraction to 
confirm this. 
 
Figure 4.16:  
MKP-1 target members of the MAP kinases and inactivate their function in both the cytosol 
and the nucleus. 
 
 
 
 
 
 
 
  
 
Chapter Five
Do similar changes in GH-induced ERK 
and STAT5 signalling also occur in 
primary preadipocytes undergoing 
differentiation? Are there species or 
depot-specific differences?
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5. Chapter Five 
5.1 Introduction 
The studies described in Chapters 2 through 4 used the 3T3-L1 murine pre-adipocyte 
cell line to investigate GH signalling during adipogenesis. These results illustrated 
major differences in signalling as differentiation proceeded, distinct effects of GH on 
the cell signalling pathway which induced STAT5 activation were observed to 
increase in differentiated cells reflecting an increase in levels of total STAT5 as well 
as GHR expression. This study has also shown that GH-induced ERK activation 
decreased in differentiated cells whereas total ERK was unaltered during 
differentiation.  
 
Characteristics specific to 3T3-L1 pre-adipocytes make them valuable for the study of 
cellular processes. As these cells are cloned they are homogenous and at the same 
stage of differentiation which allows for their response to treatment to be both 
measurable and repeatable. The 3T3-L1 pre-adipocytes can be passaged to provide 
a regular supply and are able to be maintained in culture for long periods. Also, they 
can be passaged frequently without affecting those processes necessary for 
differentiation (Green and Meuth, 1974). Pre-adipocyte cell lines have been used to 
study the molecular and cellular actions that regulate adipogenesis (Gregoire et al., 
1998). Once the cells are confluent (and hence growth arrested) exposure to 
adipogenic inducers stimulates the early proliferative phase known as mitotic clonal 
expansion (MCE) (section 1.3.1.1) which in turn is followed by a second growth 
arrest. The second growth arrest is required for terminal differentiation that leads to 
adipogenic gene expression (Qiu et al., 2001; Qian et al., 2010). Mature adipocytes 
acquire a round lipid-filled morphology as they progress through differentiation 
(Gregoire et al., 1998). They also express adipocyte-specific genes such as PPAR 
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and C/EBPs which are themselves a product of C/EBPβ and essential for MCE 
(Gregoire et al., 1998; Patel and Lane, 2000; Qian et al., 2010; Tang and Lane, 
2012). This cell line’s capacity to differentiate within 6 to 8 days makes them suitable 
for studies which are subject to a combination of time constraints and reproducibility. 
In contrast cultured human primary pre-adipocytes take at least 14 to 15 days to 
differentiate and experiments are limited by the availability of human adipose tissue 
along with inconsistencies at the molecular level due to inter-donor variation. 
Although the 3T3-L1 cell line has been invaluable in elucidating the transcriptional 
cascade that regulates new fat formation, it is possible that it may behave differently 
from primary pre-adipocytes or in fat precursors from other species. 
 
5.1.1 Human primary pre-adipocyte model 
Adipose tissue depots have different physiological profiles depending on the location 
of the tissue. Human adipose tissue is commonly described within the literature as 
residing in two general locations, subcutaneous and visceral. Pre-adipocytes from 
white adipose tissue (WAT) depots exhibit distinct depot-dependent characteristics. 
In vitro studies of subcutaneous pre-adipocytes have indicated regional variations in 
the capacity of precursors for replication of pre-adipocyte number, adipogenic 
differentiation and susceptibility to apoptosis (Tchkonia et al., 2006). Depot-
dependent distinctions in the expression level of select adipocyte differentiation 
marker genes have been identified. Aspects of depot-related pre-adipocyte gene 
expression are of an inherent and possible cell-autonomous nature. However, these 
recent studies have highlighted the fact that different white adipose depots should be 
regarded as distinct (Bjørndal et al., 2011)  
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Advances in cell culture techniques have made it possible to isolate and culture 
human primary preadipocytes, which have the advantage of being more 
physiologically relevant for the study of adipogenesis (Gregoire et al., 1998). Isolation 
of pre-adipocytes from different anatomical locations allows the characteristics 
specific to their original locations to be studied in vitro. However, there are some 
limitations when attempting to use human primary pre-adipocytes. First, while placed 
within culture medium human primary pre-adipocytes differentiate into adipocytes 
without undergoing MCE (Tang and Lane, 2012). Next, these primary cells are 
thought to represent a stage that is further along the adipogenic pathway (Gregoire et 
al., 1998). Finally, primary cell models have a limited life span in culture, grow slowly 
and vary in their adipogenic potential according to the donor (Newell et al., 2006). 
 
5.1.2 Human orbital pre-adipocytes 
Orbital adipose tissue is derived from the neuroectoderm tissue located within the 
bony orbit cavity (Wolfram-Gabel, 2002). Various in vitro studies have shown that 
adipogenesis occurs in orbital fibroblasts in Graves' orbitopathy (GO); a condition in 
which overproduction of thyroid hormones by thyroid follicular cells is stimulated by 
TSH receptor (TSHR) autoantibodies (TRAb). Expansion of orbital adipose tissue is 
the process of increasing the number and size of adipose cells. This occurs by 
hyperplasia (the formation of new fat, i.e. adipogenesis) and hypertrophy (adipose 
cell enlargement). Human orbital cells are capable of undergoing differentiation when 
cultured in the appropriate medium (Hausman and Richardson, 1998; Valyasevi et 
al., 1999). 
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5.1.3 Aims 
The principle aims of this chapter were to address these questions: - 1) Do similar 
changes in GH-induced ERK and STAT5 signalling which take place during 3T3-L1 
adipogenesis also occur in primary pre-adipocytes? 2) Are there species or depot-
specific differences? This was achieved by studying GH stimulated cell signalling in 
differentiating primary preadipocytes from murine and human sources and also by 
comparing the results in differing human depots, i.e. orbit and subcutaneous breast.  
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5.2 Material and methods 
5.2.1 Isolation and culture of primary mouse pre-adipocytes 
Samples of adipose tissue were obtained from mainly subcutaneous fat in the lower 
abdomen and groin area of male and female mice. The adipose tissue was minced 
with a sterile scalpel into small pieces and washed three times with HBSS to remove 
red blood cells. These small pieces were incubated for 40 minutes in a shaking water 
bath at 37ºC with 10 ml HBSS containing 1.5 mg/ml collagenase type II and 1.5% 
BSA. The suspension was allowed to sediment for 1 minute and then large pieces 
and debris were removed. The suspension was then centrifuged at 1500rpm for 5 
minutes, to form a preadipocytes pellet. These cells were resuspended in complete 
medium, counted and plated into 6 well plates at 300,000 per well. The 
preadipocytes were maintained in DMEM (section 2.2.1.1) modified with 20 ml 10% 
fetal calf serum. 
 
5.2.1.1 Differentiation of primary mouse pre-adipocytes 
Although several protocols were tried, the best method used was from Gharibi et al., 
(2011). In order to induce differentiation, primary mouse cell differentiation medium 
(Table 5.1) was added when the cells became confluent. The medium comprised a 
1:1 mix of DMEM and Ham’s F12 supplemented with 10% FCS along with a cocktail 
of supplements as shown (Table 5.1). 
 
Table 5.1: Components of the primary mouse pre-adipocytes differentiation medium. 
Components Final concentration 
Dexamethasone 1 µM 
Indomethacin 50 µM 
Insulin 500 nM 
 
 116 
 
5.2.2 Tissue specimen and preparation 
Orbital adipose was obtained with informed consent and relevant ethical approval 
(06/WSE03/37) as required from patients undergoing scheduled surgery (Appendix 
2). Orbital fat biopsies approximately 4-8 mm in length taken during surgery were 
transported to the laboratory in normal saline at room temperature. These biopsies 
were diced using a scalpel blade and placed in 6 well plates in complete medium 
DMEM/F12 10% FCS (see Chapter 2, section 2.2.1.1). Preadipocytes migrate out 
from the explants and were maintained in the culture plate as a monolayer at 37˚C in 
a humidified atmosphere of 5% CO2. Cells were grown to confluence replacing media 
every 7 days. The cells were trypsined and frozen in liquid nitrogen until further use. 
Cells were used at low passage number (less than 3).  
 
5.2.2.1 Cell culture of primary human pre-adipocytes 
Human primary orbital pre-adipocytes were cultured in complete medium (section 
2.2.1.1). The cells were plated in 6 well plates and once confluent the medium was 
changed to differentiation medium.  
 
5.2.2.2 Differentiation of primary human pre-adipocytes 
In order to induce differentiation in primary human orbital pre-adipocytes the medium 
was changed to differentiation medium (section 2.2.1.4) when the cells became 
confluent. This medium comprised of a 1:1 mix of DMEM and Ham’s F12 
supplemented with 10% FCS along with a cocktail of supplements (Table 2.1). 
Adipogenesis was assessed using phase contrast microscope to detect the 
characteristic morphological changes of cell rounding and accumulation of lipid 
droplets, Oil Red O staining and transcript measurement of adipogenic markers, 
PPAR and lipoprotein lipase (LPL), by QPCR as described previously (section 
2.2.2.1). 
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5.2.3 Breast fat tissue extraction 
Preadipocytes from breast adipose tissue removed during planned surgery were also 
obtained with ethical approval (06/WSE03/37) and informed consent (Appendix 2). 
Samples of adipose tissue were collected and placed in 20 ml universal container 
containing 7 ml of HBSS, 1 ml 300 mg/ml collagenase type II and 2 ml 7.5% BSA.  
These were then incubated for 1 hour in a water bath at 37ºC, shaking every 5 
minutes. The resultant solution was centrifuged at 4ºC for 5 minutes at 1500 rpm. 
Supernatant was removed leaving cell pellets that were resupended in complete 
medium and placed in 75 cm2 flask containing 20 ml complete medium at 37 ºC. 
Following 24 hours the cells were washed twice with 5 ml of HBSS to remove any 
remaining red blood cells. The cells were trypsined and frozen in liquid nitrogen until 
further use. The cells were plated in 6 well plates with compete medium (section 
2.2.1.1), once confluent medium was changed to differentiation medium (section 
2.2.1.4). 
 
5.2.4 Oil Red O staining 
Oil Red O staining was performed as previously described (section 2.2.1.5). 
 
5.2.4.1 Cell proliferation studies 
Cell numbers were determined using a hemocytometer. The 3T3-L1 or human 
primary pre-adipocyte cells were cultured as described previously (see Chapter 2, 
section 2.2.1.1). In three independent experiments cells were grown in 6-well plates. 
Once confluent, medium was changed to differentiation medium (section 2.2.1.4). 
Media in all wells was changed every 24 hours. At each time point medium was 
removed and cells trypsinized as described (section 2.2.1.2). Cells were then re-
suspended in 1 ml complete medium (section 2.2.1.1). The number of cells/ml of 
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solution was estimated using a haemocytometer. Each sample was counted three 
times and an average value used in the statistical analysis. 
5.2.5 QPCR analysis of gene expression 
QPCR analysis of gene expression was performed as previously described (section 
2.2.2.)  
 
5.2.5.1 Extraction RNA of primary mouse adipocytes cultures 
RNA was isolated as previously described (section 2.2.2.1). 
 
5.2.5.2 Reverse transcription 
RNA was reverse transcribed to cDNA as previously described (section 2.2.2.2). The 
primers for the hPPAR, hLPL and hAPRT QPCR assays are detailed (Table 5.2) 
Rice et al., 2010). The mouse cultures used the same primers as 3T3-L1 cell line 
(Table 2.2) (Zhang et al., 2006). 
 
Table 5.2: QPCR primers along with amplicon size. 
hPPAR   
Forward Reverse Amplicon size 
CAGTGGGGATGTCTCATAA 
Exon3 (300 nM) 
CTTTTGGCATACTCTGTGAT   
Exon5 (500 nM)           390 bp 
hARPT   
Forward Reverse Amplicon size 
GCTGCGTGCTCATCCGAAAG CCTTAAGCGAGGTCAGCTCC 
247 bp 
Exon 3 (300 nM; using 100nM) Exon 5 (500 nM; using 100 nM) 
hLPL   
Forward Reverse Amplicon size 
GAGATTTCTCTGTATGGACC  CTGCAAATGAGACACTTTCTC 275 bp 
Exon 7 (300 nM) Exon 9 (300 nM) 
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5.2.6 Western blot analysis of protein  
Western blotting techniques were used to determine P-ERK, total ERK, P- STAT5 
and total STAT5 levels during differentiation of the cells, using the same antibodies 
and protocol as for the 3T3-L1 cells (section 3.2.2). Western blot was also used to 
analyse the endogenous levels of total PPAR protein. Blots were incubated in rabbit 
PPAR monoclonal antibody overnight at 4C (Cell Signalling, Technology, Danvers, 
MA, USA) at 1:1000 dilution. Secondary antibody, anti-rabbit IgG horseradish 
peroxidase (GE Healthcare, Little Chalfont, Bucks, UK), was used at a 1:5000 
dilution for 1 hour. The blots were then visualised using ECL Plus (GE Healthcare) as 
described earlier (section 3.2.2.6). 
 
5.2.7 Statistical analysis 
Statistical analysis was performed as described (section 2.2.3.). 
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5.3 Results 
5.3.1 Are the changes in GH signalling during adipogenesis unique 
to the 3T3-L1 cell line? 
During 3T3-L1 differentiation GHR levels increase. Additionally there is alteration in 
GHR associated cell signalling in differentiated cells. GH-induced STAT5 activation 
and total STAT5 increased, while GH-induced ERK activation decreased in 
differentiated cells, but total ERK was unchanged and high levels of PMA-induced 
ERK activation were also observed. This inverse relationship between the decline in 
GH-induced ERK activation compared to increased GH-induced STAT5 together with 
increased levels of GHR suggests that there is a specific uncoupling of GHR 
activation from the ERK pathway differentiated 3T3-L1 cells in vitro.  
 
In the first part of this chapter mouse primary pre-adipocytes were studied to 
determine whether the effects observed in the 3T3-L1 cells were a feature unique to 
this cell line.  The differentiation protocol developed by Zhang et al. (2006) which was 
used to differentiate the 3T3-L1 cell line was used initially but the primary mouse pre-
adipocytes failed to achieve differentiation. Various parameters of this protocol were 
changed, again with no success. After exhausting all variations of this method (data 
not shown) the protocol from Gharibi et al., (2011) was used which allowed robust 
differentiation to be achieved as described below. 
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5.3.1.1 Morphology of primary mouse cells during differentiation 
During differentiation primary mouse cells underwent morphological changes 
characteristic of conversion from fibroblast to adipocyte morphology. Undifferentiated 
primary mouse cells have the appearance of fibroblasts with an elongated shape 
(Figure 5.1). Whereas the cells cultured in differentiation medium (section 5.2.1.1) 
appear to have a morphology more typical of mature adipocyte cells at day 9 where 
they appear as very rounded shape and with lipid droplet accumulation in 
approximately 50-60% cells (Figure 5.1D), which is slightly less than in the 3T3L1 cell 
line. Apart from this, no differences were observed between primary mouse and 3T3-
L1 mouse pre-adipocytes cell line samples at the microscopic level during routine 
differentiation occurring over the same time points in both cultures. However, the 
primary cells were obviously larger and more rounded than 3T3-L1 cell line pre-
adipocytes. 
 
5.3.1.2 Oil Red O of primary mouse cells during differentiation 
Primary mouse cells undergoing adipogenic differentiation were stained with Oil Red 
O to highlight the lipid droplets (Figure 5.1). No Oil Red O staining was detected at 
day 0 (Figure 5.1B). However, by day 9 in differentiation medium approximately 50-
60% of the cells contained Oil Red O (Figure 5.1D). The results show that primary 
mouse cells differentiate well using this protocol as assessed by Oil Red O staining 
after 9 days. 
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Figure 5.1: Mouse adipocyte differentiation 
Phase contrast photomicrographs which show various stages of mouse pre-adipocyte 
differentiation. (A) Undifferentiated mouse pre-adipocytes at day 0 and cells (C) after 9 days 
in differentiation medium. (B) Undifferentiated Oil Red O stained cells at day 0, and (D) after 
9 days in differentiation medium. After 9 days in differentiation medium lipid droplet 
accumulation in differentiated cells is clearly visible. Magnification 100x 
 
5.3.1.3 PPAR expression during primary mouse cells differentiation 
QPCR was used to determine PPAR (Table 2.2) gene expression at 0, 5 and 9 days 
after the start of differentiation. Mouse ARP (Table 2.2) housekeeping gene was 
used for studies investigating differentiation of the mouse per-adipocytes cells. ARP 
housekeeping gene expression showed minimal change during differentiation (Figure 
5.2). Results are expressed as fold increase compared to cultures at day 0 with 
mean ± SE, n=3. PPAR expression increased (Figure 5.3 and Table 5.3) with high 
expression of PPAR observed in differentiated cells at day 5 (5.19 ± 1.80 mean ± 
SE, n=3 *p < 0.046) and day 9 (4.90 ± 1.11 mean ± SE, n=3, compared to day 0, *p 
<0.050).  
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This data demonstrates an overall increase in PPAR transcript number following the 
differentiation protocol in mouse adipocytes and 3T3-L1 cells, with the magnitude of 
increase slightly greater in 3T3-L1 (Table 5.4).  
 
 
Figure 5.2: ARP amplification plot 
Amplification plots show that ARP expression was unchanged during primary mouse pre-
adipocytes differentiation. Cells were treated in differentiation medium at day 0, 5 and 9. The 
plots show that the Ct values were minimally altered by the length of time in differentiation 
medium (Table 5.3). 
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Figure 5.3: PPAR amplification curve  
PPAR amplification curves at day 0, 5 and 9 after the addition of differentiation medium. 
PPAR expression was increased during primary mouse pre-adipocytes differentiation. 
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Figure 5.4: PPAR expression during primary mouse pre-adipocytes differentiation  
QPCR analysis of PPAR expression during primary mouse pre-adipocytes differentiation 
shows increase of PPAR at day 5 and day 9 with differentiation medium compared to control 
cultures at day 0 (n=3).  
 
Table 5.3: PPAR/ARP Ct values 
Ct values for PPAR and ARP QPCR assays during mouse adipogenic differentiation at day 
0, 5 and 9 shows increased the level of PPAR expression, reduced the Ct value, minimal 
effect on ARP. 
 
 Ct value 
 0 days 5 days 9 days 
ARP 15.45 15.45 15.89 
PPAR 23.77 22.77 21.89 
 
 
Table 5.4: QPCR for PPAR 
QPCR for PPAR in both 3T3-L1 cells and mouse primary adipocytes following 9 days 
exposure to differentiation medium. Data are presented as mean ± SE. Mean values of the 
results obtained from 3 separate experiments (n=3). The PPAR expression increased in 
both, but was slightly greater in 3T3-L1 than mouse primary adipocytes. 
 
 
PPAR  expression relative to day 0 
Samples 
 
Day 5 Day 8 Day 9 
3T3-L1 
 
7.68 ± 1.346 11.73 ± 3.11  
Primary adipocytes 
 
 5.19 ± 1.80  4.9 ± 1.11 
* * 
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5.3.1.4 GPDH expression during primary mouse cells differentiation 
QPCR was used to determine GPDH (Table 2.2) gene expression at 0, 5 and 9 days 
after the start of differentiation. Mouse ARP housekeeping gene was used for studies 
that investigated differentiation of the mouse adipocytes cells. ARP housekeeping 
gene expression showed minimal change during differentiation (Figure 5.2). Results 
are expressed as fold increase compared to cultures at day 0 with mean ± SE, n=3. 
GPDH expression increased (Figure 5.5 and 5.6, Table 5.5 and 5.6) with high levels 
of GPDH observed in differentiated cells at day 9 (16.44 ± 4.53) compared to day 0,* 
p<0.05 (Figure 5.6). This data demonstrate an overall increase in GPDH transcript 
number following the differentiation protocol in both mouse adipocytes cells and 3T3-
L1 cell line, again with the increase greater in the cell line.  
 
 
Figure 5.5: GPDH amplification curve 
GPDH amplification curves at day 0, 5 and 9 after the addition of differentiation medium. 
GPDH expression was increased during primary mouse pre-adipocytes differentiation. 
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Figure 5.6: GPDH expression during primary mouse pre-adipocytes differentiation 
QPCR analysis of GPDH expression during primary mouse pre-adipocytes differentiation 
shows increase of GPDH at day 9 with differentiation medium compared to control cultures at 
day 0. *p<0.05, vs. control cultures, n=3 separate experiments, ANOVA, post hoc analysis 
with Student-Newman-Keuls test. 
 
 
Table 5.5: GPDH Ct values 
Ct values for GPDH and ARP QPCR assays during mouse adipogenic differentiation at day 0, 
5 and 9 shows increased the level of GPDH expression, reduced the Ct value, minimal effect 
on ARP. 
 
 Ct value 
 0 days 5 days 9 days 
ARP 15.45 15.45 15.89 
GPDH 20.60 17.17 15.94 
 
 
Table 5.6: QPCR for GPDH 
QPCR for GPDH in both 3T3-L1 cells and mouse primary adipocytes follow 9 days exposure 
to differentiation medium. Data are presented as mean and SE. Mean values of the results 
obtained from 3 separate experiments. GPDH in both 3T3-L1 cells and mouse primary 
adipocytes increase during cell differentiation while slight increase in 3T3-L1 cell line. 
 
 
GPDH expression relative to day 0 
Samples 
 
Day 5 Day8 Day 9 
3T3-L1 
 
8.97 ± 1.20 53.76 ± 2.65  
Primary adipocytes 
 
3.76 ± 1.10  16.44 ± 4.53 
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5.3.1.5 GHR expression during primary mouse pre-adipocytes 
differentiation 
The level of GHR (Table 3.3) gene transcription during mouse pre-adipocytes 
differentiation was analyzed using QPCR. Results are expressed as fold increase 
compared to cultures at day 0 with mean ± SD, n=3. GHR expression increased 
during the differentiation process (Figure 5.7 and Table 5.7) with higher expression 
levels being observed in differentiated cells at day 9 (7.033 ± 1.86 of day 0 *p<0.05 
vs. day 0, n=3). These data demonstrate an overall increase in GHR transcript 
number following the differentiation protocol in mouse adipocyte cells and 3T3-L1 cell 
lines. In both cases GHR expression increased with differentiation and by the same 
amount in 3T3-L1 and primary cells.  
 
 
 
 
Figure 5.7: Amplification curve of GHR 
GHR QPCR amplification curve primary mouse cells in differentiation medium at day 0, 5 and 
9. GHR expression increased with the primary mouse cells differentiation. 
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Figure 5.8: GHR expression during mouse pre-adipocytes differentiation 
QPCR analysis of GHR expression during mouse pre-adipocytes differentiation shows a 
significant increase with cellular differentiation compared to control cultures, * p<0.05 vs. day 
0 cultures, n=3. 
 
 
Table 5.7: GHR and ARP QPCR assays 
Ct values for the GHR and ARP QPCR assays during primary mouse adipogenic 
differentiation at day 0, 5 and 9 shows that differentiation increased GHR expression reducing 
Ct value, but had minimal effect on ARP. 
 
 Ct value 
 0 days 5 days 9 days 
ARP 15.45 15.45 15.89 
GHR 26.13 25.43 24.61 
 
 
Table 5.8: QPCR for GHR 
QPCR for GHR in both 3T3-L1 cells and mouse primary adipocytes following a 9 day 
exposure to differentiation medium. Data are presented as mean and SE. Mean values of the 
results obtained from 3 separate experiments. The GHR expression increased was similar in 
3T3-L1 and primary cells. 
 
 
GHR expression relative to day 0 
Samples 
 
Day 5 Day 8 Day 9 
3T3-L1 
 
4.5 ± 3.20 6.0 ± 2.65  
Primary adipocytes 
 
4.0 ± 2.4  7.033 ± 1.86 
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5.3.1.6 Basal ERK activation during mouse primary pre-adipocytes 
differentiation 
Mouse primary pre-adipocyte were plated in 6 well plates and once confluent were 
incubated with differentiation medium and samples collected at day 0, 5 and 9. 
Medium was changed every two days. The mouse primary cells were analysed over 
time points when the medium was removed and cells were then washed twice with 1 
ml of PBS. Cells were lysed with 250 l loading buffer and were rapidly frozen in 
liquid nitrogen before being stored at -20˚C. Basal ERK phosphorylation (activation) 
was detected by western blotting. The bands are phospho-ERK1 (p44) and ERK2 
(p42) (Figure 5.9 below). Basal ERK activation was influenced by the length of time 
in differentiation medium with high activation at day 0 of both ERK1 (p44) and ERK2 
(p42). The level of p42 ERK activation reduced with increased adipogenic 
differentiation to a level that is barely detectable by day 9 in contrast levels of p44 
ERK remained unchanged. The appearance of the cells altered over the time points 
of experiment changing from an elongated fibroblast shape into more rounded cells 
which can be seen from day 9 onward. This observation was accompanied by an 
increase in lipid droplet accumulation, being seen in approximately 50-60% of the 
mouse primary cells by day 9. The data demonstrated slower reduction in p ERK in 
primary mouse adipocytes compared with 3T3-L1 samples (see Chapter 3 section 
3.3.1).  
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Figure 5.9: Basal P-ERK and total ERK levels 
Basal P-ERK activation and total ERK during mouse primary pre-adipocytes differentiation. 
 
5.3.1.7 GH stimulated ERK and STAT5 activation during primary mouse 
pre-adipocytes differentiation 
In vitro differentiated mouse primary adipocytes were treated with GH and PMA. GH-
induced ERK and STAT5 activation was analysed by phospho-specific western 
blotting in cells treated for 10 minutes with GH (50nM). These experiments were 
performed and the combined results are summarised in a histogram shown in (Figure 
5.11). The results of each experiment were somewhat different as illustrated by the 
large error bars, but in all cases demonstrated very little GH induced p ERK at day 0 
in three separate expermints (n=3). In two experiments the highest GH-induced p 
ERK occurred on day 9, but in the third experiment day 5 was maximal, total ERK 
was unchanged in all cases indicating equal lane loading (Figure 5.10).  
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Following densitometry assessment, the maximum phosphorylated ERK by GH in 
primary mouse adipocyte cells was observed at day 5 compared to control at day 0 
(242.30%  141.53 of day 0, at day 5 vs. day 0, p>0.05 n=3) and at day 9 (230.28%  
84.21 of day 0, at day 9 vs. day 0, p>0.05 n=3). Phospho-STAT5 was undetectable at 
day 0, but easily detectable at days 5 and 9, however, since there are no bands at 
day 0 results are expressed as IDV absolute values, mean ± SE, n=3. GH-stimulated 
STAT5 phosphorylation was increased with higher change being observed in 
differentiated cells at day 5 (5829084  1567543, absolute value IDV, n=3) and 9 
(10701144  3565432, *p<0.05 n=3) and total STAT5 increased with significantly 
higher levels being observed in differentiated cells (228.23%  24.97 of day 0, at day 
9, p<0.01 vs. day 0, *p<0.05 n=3) (Figure 5.11).  
 
This data demonstrated significant variations between preadipocytes from primary 
sources compared with a cell line during differentiation. Hence levels of ERK 
activation in primary mouse adipocytes and 3T3-L1 samples (see Chapter 3 section 
3.3.2) were different. These results seem to indicate that the specific uncoupling of 
GHR activation from the ERK pathway during adipogenesis may be unique to the 
3T3-L1 cell line. 
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Figure 5.10: Phosphorylation of ERK and STAT5  
A western blot which shows phosphorylation of ERK and STAT5 following GH stimulation (+) 
over a time points at day 0, 5 and 9 in adipocyte differentiation medium. The level of GH-
stimulated ERK phosphorylation shows change with increasing time in differentiation medium. 
The total ERK blot has two bands; the upper is p44 and lower the p42. In contrast the level of 
total STAT5 and GH stimulated STAT5 phosphorylation increased with mouse primary 
adipocytes differentiation. PMA shows levels of ERK activation were the same during 
differentiated cells with no significant difference between them. 
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Figure 5.11: Densitometric analysis of ERK and STAT5 
Densitometric analysis of the western blots (Figure 5.10) the results are expressed as % day 
0 for P-ERK, total ERK and total STAT5 but P-STAT5 undetectable at day 0, but easily 
detectable at days 5 and 9, however, the result for P-STAT is expressed as IDV absolute 
values, mean ± SE, n=3 and demonstrated increased total STAT5 and GH-stimulated STAT5 
activation following differentiation despite no changed in ERK activation and total ERK. 
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5.3.2 Are the changes in GH signalling during adipogenesis 
species dependent? 
Having established the similarities and differences between mouse pre-adipocyte cell 
lines and primaries, this study considered whether the change in GH signalling might 
be dependent on donor species and fat depot. The capacity for differentiation may 
differ significantly depending on the species, the anatomical origin of the adipose 
tissue, the age and gender of the donor. Samples of human adipose tissue were 
collected during surgery, the research interests of another group made fat from the 
orbit available. This fat is not typical being derived from neural crest whereas other 
fat depots originate from the mesoderm, but there was sufficient supply to investigate 
whether there are differences in GH induced ERK activation and other aspects of 
adipogenesis, for comparison  with the  3T3-L1 pre-adipocytes cell line. 
5.3.2.1 Morphology of primary human orbital cells during differentiation 
While in differentiation medium (section 5.2.2) (Zhang et al., 2006) primary human 
orbital cells underwent morphological change characteristic of conversion from 
fibroblast to adipocyte morphology. Undifferentiated primary human orbital cells have 
the appearance of fibroblasts with an elongated shape (Figure 5.12). Whereas the 
cells cultured in differentiation medium for 15 days (section 5.2.2) appear to have 
morphology more typical of mature adipocyte cells where they appear rounded in 
shape and some of them eventually acquire large lipid vacuoles with lipid droplet 
accumulation. The amount of differentiation induced was highly variable across the 
plate. In some regions it was observed in approximately 40-50% of the primary 
human orbital cells (foci of differentiation, Figure 5.12C) but was absent in other parts 
of the plate. In addition, adipogenesis in the orbital requires at least 15 days in 
differentiation medium, thus less differentiation can be induced when compared with 
murine cell lines or primary preadipocytes. 
 136 
 
5.3.2.2 Oil Red O of human orbital during differentiation 
Primary human orbital cells undergoing adipogenic differentiation stained with Oil 
Red O to highlight lipid droplets (Figure 5.12). No Oil Red O staining was detected at 
day 0 (Figure 5.12B). However, by day 15 in differentiation medium approximately 
40-50% of the cells in foci of differentiation contained Oil Red O (Figure 5.12D). The 
results show that primary human orbital cells differentiate well using this protocol as 
assessed by Oil Red O staining after 15 days. 
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Figure 5.12: Adipocyte differentiation 
Phase contrast photomicrographs show various stages of adipocyte differentiation. (A) 
Undifferentiated human orbital pre-adipocytes at day 0 and (C) cells after 15 days in 
differentiation medium. (B) Undifferentiated Oil Red O stained cells at day 0 and (D) after 15 
days in differentiation medium stained with Oil Red O. After 15 days in differentiation medium 
lipid droplet accumulation in differentiated cells was clearly visible in 40-50% of the cells. 
Magnification 100x 
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5.3.2.3 LPL expression during primary orbital cells differentiation 
QPCR was used to determine LPL (Table 5.2) gene expression in the human orbital 
cells at day 0, 7 and 15 after the start of differentiation. Human adenine 
phosphorybosyltransferase (APRT) (Table 5.2) housekeeping gene was used for 
studies which investigated differentiation of the orbital adipocytes cells (Rice et al., 
2010). APRT housekeeping gene expression showed minimal change during 
differentiation of the human orbital pre-adipocytes to mature adipocytes (Figure 
5.13). Results are expressed as fold increase compared to cultures at day 0 and are 
mean ± SE, n=3. LPL is a marker of late adipogenesis stage expression increased 
(Figure 5.14 and Table 5.6) with high expression of LPL observed in differentiated 
cells at day 15 (77.44 ±.11) compared to day 0, (mean ± SE, n=3 separate 
experiments *p 0.05, ANOVA post hoc analysis with student-Newman-Keuls test 
(Figure 5.15). 
 
Figure 5.13: APRT Amplification plot 
Amplification plots show that APRT expression was unchanged during primary human orbital 
pre-adipocytes differentiation. Cells were treated in differentiation medium at day 0, 7 and 15. 
The plots show the Ct values were minimally altered by the length of time in differentiation 
medium (Table 5.6). 
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Figure 5.14: LPL amplification curve 
LPL amplification curve of the human orbital cells shows at day 0, 7 and 15 after the addition 
of differentiation medium. LPL expression was increased during primary human orbital 
differentiation. 
 
Figure 5.15: LPL expression during primary human orbital cells differentiation 
QPCR of LPL expression during primary human orbital differentiation shows increase of LPL 
at day 0, 7 and 15 with differentiation medium compared to control cultures day 0. * p<0.05, 
vs control cultures, n=3 separate experiments, ANOVA, post hoc analysis with student-
Newman-Keuls test. 
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Table 5.9: LPL CT values 
Ct values for LPL and APRT QPCR assays during human orbital adipogenic differentiation at 
day 0, 7 and 15 shows increased the level of LPL expression, reduced the Ct value, minimally 
effect on ARPT. 
 
 Ct value 
 0 days 7 days 15 days 
APRT 21.55 21.50 21.85 
LPL 30.36 24.97 24.48 
 
 
Table 5.10: QPCR GPDH and LPL late marker for adipogenesis 
QPCR for GPDH in 3T3-L1 cells following 9 days exposure to differentiation medium 
increased and LPL in human primary orbital adipocytes following 15 days in differentiation 
medium that LPL and GPDH are used as markers of terminal differentiation and that both are 
greatly increased. 
 
Samples 
 
Day 5 Day 7 Day 8 Day 15 
3T3-L1 GPDH 
 
8.97 ± 1.20 - 53.76 ± 2.65 - 
Human Primary adipocytes 
LPL 
 
- 8.58 ± 2.90 - 77.44 ± 34.11 
 
 
5.3.2.4 PPAR expression during human orbital pre-adipocytes differentiation. 
Cells were seeded in 6 well plates and once confluent were incubated with 
differentiation medium until day 15. Medium was changed every two days. The cells 
were analysed over a time course when the medium was removed and cells were 
then washed twice with 1 ml of PBS. Cells were lysed with 250 l loading buffer and 
were rapidly frozen in liquid nitrogen before being stored at -20˚C. Total PPAR was 
detected by western blotting (section 3.3.2). The bands representing PPAR are 
shown below (Figure 5.16). Levels of PPAR protein were influenced by the length of 
time in differentiation medium. After an initial decline, amounts of the transcription 
factor showed an approximate doubling and peaked at day 8, the point at which 
elongated fibroblast shape cells had started changing into more rounded cells.  
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Figure 5.16: PPAR expression 
A representative western blot which shows total of PPAR over a time points of 15 
days was during adipocyte differentiation medium. The level of PPAR level was high 
at day 0 and decline at day 1 then increase at day 4 with a high level can observed at 
day 8.  
 
5.3.2.5 GHR expression during human orbital pre-adipocytes 
differentiation 
The level of GHR gene transcription during primary human orbital pre-adipocytes 
differentiation was analyzed using QPCR. GHR expression was increased during the 
differentiation process (Figure 5.17, 5.18 and Table 5.7) with significantly higher 
expression being observed in differentiated cells at day 15 (11.04  4.51 of day 0 
p<0.05 vs. day 0, n=4). This data demonstated that in human orbital cells, primary 
mouse adipocytes cells and 3T3-L1 cell lines general there was a increase in GHR 
trancript number following the differetiation protocol. 
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Figure 5.17: Amplification curve of GHR 
QPCR amplification curve of GHR shows human primary orbital cells in differentiation 
medium at day 0, 7 and 15. GHR expression was increased with the human primary orbital 
cells differentiation. 
 
 
 
 
 
 
Figure 5.18: GHR expression during human orbital pre-adipocytes differentiation 
QPCR analysis of GHR expression during human orbital adipocytes differentiation shows a 
significant increase with cellular differentiation compared to control cultures, * p<0.05 vs. day 
0 cultures, n=4. 
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Table 5.11: GHR and APRT QPCR assays 
Ct values for the GHR and APRT QPCR assays during primary human orbital adipogenic 
differentiation at days 0, 7 and 15 show that differentiation increased GHR expression 
reducing Ct value, but had a minimal effect on APRT. 
 
 Ct value 
 0 days 7 days 15 days 
APRT 21.55 21.5 21.85 
GHR 22.69 20.42 18.80 
 
 
Table 5.12: QPCR for GHR 
QPCR for GHR in both 3T3-L1 cells follow 9 days of exposure to differentiation medium and 
human primary adipocytes following 15 days in differentiation medium were increased.  
 
Samples 
 
Day 5 Day 7 Day 8 Day 15 
3T3-L1 GHR 
 
4.5 ± 3.20  6.0 ± 2.65 - 
Human primary 
adipocytes GHR 
 
 3.86 ± 3.38 - 11.04 ± 4.51 
 
 
5.3.2.6 Basal ERK activation during human orbital pre-adipocyte 
differentiation 
Human orbital pre-adipocyte were plated in 6 well plates and once confluent 
incubated with differentiation medium for 17 days with protein samples being 
collected at various time points (section 3.3.2). Basal unstimulated ERK 
phosphorylation was detected by western blotting. The phospho-ERK1 (p44) and 
ERK2 (p42) bands are shown (Figure 5.19). Basal ERK activation started high then 
declined following a similar pattern of expression to that seen for PPAR (Figure 
5.16) before rebounding then declined to levels that are barely detectable through 
day 8, but increasing again from day 11 onwards. This increase in basal phospho-
ERK in the late stages of adipogenesis is in a marked contrast to the steady decline 
observed in mouse primaries and 3T3-L1 cell line. Whether it is a feature of all 
human precursors differentiating into fat or a particularity of the orbital requires 
further study. 
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Figure 5.19: Basal ERK levels 
Basal ERK activation during human orbital adipocytes differentiation 
 
 
 
5.3.2.7 GH stimulated ERK and STAT5 activation during orbital human 
pre-adipocytes differentiation 
Differentiating human orbital pre-adipocytes were treated with GH and PMA (10 
minutes) at various time points following addition of differentiation medium. GH-
induced ERK and STAT5 activation was analysed by phospho-specific western 
blotting in cells treated for 10 minutes with GH (50 nM). Results do not show any 
difference between the levels of GH-induced ERK activation in cells at day 0, 7 and 
15. Analysis of the data from multiple experiments showed no significant increase of 
GH-induced ERK activation at day 7 (114.63%  22.6 vs. day 0, p>0.05 n=3) 
compared with % day 0 and the total ERK was unchanged. As can be observed 
(Figure 5.10) GH induces ERK activation was detected in mouse primaries, but with 
orbital cells no activation of the ERK pathway occurs during adipogenesis. Orbital 
pre-adipocytes are a particular fat depot, being derived from the neural crest which 
may explain the differences between these results following GH induced ERK 
activation and those obtained using a murine pre-adipocyte cell line.  
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Phospho-STAT5 undetectable at day 0, but easily detectable at days 7 and 15, 
however, the result is expressed as IDV absolute values, mean ± SE, n=3. GH-
stimulated STAT5 phosphorylation increased with a significantly higher change being 
observed in differentiated cells at day 7 (7772112  2389451 **p <0.01, n =3), at day 
15 (12655344  3123410, **p<0.01 n=3) and total STAT5 increased with significantly 
higher levels being observed in differentiated cells at day 15 (225.01  11.30 of day 
0) (Figure 5.21).  
 
 
 
 
Figure 5.20: Phosphorylation of ERK and STAT5 in human orbital adipocyte 
differentiation A representative western blot which shows phosphorylation of ERK and 
STAT5 following GH stimulation at day 0, 7 and 15 in adipocyte differentiation medium. The 
level of GH-stimulated ERK phosphorylation over time did not change in differentiation 
medium. The total ERK blot has two bands where the upper is p44 and the lower is p42. In 
contrast the level of total STAT5 and GH-stimulated STAT5 phosphorylation increased with 
human orbital adipocytes differentiation. PMA shows levels of ERK activation were the same 
during differentiation cells with no significant difference between the bands. 
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Figure 5.21: Densitometric analysis of ERK and STAT5 in human orbital adipocyte 
differentiation 
Densitometric analysis of the western blots shown in (Figure 5.20) the results are expressed 
as % day 0 control for P-ERK, total ERK and total STAT. Phospho-STAT5 undetectable at 
day 0, but easily detectable at days 7 and 15, however, the result is expressed as IDV 
absolute values, mean ± SE, **p<0.01, n=3. The results demonstrate that an increase in total 
STAT5 and GH-stimulated STAT5 activation following differentiation; despite unchanged in 
the levels of total ERK also no P-ERK activation at any time point.  
 
5.3.2.8 Mitotic clonal expansion (MCE) 
The human primary orbital pre-adipocytes had very different GH-induced signalling 
with no activation of ERK by GH in orbital cells compared with the 3T3-L1 cell line. 
GH signalling is thought to be important in the MCE phase of differentiation which 
seems to occur in the cell line, but not in primary precursors. The abundance of 
orbital pre-adipocytes enabled this study to investigate whether MCE occurs in 
human primary orbital cells and then compared with 3T3-L1cell line. 
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5.3.2.8.1 MCE of human orbital pre-adipocyte during adipogenic 
differentiation 
Cells were grown to confluence and medium changed to either differentiation or 
complete medium and then cells counted at day 0 to 15 (Figure 5.23). In the human 
orbital cells there was no difference in number between cells in differentiation 
medium compared to those in complete medium. Furthermore, there was a gradual 
increase in cell number in both types of medium (p>0.05, n=3). The data presented 
clearly illustrates differentiation of human orbital pre-adipocytes is not accompanied 
by an initial MCE.  
 
 
Figure 5.22: MCE in human orbital cells 
Human orbital pre-adipocyte incubated from day 0 to 15 with differentiation medium (red) or 
complete medium (blue). No variations in the cell number observed indicated that orbital pre-
adipocyte do not require MCE during differentiation. 
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5.3.2.8.2 MCE of the 3T3-L1 during adipogenic differentiation 
Cells were grown to confluence and medium changed to either differentiation or 
complete medium, then counted at day 0 to day 7. In the 3T3-L1 cells samples, there 
was an obvious increase in the number of cells in differentiation medium compared to 
those in complete medium. The difference was most marked on days 2 and 3 
following addition of differentiation medium compared with complete 
medium,(p<0.01, n=3) and indicated MCE. It is possible that the absence of GH-
induced P-ERK activation in the orbital cells, which contrasts with its robust activation 
in 3T3-L1 before adipogenesis is underway, may provide some explanation for lack 
of MCE in the orbital cells. 
 
 
Figure 5.23: MCE in 3T3-L1 cell line 
3T3-L1 pre-adipocyte was incubated from day 0 to day 7 with either differentiation medium 
(Red) or complete medium (blue). 3T3-L1 pre-adipocyte differentiation was induced with the 
induction protocol. Cells in complete medium remain constant, while cells in differentiation 
medium spiked on day 1 and 2 which is consistent with MCE. 
** 
** 
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5.3.3 Are there depot-specific differences in GH signalling during 
adipogenesis? 
Fat depots in mice are very small making it difficult to compare the responses 
between them. Human adipose tissue can be obtained from patients undergoing 
elective surgery of which breast adipose tissue has been used as a more typical 
human fat as its behaviour in vitro is very similar to subcutaneous fat. Consequently 
experiments were performed using subcutaneous pre-adipocytes from breast tissue 
for comparison with the atypical orbital. 
 
5.3.3.1 Morphology of primary human breast fat cells during 
differentiation 
During differentiation primary human breast fat cells underwent the characteristic 
conversion from fibroblast to adipocyte morphology. Undifferentiated primary human 
breast fat cells have the appearance of fibroblasts with an elongated shape (Figure 
5.25). However, a much longer time in differentiation medium is required to achieve 
adipogenesis in breast precursors, up to 19 days. Furthermore, far fewer cells can be 
induced to differentiate in vitro when compared with murine cell lines, primary mouse 
or human orbital cells 
 
5.3.3.2 Oil Red-O of human breast fat cells during differentiation 
Human breast fat cells undergoing adipogenic differentiation were stained with Oil 
Red O (Figure 5.25). No Oil Red O was detected at day 0 (Figure 5.25B). However, 
by day 19 in differentiation medium a small number of cells contained Oil Red O 
(Figure 5.25D).  
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Figure 5.24: Breast fat pre-adipocyte differentiation 
Phase contrast photomicrographs show various stages of adipocyte differentiation. (A) 
Undifferentiated human breast fat pre-adipocytes at day 0 and (C) cells after 19 days in 
differentiation medium. (B) Undifferentiated Oil Red O stained cells at day 0, and (D) after 19 
days in differentiation medium stained with Oil Red O. After 19 days in differentiation medium 
lipid droplet accumulation in small number of differentiated cells is clearly visible. 
Magnification 100x.  
 
5.3.3.3 hPPAR expression during breast fat cells differentiation 
QPCR was used to determine PPAR (Table 5.2) gene expression in the human 
breast fat cells at day 0, 15 and 19 after the start of differentiation. APRT (Table 5.2) 
housekeeping gene was used for studies which look at differentiation of the breast fat 
cells. APRT housekeeping gene expression showed minimal change during 
differentiation (Table 5.13). Results are expressed as fold increase compared to 
cultures at day 0 with mean ± SE, p> 0.05, n=3. PPAR expression was reduced 
(Figure 5.25 and Table 5.13). As can be observed from Oil Red O staining a few cells 
able to accumulate lipid droplets, this may explain why PPAR reduced during the 
time of differentiation.  
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Figure 5.25: hPPAR amplification curve. PPAR amplification curve of the human breast 
cells shows at day 0, 15 and 19 after the addition of differentiation medium. PPAR 
expression was decreased during breast fat cells differentiation  
 
 
Figure 5.26: hPPAR expression during breast fat differentiation  
QPCR analysis of PPAR expression during breast fat differentiation shows reduced of 
PPAR at day 15 and day 19 with differentiation medium compared to control cultures at 
day0.  
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Table 5.13: hPPAR QPCR assays 
Ct values for the PPAR assays during breast fat adipogenic differentiation at days 0, 15 and 
19 show that differentiation down regulation of PPAR with increase Ct value. 
 
 Ct value 
 0 days 15 days 19 days 
APRT 24.39 23.78 24.04 
PPAR 19.87 20.30 20.84 
 
5.3.3.4 hLPL expression during breast fat cells differentiation 
QPCR was used to determine LPL (Table 5.2) gene expression in the human breast 
fat cells at day 0, 15 and 19 after the start of differentiation. APRT (Table 5.2) 
housekeeping gene was used for studies which investigated differentiation marker of 
the breast fat cells. APRT housekeeping gene expression showed minimal change 
during differentiation of the human breast fat (Table 5.13). LPL, a marker of late 
adipogenesis expression appeared to be down regulated and only a very low level 
was detected (Figure 5.26 and Table 5.14) in differentiated cells at day 19, in keeping 
with the very limited induction of adipogenesis in these cells. Results are expressed 
as fold increase compared to cultures at day 0 with (mean ± SE, p= 0.13, n=3). 
 
Figure 5.27: hLPL amplification curve. LPL amplification curve of the breast fat cells shows 
at day 0, 15 and 19 after the addition of differentiation medium. LPL expression was reduced 
during breast fat cells differentiation as can be seen Ct value at day 19 forms later. 
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Figure 5.28: hLPL expression during breast fat differentiation 
QPCR analysis of LPL expression during breast fat differentiation shows reduced of LPL at 
day 15 and day 19 with differentiation medium compared to control cultures at day 0 with 
mean ± SE, p> 0.05, n=3.  
 
 
Table 5.14: hLPLQ PCR assays 
Ct values for the LPL assays during breast fat adipogenic differentiation at days 0, 15 and 19 
shows that differentiation caused down regulation of LPL with increase Ct value at day 19. 
 
 Ct value 
 0 days 15 days 19 days 
APRT 24.39 23.78 24.04 
LPL 37.34 37.07 40.90 
 
5.3.3.5 hGHR expression during human breast fat differentiation 
Experiments to measure the transcript copy number adjusted to the quantity of RNA 
were performed. RNA was extracted at day 0, 15 and 19 and reverse transcribed. 
The levels of GHR gene transcription during human breast fat cells differentiation 
were analyzed using QPCR. GHR expression was unchanged by the differentiation 
process (Figure 5.28, 5.29). Results are expressed as fold compared to cultures at 
day 0 with mean ± SE, p= 0.09, n=3. This result is very different from all other fat 
depots studied, irrespective of species or source from cell lines or primaries. 
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Therefore, it may be possible that the very low level of adipogenesis induced masked 
any increase in GHR expression. 
 
Figure 5.29: Amplification curve of hGHR 
QPCR amplification curve of GHR shows human breast fat cells in differentiation medium at 
day 0, 15 and 19. GHR expression did not increase with the primary breast fat cells during 
differentiation. NTC no template contol. 
 
 
 
 
Figure 5.30: hGHR expression during human breast fat differentiation 
QPCR analysis of GHR expression during human breast fat adipocytes differentiation shows 
no increase with cellular differentiation compared to control cultures at day 0. 
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Table 5.15: hGHR Q PCR assays 
Ct values for the GHR assays during breast fat adipogenic differentiation at days 0, 15 and 19 
shows that differentiation no significant increase with of GHR with increase Ct value at day 
19. 
 Ct value 
 0 days 15 days 19 days 
APRT 24.39 23.78 24.04 
hGHR 30.93 30.32 29.43 
 
5.3.3.6 GH stimulated ERK and STAT5 activation during breast fat cells  
Human breast fat pre-adipocytes were treated with GH and PMA (10 minutes) at 
various time points following addition of differentiation medium. GH-induced ERK and 
STAT5 activation was analysed by phosph-specific western blotting (section 3.3.2). 
Results show no difference between the levels of activation ERK in cells treated with 
GH or without treatment at day 0, 15 and after 19 days (Figure 5.31). Analysis of the 
data from multiple experiments showed no change of GH-induced ERK activation at 
day 15 (135  17.00 of % day 0, n=3 compared with % day 0, p= 0.26), 19 (161.78  
17.13 of % day 0, n=3 compared with % day 0, p= 0.15) and that total ERK was 
unchanged. In contrast, GH-stimulated STAT5 phosphorylation was increased with 
significantly higher change being observed in differentiated cells at day 19 (7189829 
 2395456 of day 0, *p<0.05, vs. day 0, n=3) (Figure 5.32). 
  
GH-stimulated ERK activation during adipogenesis behaved differently, depending 
on the fat depots (Figures 3.5, 5.10 and 5.20). In primary human orbital pre-
adipocytes and breast fat cells there is no activation at all in GH-stimulated ERK 
activation during adipogenesis. In contrast, mouse primary pre-adipocyte cells show 
GH–stimulated ERK activation which increased, whilst 3T3-L1 cell-line GH-stimulated 
ERK activation declined throughout adipogenesis.  
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Figure 5.31: Phosphorylation of ERK and STAT5 in breast fat cells  
A representative western blot shows phosphorylation of ERK and STAT5 following GH 
stimulation at day 0, 15 and 19 of the breast fat cells in adipocyte differentiation medium. The 
level of GH-stimulated ERK phosphorylation in differentiation medium appears with no 
changes. The phosphorylation and total ERK blot have two bands where the upper is p44 and 
the lower is p42. In contrast the level of total and GH stimulated STAT5 phosphorylation 
increased with breast fat adipocytes differentiation. PMA shown levels of ERK activation were 
the same between the bands in differentiated cells. 
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Figure 5.32: Densitometric analysis of ERK and STAT5 
Densitometric analysis of the western blots shown in Figure 5.30 the results are expressed as 
% day 0 for P-ERK, total ERK and total STAT5. P-STAT5 undetectable at day 0, but easily 
detectable at days 15 and 19, however, the result is expressed as IDV absolute values, mean 
± SE, n=3. The results demonstrated increased total STAT5 and GH-stimulated STAT5 
activation following differentiation, despite unchanged in ERK activation and total ERK, * 
p<0.05, **p<0.01 vs. control cultures at day 0, n=3 separate experiments. 
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5.5. Discussion 
As discussed in Chapter 3 and 4 studies using the 3T3-L1 cell line showed that GH-
stimulated ERK activation decreased as differentiation progressed. In this chapter I 
have investigated whether adipogenesis in primary pre-adipocytes from different 
species and fat depots results in the alterations to GH-induced signalling 
characterized in the 3T3L1 pre-adipocyte cell line (section 3.3.2). 
 
The results indicate both similarities and differences. Firstly, in all fat depots in which 
adipogenesis can be induced in vitro, transcript expression levels of the GHR 
increased as differentiation progresses. The increase is about 10-fold compared with 
undifferentiated cells in primary pre-adipocytes and the cell line. This level of 
increase illustrates the short-comings in my attempts to mimic the increase in GHR 
by transfecting with an expression plasmid (section 4.3.4) and will be discussed 
further in chapter 6. 
 
Secondly, GH-induced activation of P-ERK, and its reduction during adipogenesis, 
appears to be unique to the 3T3-L1 cell line. In all primaries studied, there was 
minimal GH-induced phosphorylation of ERK at all time points before and during 
differentiation and no depot, either murine or human, demonstrated a reduction in P-
ERK when comparing pre-adipocytes with in vitro differentiated adipocytes. 
 
Thirdly, in all pre-adipocytes studied, whether cell line or primary, GH-induced STAT5 
activation is increased as adipogenic differentiation proceeds. Similar results were 
obtained using two different adipogenic cocktails (differentiation medium) supporting 
the conclusion that differentiation per se is responsible, rather than one of the 
components of the adipogenic medium. The only caveat is the similar pattern of 
reactivity obtained using human breast preadipocytes, despite very poor induction of 
adipogenesis. Possible methods to explore this will be discussed in chapter 6. 
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In contrast, the orbit is a very active depot and several of the samples were from 
people with Graves’ Orbitopathy, a condition in which adipogenesis contributes to the 
tissue remodelling causing the disease. Although the depot is not typical, I was 
provided with sufficient cells to investigate whether the lack of ERK phosphorylation 
in primaries could affect mitotic clonal expansion (MCE). MCE is known to take place 
in the first few days after addition of adipogenic medium to confluent 3T3-L1 cells. 
There is some controversy as to whether MCE is necessary for differentiation to 
occur but if some pre-adipocyte populations undergo adipogenesis without an initial 
MCE it would suggest that it is not essential. I measured proliferation in 3T3-L1 and 
human orbital pre-adipocytes after addition of adipogenic medium to confluent cells 
and the two populations behaved very differently. The cell line demonstrated MCE 
but orbital primaries did not. This result indicates that MCE is not a requirement for 
adipogenic differentiation, at least in human orbital pre-adipocytes. The lack of GH-
induced ERK activation by phosphorylation in all primary pre-adipocyte cells leads 
me to suggest that this is an explanation for the absence of MCE in primaries and 
that it may be the stimulus driving MCE seen in 3T3-L1. 
 
The results obtained with fat from some special mouse strains in which adipogenesis 
was induced very rapidly and as efficiently as in 3T3-L1 suggests that the main 
difference between primaries and the cell line is that the majority of 3T3-L1 have 
committed to the adipogenic lineage, but in the mixed populations of primaries we 
use, only a small proportion are true pre-adipocytes (Pref1 positive). It seems that the 
genetic modification altering levels of insulin expression in the mice has increased 
the numbers of cells committing to being preadipocytes. 
 
 
 
 
 
 
 
  
Chapter Six
General Discussion
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6. Chapter Six 
6.1 Discussion 
The 3T3-L1 fibroblast cell line can differentiate into mature adipocytes under appropriate 
conditions and is a very well characterized in vitro model system for the study of adipocyte 
differentiation. During adipogenesis, GH progressively loses the ability to activate p42/44 
ERK despite elevated GHR and unaltered total ERK levels. In contrast, GH-stimulated 
STAT5 activation increases as 3T3-L1 differentiation proceeds. As the role of ERK during 
differentiation is complex an initial framework for this study was based upon research by 
Lewis et al., 2004 who argued that adipocyte differentiation controls the GHR to allow 
activation of the ERK pathway. An inverse relationship between the decline in GH-induced 
ERK activation and GH-induced STAT5 activation/PMA-induced ERK activation and an 
apparent uncoupling of GHR from the ERK pathway in adipocyte differentiated 3T3-L1 cells 
was observed. This study confirmed previous research by Lewis et al., 2004 that GH-
induced STAT5 activation increased during differentiation of BMSCs into adipocytes. 
However, Lewis et al. study also demonstrated that GH-induced ERK activation increased in 
differentiated adipocyte cells. Conversely, this discrepancy with my finding in 3T3-L1 cells 
may be due to the presence of cells other than those which differentiated along the 
adipocyte lineage. 
 
In order to explain why GH-stimulated ERK activation declined as 3T3-L1 cells underwent 
adipogenic differentiation this study drew upon the paper by Love et al., (1998) who 
suggested that the ERK pathway adapter protein p66Shc was necessary to couple the GHR 
to the ERK pathway. To test whether p66Shc levels declined in 3T3-L1 cells as they 
underwent adipocyte differentiation levels of Shc were measured using western blotting. 
Interestingly, p66Shc levels did not decline, but were similar in cells at day 0 and day 8. 
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Therefore, as a reduction in p66Shc cannot explain why GH-stimulated ERK activation 
declined this explanation could be eliminated. 
 
Nonetheless, as expression of GHR was observed to increase (section 3.4.5) this study 
tested whether altered levels of GHR expression could modulate signalling pathways 
coupled to the GHR. To mimic the increase in GHR transcripts which take place during 
adipogenesis, varying levels of the receptor was introduced using an expression plasmid. 
Transfection efficiency was monitored using a control GFP plasmid, while GH stimulated 
pERK and pSTAT5 were analysed using western blotting and densitomertic analysis. With 
this hypothesis it was expected to observe GH-induced pERK signal reduce as the amount 
of receptor introduced into the cells as confirmed by QPCR GHR gene expression 
increased. However, the data suggests that there is no relationship between the over 
expression of GHR in 3T3-L1 cells and the decline in ERK activation. Instead, the level of 
ERK activation was the same in empty vector and GHR 3T3-L1 transfected cells, while GH-
induced STAT5 activation increased in 3T3-L1 cells transfected with the hGHR vector 
compared to the empty vector. Transfection of the cells with the GHR expression vector 
increased GHR transcript to much higher levels than occurs during adipogenesis as 
determined by QPCR analysis. Therefore, the conclusion reached using the 3T3-L1 cell line 
is that during adipogenesis, the decrease GH stimulated ERK activation is not related to the 
increase in GHR expression seen in differentiated cells. Howeve, the finding that high 
expression levels of GHR increased during 3T3-L1 differentiation into adipocytes supports 
the argument that GH acts on adipose tissue through GHR and modulates cellular function. 
 
Results from this study are in general agreement with other studies that show the level of 
GHR expression increases during adipocyte differentiation (Zou et al., 1997; Ji et al., 2002). 
GH binds to its receptor results in activation of STAT5 pathway in many cell types including 
adipocytes (Story and Stephens, 2006). Fleenor et al., (2006) demonstrated that mouse GH 
stimulated increases in STAT5 activity in undifferentiated and differentiating 3T3-L1 cells. 
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Additionally, GH activates ERK pathway in BMSCs and adipocytes (Winston and Bertics, 
1992; Bost, et al., 2005; Lewis et al., 2006; Wang et al., 2009). The expression of STAT5 
proteins correlates well with lipid accumulation and the expression of PPAR and C/EBPα. 
MKP-1 inactivates ERK1 and ERK2. Therefore, up regulation of MKP-1 in adipocytes 
differentiation could be an alternate mechanism to explain the observed reduction of ERK 
activation in adipocytes, future studies are planned to investigate this possibility. 
 
A further investigation was undertaken to test whether adipogenesis in primary pre-
adipocytes from different species and fat depots results in the alterations to GH-induced 
signalling characterized in the 3T3-L1 pre-adipocyte cell line. In all fat depots in which 
adipogenesis can be induced in vitro, transcript expression of the GHR increase as 
differentiation progresses. However, in all primaries studied, there was minimal GH-induced 
phosphorylation of ERK at all time points before and during differentiation and no depot, 
either murine or human, demonstrated a reduction in P-ERK when comparing pre-
adipocytes with in vitro differentiated adipocytes. As such it would appear that the reduction 
seen in GH-stimulated ERK phosphorylation during adipogenesis in 3T3-L1 cells may be 
unique to this type of experimental model and may not reflect what occurs in vivo.  
 
In all pre-adipocytes studied, whether cell line or primary, GH-induced STAT5 activation is 
increased as adipogenic differentiation proceeds. The GHR increase with adipogenesis 
might explain this increase in STAT5, since similar results were obtained by transfecting with 
the GHR plasmid (section 4.3.4). Although the results add to current knowledge, they also 
lead to further questions and ideas. The studies included in this thesis are based on 
expression using QPCR and western blotting. These are powerful, reliable and reproducible 
methods that could be used in related future research. The coupling of the GHR to the ERK 
pathway requires that the GHR is localized in the caveolae–lipid raft membrane fraction. 
Subcellular fractionation of pre-adipocytes shows a high level of GHR in the caveolae 
membrane fraction (CM) along with components of the ERK pathway (Yang et al., 2004; 
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Lanning and Carter-Su, 2006). In differentiated 3T3-L1 cells, the level of GH activation of 
ERK declined, therefore the possibility may exist that differentiation caused the GHR to 
move out of the CM thereby explaining the decrease in GH-stimulated ERK signalling in 
differentiated 3T3-L1 cells. Further research will be required involving the separation of the 
plasma membrane and CM fraction using differential detergent solubility and 
ultracentrifugation to confirm this possibility. 
 
Similar results were obtained using two different adipogenic cocktails supporting the 
conclusion that differentiation is responsible for the observed affects rather than one of the 
components of the adipogenic medium. However, human breast pre-adipocyte cultures also 
showed increased GHR expression and GH-induced STAT5 activation following incubation 
in differentiation medium despite few cells showing lipid droplet accumulation. This leads to 
the question of whether in these cultures adipogenic differentiation actually caused the 
observed affects. One approach to determine whether differentiation is responsible would be 
to incubate parallel cultures in ‘normal’ complete medium and differentiation medium to see 
whether ‘complete medium’ cultures exhibit the same changes as those seen in cultures 
incubated in differentiation medium. This highlights one of the main problems in using 
primary cultures i.e. heterogeneity, meaning it is not always possible to be sure in a mixed 
culture which cell type is responsible for the observed effect. One approach that could 
improve the protocol would be to increase the proportion of pre-adipocytes at the start of the 
experiment using fluorescence-activated cell sorting (FACS) or magnetic beads to enrich 
cells positive for the pre-adipocyte marker Pref 1. 
 
Despite the above observed difference between primary cultures, the 3T3-L1 cell line as an 
adipocyte model will continue. Although, it is not clear how close or how far 3T3-L1 
adipocytes are from a perfect adipocytes model, some characteristics, at least the key ones, 
such as fat accumulation, PPAR expression and GH signalling pathways are reflected well 
in 3T3-L1 cells. The advantage of using a cloned cell line is also of importance with regard to 
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convenience reproducibility and cell homogeneity. To highlight the importance of human 
validation, in this thesis we showed the widely observed ability of GH to stimulate ERK in 
3T3-L1 cells however little to no GH-induced ERK activation was observed in primary 
cultures. Additionally, MCE was observed in 3T3-L1 cells, but not in primary cultures. This 
question is the relevance of the 3T3-L1 cell line as a model of human adipogenic 
differentiation. 
 
Another important question which remains to be clarified is whether altered GHR expression 
is a cause or a consequence of adipogenesis. In order to clarify these issues, experiments 
could be performed using siRNA to inhibit GHR expression in differentiating cells to 
determine whether GHR expression is necessary for this process. 
 
Ex vivo analyses of whole adipose tissue could also be performed. Since fat is comprised of 
different cell type (e.g. fibrobast-like pre-adipocytes, mature adipocytes, macrophages), it 
would be important to study these cells independently in order to account for any changes in 
adipose tissue composition between different donors (e.g. increased macrophage infiltration, 
altered adipogenesis and increased apoptosis of certain cell types). This may be of most 
relevance for future studies of GHR expression and function. 
 
In summary, this study observed that GH-induced STAT5 activation increased as all pre-
adipocytes from various fat depots underwent adipocyte differentiation. However, GH–
stimulated ERK activation during adipogenesis behaved differently depending on the type of 
cells. The selection and use of an in vitro system must consider multiple levels of regulation 
of proliferation, differentiation and function to ensure relevant results. Further research is 
necessary to gain insight in the molecular processes that are involved in adipocyte 
differentiation. 
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Appendix 1 
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30% acrylamide stock solution 
Acrylamide 29g  
bisacrylamide 1g  
 
Adjusted to final volume of 100ml and stored in the dark at 4˚C. 
Loading buffer 
10% SDS                                 2ml  
Glycerol  1ml  
0.5M Tris (pH6.8)                   1ml 
Distilled water                            800μl  
2% Pyronin Y                          100μl  
β-mercaptoethanol                  (20μl/ml) 
*PMSF                                    (100mM, 10μl/ml)  
*Sodium orthovanadate          (100mM, 10μl/ml)  
 
This stock solution was then stored at 4˚C. 
* added immediately prior to use. 
Running buffer  
Tris  15g 
Glycine 2g 
SDS                    5g  
 
Make up to 1 litre distilled water. 
Blotting buffer  
0.025M Tris                  3.025g 
0.182M glycine            13.66g  
Methanol 200 ml 
Distilled water                            800ml 
Cool to -20˚C for 1 hour prior to use.  
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Sodium orthovanadate 
Sodium orthovanadate             9.5g 
Distilled water                     ~400 ml  
 
Adjusted to pH 10.2 with hydrochloric acid. 
Heat just the pH to 10.2 with 1M NaOH. 
pH between 9.9 and 10.1.  
Chymostatin, Leupeptin, Antipain, Pepstatin (CLAP) 
1000X protease inhibitor (CLAP) 5mg 
DMSO 500μl  
 
5μl were stored at -20˚C. 
TBS (x10) 
Tris 24.2g 
Sodium chloride 80g 
 
Adjusted to pH 7.6 with hydrochloric acid. 
Make up to 1 litre with distilled water. 
TBS – T 
TBS (10x) 100ml  
Distilled water 900ml 
Tween 20            1ml 
Blocking buffer  
Non-fat milk powder 5g 
TBS – 1x 100ml 
Stripping buffer 
Tris (0.5M, pH 6.8)                     6.25ml      
10% SDS                                   10ml 
β-mercaptoethanol                     0.35ml  
Distilled water                            3.5ml  
Phosphate buffered saline (PBS) 
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NaCl 16g 
Na2HPO4 2.9g 
KH2PO4   0.5g 
KCL 0.4g 
Distilled water                            2L 
 
Adjusted to pH 7.2 using 10M sodium hydroxide. 
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Molecular biology reagent 
Luria agar (ampicillin- 10µg/ml) 
Luria agar 7.4g 
Distilled water     200ml 
 
Autoclave and leave to cool to approximately 50ºC, then add 200µl ampicillin (100mg/ml). 
Mix thoroughly, pour out into sterile plates (approximately 10) and allow to set. Store at 4ºC 
until required.  
Luria agar 
LB medium  1.8g 
Distilled water     490ml 
 
Autoclaved, cooled and stored at 4ºC. 
Glycerol stock (40%) 
Glycerol 4ml 
Distilled water     6ml 
TEA buffer x1    
Tris base 40Mm pH 7.6 
EDTA     1ml 
Glacial acetic acid  20mM 
1% agarose gel 
Agarose  1g 
TEA buffer     50ml 
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66 kDa form of Shc levels 
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66 kDa form of Shc levels 
Data from Figure 4.3 66 kDa form of Shc levels were reanalysed and plotted on a scatter 
plot. There was no difference between groups or with respect to Day 0, p=0.337. Thus 
confirming that p66Shc level did not decline as 3T3-L1 cells underwent adipogenic 
differentiation. 
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